data_2rqc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.216 0.531 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt . . . . . 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt . . . . . 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.362 0.601 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.51 0.672 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.386 0.612 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.517 0.675 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.527 0.68 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.521 0.677 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.229 0.538 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.434 0.635 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.509 0.671 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.166 0.508 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.4 0.619 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 98.6 p -165.05 174.15 10.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.251 1.421 . . . . 0.0 111.911 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.3 m -75.87 1.36 15.29 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.68 -34.42 1.85 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.895 1.712 . . . . 0.0 114.958 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.2 t -160.84 145.71 14.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.528 1.531 . . . . 0.0 111.462 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 69.1 m -79.54 -9.07 59.55 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -93.1 -1.14 67.37 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.281 1.42 . . . . 0.0 114.227 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 30.7 tp -77.91 146.45 35.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.855 1.262 . . . . 0.0 111.821 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.3 p -82.78 15.43 2.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.938 2.095 . . . . 0.0 113.531 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -147.78 175.38 10.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.893 2.477 . . . . 0.0 108.993 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.56 172.63 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.648 0.779 . . . . 0.0 112.683 -173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 70.4 m -57.93 142.51 46.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.589 1.156 . . . . 0.0 112.2 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.4 67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.189 0.996 . . . . 0.0 109.925 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -102.74 6.15 51.78 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 125.145 1.355 . . . . 0.0 114.202 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -119.57 -17.12 8.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.124 1.369 . . . . 0.0 114.526 -169.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm -104.5 134.36 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.21 119.9 12.29 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.306 1.042 . . . . 0.0 111.049 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.63 -10.93 30.09 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -93.19 -29.47 15.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 112.869 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.5 p -133.0 -10.89 2.98 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.85 24.8 12.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.231 1.812 . . . . 0.0 113.715 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.5 mt -101.28 148.25 25.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 111.122 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t -71.15 143.16 50.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -72.47 150.09 43.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -74.41 145.42 43.72 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.446 1.498 . . . . 0.0 111.29 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.7 p -168.87 154.45 6.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.241 1.816 . . . . 0.0 110.875 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -67.61 131.17 45.11 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.846 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -157.11 31.36 0.29 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.444 1.498 . . . . 0.0 111.32 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -163.15 170.58 17.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.983 1.713 . . . . 0.0 112.343 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -145.86 164.95 30.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.683 1.593 . . . . 0.0 111.756 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -144.76 156.99 44.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.89 1.676 . . . . 0.0 111.842 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.5 m -64.94 146.49 54.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.525 1.13 . . . . 0.0 112.967 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.07 -74.15 0.95 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.652 1.12 . . . . 0.0 112.715 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 138.99 26.41 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.509 2.806 . . . . 0.0 111.065 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 61.5 p -103.68 -2.73 26.07 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.948 1.299 . . . . 0.0 113.729 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 64.4 p -117.76 -0.57 11.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.633 1.573 . . . . 0.0 114.406 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.075 1.321 . . . . 0.0 113.114 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 0 C5'-C4'-C3' 112.455 -2.03 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.313 1 O4'-C1'-N19 114.577 6.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 O5'-C5'-C4' 113.467 2.334 . 0.441 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.466 0 C5'-C4'-O4' 113.327 2.948 . 0.232 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.026 1 O4'-C1'-N19 114.206 6.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 O4'-C1'-N19 111.53 3.33 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 48.2 p -89.83 -8.13 52.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.0 t -163.78 154.52 15.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.582 1.553 . . . . 0.0 111.555 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.38 2.67 85.15 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.114 1.34 . . . . 0.0 113.846 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 69.2 m -138.7 163.82 31.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.6 t -158.29 170.68 21.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.981 1.313 . . . . 0.0 111.631 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 88.06 -179.12 46.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.332 1.444 . . . . 0.0 113.14 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 40.3 tp -157.94 143.23 16.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.909 1.284 . . . . 0.0 111.08 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -116.87 8.63 13.61 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.377 1.871 . . . . 0.0 113.708 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -143.59 168.76 19.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.016 1.727 . . . . 0.0 110.816 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -67.62 -7.72 28.73 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.345 1.458 . . . . 0.0 114.665 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.0 p -165.99 165.1 18.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.514 1.926 . . . . 0.0 110.27 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.7 mt -81.24 74.05 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.182 -0.949 . . . . 0.0 109.294 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 74.43 13.41 81.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.013 1.292 . . . . 0.0 114.925 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.66 -27.74 0.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 128.624 2.77 . . . . 0.0 116.519 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm -111.79 122.59 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 124.72 23.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.107 0.563 . . . . 0.0 110.945 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -80.2 4.41 17.6 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -96.69 -29.6 13.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.686 1.195 . . . . 0.0 111.569 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.8 p -126.74 -13.93 5.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.313 1.845 . . . . 0.0 114.016 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.4 t30 67.03 22.72 9.92 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.133 2.173 . . . . 0.0 113.51 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.17 144.67 26.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.051 1.341 . . . . 0.0 112.219 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t -71.62 139.1 49.17 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -77.0 166.57 23.14 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -81.92 164.05 21.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.529 1.932 . . . . 0.0 112.74 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.7 m -81.61 135.59 35.55 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.376 1.071 . . . . 0.0 109.863 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -83.37 37.63 0.57 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -151.53 167.31 28.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.463 1.505 . . . . 0.0 112.651 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.35 14.77 16.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.331 1.852 . . . . 0.0 113.45 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.1 m -67.03 115.84 7.19 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.285 1.034 . . . . 0.0 112.377 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.24 -22.48 44.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 5.1 t 63.21 -160.85 0.3 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.604 1.562 . . . . 0.0 112.381 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 98.7 -159.45 20.31 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 125.493 1.521 . . . . 0.0 113.47 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -56.25 145.18 78.67 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.589 3.526 . . . . 0.0 113.645 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 77.4 p -148.4 13.42 0.96 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.4 m 68.9 6.09 5.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.539 1.936 . . . . 0.0 115.373 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.167 1.365 . . . . 0.0 113.271 177.701 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.25 0 C5'-C4'-C3' 112.108 -2.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 1 O4'-C1'-N19 114.048 5.848 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.346 0 C4'-C3'-C2' 100.471 -2.229 . 0.455 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 C5'-C4'-O4' 113.127 2.805 . 0.349 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.227 1 O4'-C1'-N19 113.951 5.751 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.048 0 O4'-C1'-N19 111.243 3.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 79.9 p -163.0 172.71 14.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.352 1.061 . . . . 0.0 112.416 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -46.59 132.41 10.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.179 1.792 . . . . 0.0 114.179 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.01 -8.46 76.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.51 1.052 . . . . 0.0 113.942 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.0 p -141.28 -49.8 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.581 1.19 . . . . 0.0 112.177 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.8 m 60.27 11.42 2.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.348 1.859 . . . . 0.0 115.111 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.92 -159.62 28.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.325 1.917 . . . . 0.0 112.201 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.4 mt -104.8 -6.79 19.96 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.2 p -148.92 151.06 33.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.358 1.863 . . . . 0.0 111.13 -174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 72.78 148.24 0.09 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.257 2.623 . . . . 0.0 113.169 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -89.23 134.75 33.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.972 0.909 . . . . 0.0 110.341 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 61.3 m -124.21 147.79 47.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.077 1.351 . . . . 0.0 110.377 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mm -84.79 61.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 122.611 1.196 . . . . 0.0 111.482 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -116.18 19.54 13.31 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.635 2.064 . . . . 0.0 112.095 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.3 -17.0 25.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.579 1.951 . . . . 0.0 114.536 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt -138.75 142.18 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 125.91 26.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.843 0.857 . . . . 0.0 111.989 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -75.47 -3.01 31.5 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -115.86 -25.85 7.59 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.609 1.164 . . . . 0.0 113.24 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.4 p -123.05 -8.5 8.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.362 1.465 . . . . 0.0 114.05 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 65.63 18.4 11.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.355 1.862 . . . . 0.0 113.692 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.29 126.33 31.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.581 1.152 . . . . 0.0 110.878 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t -69.42 137.38 52.67 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.752 -0.592 . . . . 0.0 111.421 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -57.86 150.82 19.31 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -40.84 125.47 2.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.732 1.613 . . . . 0.0 114.26 -172.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.8 t -165.96 12.59 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.881 1.272 . . . . 0.0 113.339 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.68 156.41 45.04 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.417 1.487 . . . . 0.0 112.251 -170.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.6 159.07 35.04 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.685 0.794 . . . . 0.0 112.398 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.58 157.35 39.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.57 1.948 . . . . 0.0 109.749 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.3 m -56.31 -24.46 43.58 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -63.29 -23.96 67.65 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.607 1.163 . . . . 0.0 113.105 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 34.1 m -102.5 4.69 38.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.386 1.874 . . . . 0.0 112.829 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 100.57 144.09 15.18 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.111 1.815 . . . . 0.0 113.05 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.31 146.82 87.88 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.865 3.044 . . . . 0.0 112.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 36.0 p -79.16 -3.29 44.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.446 1.098 . . . . 0.0 113.758 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 47.2 p -87.84 -5.78 58.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 114.463 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 124.996 1.284 . . . . 0.0 113.275 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.31 0 C4'-C3'-C2' 100.305 -2.395 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.327 1 O4'-C1'-N19 112.412 4.212 . 0.052 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.96 3.76 . 0.236 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.368 0 C3'-C2'-C1' 104.922 3.803 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 1 O4'-C1'-N19 114.424 6.224 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.426 0 O4'-C1'-N19 111.176 2.976 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.9 m -68.26 -14.32 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -77.72 1.2 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.931 1.292 . . . . 0.0 113.869 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 65.55 26.5 71.93 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.43 1.014 . . . . 0.0 114.043 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.2 t 62.45 20.99 12.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.284 1.434 . . . . 0.0 112.496 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.1 m 69.49 11.07 7.94 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.024 2.129 . . . . 0.0 113.563 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -84.05 5.22 80.63 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.661 1.601 . . . . 0.0 114.666 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.6 158.51 36.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.309 1.444 . . . . 0.0 111.794 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 t -156.86 177.91 10.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.408 1.483 . . . . 0.0 111.811 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.89 3.56 22.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.98 1.712 . . . . 0.0 113.977 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -148.39 149.39 31.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 111.406 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 83.0 p -128.81 176.79 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.27 1.428 . . . . 0.0 111.585 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 51.5 mt -73.66 -10.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.498 1.119 . . . . 0.0 111.985 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.56 59.16 1.24 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 127.545 2.498 . . . . 0.0 113.502 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.64 -29.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.736 2.814 . . . . 0.0 112.263 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.99 118.33 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -64.8 112.36 3.22 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.131 0.972 . . . . 0.0 110.635 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.43 -5.84 21.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.56 -21.99 22.6 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.175 0.99 . . . . 0.0 112.763 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.6 p -132.68 -13.63 2.9 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.7 t30 67.58 21.3 9.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.403 2.281 . . . . 0.0 113.904 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -101.78 152.0 21.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.375 1.47 . . . . 0.0 111.121 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t -71.77 140.74 49.61 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.304 -0.873 . . . . 0.0 111.211 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -64.9 139.83 58.8 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.68 165.73 16.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.665 0.786 . . . . 0.0 112.205 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.5 p -157.33 161.91 39.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.956 1.302 . . . . 0.0 111.959 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -159.89 146.24 15.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.814 1.245 . . . . 0.0 111.744 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.99 156.25 37.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -159.9 -42.04 0.05 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.582 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 8.6 t -165.15 161.3 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.28 1.432 . . . . 0.0 111.319 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -69.61 153.71 43.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.401 1.08 . . . . 0.0 113.556 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 39.5 p -82.94 -12.38 57.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.69 1.196 . . . . 0.0 113.938 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.98 -163.34 37.79 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.5 1.524 . . . . 0.0 113.376 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.37 165.14 33.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.732 2.955 . . . . 0.0 111.62 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.7 m -73.15 24.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.248 1.819 . . . . 0.0 114.567 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.3 t -158.14 -178.81 7.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.541 1.936 . . . . 0.0 111.007 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.441 1.496 . . . . 0.0 112.754 -178.671 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.353 0 C3'-C2'-C1' 99.601 -2.11 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.208 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O5'-C5'-C4' 113.368 2.263 . 0.506 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 C5'-C4'-O4' 113.459 3.042 . 0.41 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.247 1 O4'-C1'-N19 112.877 4.677 . 0.023 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 O4'-C1'-N19 110.741 2.541 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 83.4 p -164.08 167.29 20.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.281 1.433 . . . . 0.0 111.774 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -162.82 165.77 24.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.583 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.84 -87.18 1.16 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 124.313 0.959 . . . . 0.0 111.618 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.4 m -67.41 -14.73 63.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.723 1.209 . . . . 0.0 113.889 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.7 p -91.46 -4.59 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.429 1.492 . . . . 0.0 113.701 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.98 60.17 4.21 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.894 1.712 . . . . 0.0 112.717 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.92 14.52 0.47 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.013 1.725 . . . . 0.0 114.059 -171.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.3 p -59.78 -43.68 94.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.864 1.665 . . . . 0.0 113.64 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.19 -14.96 3.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.967 1.307 . . . . 0.0 112.98 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -176.14 173.51 2.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.345 2.658 . . . . 0.0 109.927 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.4 p -85.19 170.14 13.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.333 1.053 . . . . 0.0 112.109 168.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.22 133.6 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.382 . . . . 0.0 109.561 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 132.52 69.13 0.09 OUTLIER Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.564 1.554 . . . . 0.0 111.01 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -150.97 12.29 0.67 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.931 1.292 . . . . 0.0 114.054 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.18 141.38 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.65 121.99 15.8 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.954 0.902 . . . . 0.0 111.091 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -72.24 -1.81 16.58 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -114.69 -36.55 4.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.931 1.293 . . . . 0.0 112.575 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 45.2 p -105.41 -13.36 15.67 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.3 t30 65.32 16.65 10.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.534 1.934 . . . . 0.0 113.769 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.46 140.51 29.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t -70.18 137.87 51.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -64.51 158.18 24.76 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -74.67 37.5 0.11 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -168.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.8 m -77.71 -10.86 59.76 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.707 -1.246 . . . . 0.0 113.99 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 166.68 20.38 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.693 1.197 . . . . 0.0 114.223 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.65 156.98 40.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.89 1.676 . . . . 0.0 112.519 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.44 -38.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.467 1.107 . . . . 0.0 113.907 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 61.0 p -77.96 -20.34 52.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -135.05 -11.7 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 113.801 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 22.6 t -175.59 160.88 2.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.421 2.688 . . . . 0.0 108.382 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 137.62 -159.46 24.91 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.626 1.108 . . . . 0.0 113.556 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.14 163.71 34.5 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.992 3.128 . . . . 0.0 112.225 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 72.1 m -144.0 150.49 38.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.47 1.508 . . . . 0.0 111.315 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.2 m -77.15 -5.61 49.76 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.65 1.595 . . . . 0.0 113.072 -178.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.241 0 O4'-C1'-N19 111.041 2.841 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.356 1 O4'-C1'-N19 112.738 4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.416 0 O5'-C5'-C4' 113.229 2.164 . 0.478 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-O4' 113.238 2.884 . 0.339 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.932 3 C3'-C2'-C1' 106.044 5.049 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.617 2.419 0 O4'-C1'-N19 111.771 3.571 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 64.2 m -145.89 146.49 31.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.871 1.269 . . . . 0.0 111.519 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.9 p -165.92 156.25 12.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.347 1.459 . . . . 0.0 111.565 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.25 -166.83 28.92 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.669 1.128 . . . . 0.0 112.749 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.5 p -77.72 -3.91 43.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.652 1.181 . . . . 0.0 113.585 173.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 22.9 t -164.51 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.461 1.904 . . . . 0.0 111.798 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.12 26.98 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.456 1.027 . . . . 0.0 113.031 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.72 166.99 24.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.04 2.136 . . . . 0.0 110.631 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.2 m -76.17 81.13 2.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.413 1.485 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -166.45 163.61 17.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 0.0 110.803 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.51 162.04 38.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.043 1.337 . . . . 0.0 109.925 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.7 t -150.23 -165.46 2.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.594 1.557 . . . . 0.0 110.36 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 44.4 mm -77.38 145.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.56 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 124.42 0.16 8.69 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.183 1.373 . . . . 0.0 116.132 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.4 -15.08 60.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.996 1.319 . . . . 0.0 113.701 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.92 132.69 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.5 124.83 24.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.431 0.693 . . . . 0.0 111.318 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -62.64 -12.28 22.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -96.77 -28.31 14.33 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 113.027 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -131.82 -12.54 3.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 62.68 19.72 11.56 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.879 1.672 . . . . 0.0 113.976 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.84 139.85 32.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.399 1.08 . . . . 0.0 110.576 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t -76.07 138.75 41.02 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.737 -0.602 . . . . 0.0 111.251 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.8 146.06 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -69.88 141.77 53.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.036 1.334 . . . . 0.0 112.005 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.3 t -101.81 143.01 32.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.001 1.321 . . . . 0.0 109.395 168.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -142.19 143.71 33.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.334 1.054 . . . . 0.0 112.392 -169.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -155.34 165.3 37.05 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.165 1.786 . . . . 0.0 111.377 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.29 136.15 14.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.108 1.363 . . . . 0.0 110.935 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 28.7 t -173.0 154.15 2.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.676 1.59 . . . . 0.0 110.949 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.1 -30.12 61.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.449 1.099 . . . . 0.0 112.238 168.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.0 m -113.75 6.81 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.053 1.341 . . . . 0.0 113.507 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 79.71 -157.21 41.57 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.607 1.099 . . . . 0.0 113.868 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.45 148.53 42.45 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.699 3.599 . . . . 0.0 113.627 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.3 m -59.74 132.72 54.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.99 1.316 . . . . 0.0 113.816 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 46.0 p -86.57 -6.2 58.94 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 C-N-CA 125.671 1.605 . . . . 0.0 112.929 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.477 3.277 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.164 2 C5'-C4'-C3' 108.915 -4.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 C5'-C4'-C3' 112.522 -1.985 . 0.514 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.342 0 C5'-C4'-O4' 113.621 3.158 . 0.147 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.013 1 O4'-C1'-N19 113.842 5.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 1 O4'-C1'-N19 114.297 6.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.079 -0.409 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 72.7 p -164.2 162.47 22.7 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.433 1.493 . . . . 0.0 111.739 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -163.71 164.66 23.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.291 1.436 . . . . 0.0 111.31 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.97 -166.36 46.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 0.0 113.809 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 m 69.9 -5.03 1.32 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.346 2.259 . . . . 0.0 115.353 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 m -169.55 153.86 5.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.5 2.32 . . . . 0.0 110.614 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -83.3 157.77 35.27 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.211 0.91 . . . . 0.0 112.404 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.9 tp -159.11 136.37 9.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.003 1.321 . . . . 0.0 110.81 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.5 p -63.67 131.09 46.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.103 1.361 . . . . 0.0 110.979 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -88.65 149.23 23.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.934 0.894 . . . . 0.0 110.432 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -152.52 130.71 11.96 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.984 0.914 . . . . 0.0 110.489 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.2 p -86.54 155.71 20.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.316 1.046 . . . . 0.0 112.965 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 85.4 mt -88.36 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.798 1.239 . . . . 0.0 110.703 -174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.73 15.31 27.16 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.912 1.244 . . . . 0.0 115.462 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.0 -7.53 59.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.44 128.6 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.86 122.08 16.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.825 0.85 . . . . 0.0 110.976 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -80.08 4.46 17.13 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -108.12 -23.75 11.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.438 1.095 . . . . 0.0 112.774 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.3 p -124.8 -12.48 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.44 1.496 . . . . 0.0 114.118 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.4 t30 66.38 17.69 10.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.899 2.08 . . . . 0.0 113.603 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.14 142.67 27.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.894 1.277 . . . . 0.0 111.712 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t -70.55 143.6 51.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.616 -0.678 . . . . 0.0 111.16 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 162.81 22.46 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -70.57 167.01 19.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.883 1.273 . . . . 0.0 113.685 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.2 t -137.4 135.69 37.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.869 1.268 . . . . 0.0 110.236 169.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.82 -21.28 29.92 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -161.36 146.26 13.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.847 1.259 . . . . 0.0 112.143 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.77 146.78 13.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.342 1.857 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 43.1 t -162.28 145.23 11.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.835 1.254 . . . . 0.0 111.737 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -82.03 -5.33 58.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.543 1.137 . . . . 0.0 112.716 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 25.6 p 71.32 8.88 6.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 128.19 2.596 . . . . 0.0 115.092 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.38 95.59 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-O 117.456 -1.747 . . . . 0.0 115.829 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.95 138.2 80.78 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.93 3.087 . . . . 0.0 112.96 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 69.2 m -75.73 -4.63 41.48 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 42.4 p -88.06 -4.74 58.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.868 1.667 . . . . 0.0 113.725 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 C-N-CA 125.627 1.584 . . . . 0.0 113.703 178.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 0 O4'-C1'-N19 110.494 2.294 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 O4'-C1'-N19 113.844 5.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.44 0 O5'-C5'-C4' 113.258 2.184 . 0.439 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.506 0 C5'-C4'-O4' 114.156 3.54 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C3'-C2'-C1' 104.91 3.789 . 0.01 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 1 O4'-C1'-N19 112.965 4.765 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.3 t -154.44 29.42 0.44 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.437 1.095 . . . . 0.0 112.346 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.7 m -75.99 -9.48 58.65 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.17 7.6 86.83 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 124.77 1.176 . . . . 0.0 115.017 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.3 p -70.11 -15.46 62.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 114.113 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 14.4 m -64.51 -18.01 64.42 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.802 -1.186 . . . . 0.0 113.855 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -102.96 0.72 48.03 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.376 1.465 . . . . 0.0 114.551 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 33.0 tp -65.33 -14.98 62.03 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.4 1.6 . . . . 0.0 114.71 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.6 p -91.92 0.54 57.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.022 2.129 . . . . 0.0 113.76 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -158.55 -164.78 1.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.343 1.457 . . . . 0.0 111.2 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -92.22 -7.79 47.24 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 58.9 p -170.25 -171.08 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.191 1.396 . . . . 0.0 111.883 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.6 mm -78.38 -5.78 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.642 -1.286 . . . . 0.0 112.179 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 133.67 17.69 1.05 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 125.778 1.656 . . . . 0.0 115.213 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.95 -42.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.512 3.525 . . . . 0.0 115.307 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -111.38 136.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.8 124.5 23.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 111.262 172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -75.38 3.72 8.59 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -126.44 -33.2 2.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.02 1.328 . . . . 0.0 113.137 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 43.5 p -102.26 -9.87 20.04 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.279 8.0 p30 60.96 9.73 2.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.725 2.41 . . . . 0.0 115.316 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.84 147.71 29.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.631 1.172 . . . . 0.0 111.837 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t -74.54 138.53 43.15 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.423 0.689 . . . . 0.0 110.259 168.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.36 146.63 50.74 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.0 124.56 20.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 110.758 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.4 m -93.93 -13.66 26.85 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -162.18 154.92 19.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.035 1.334 . . . . 0.0 113.444 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.47 -31.09 12.53 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.21 155.42 24.93 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.606 1.163 . . . . 0.0 113.348 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.1 p -165.67 156.32 13.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.548 1.539 . . . . 0.0 111.621 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -162.4 158.44 23.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.594 1.558 . . . . 0.0 112.416 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.2 m -80.76 116.4 20.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.787 0.835 . . . . 0.0 111.185 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -90.31 167.33 32.67 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.463 1.03 . . . . 0.0 113.515 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.5 159.34 46.46 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.032 3.155 . . . . 0.0 111.517 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 79.7 p -165.21 -47.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.383 1.073 . . . . 0.0 112.718 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.7 m 68.29 9.7 7.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.64 1.976 . . . . 0.0 114.619 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.563 1.554 . . . . 0.0 112.824 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.303 0 C5'-C4'-C3' 112.317 -2.122 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.307 1 O4'-C1'-N19 113.757 5.557 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 110.363 2.163 . 0.601 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-O4' 113.413 3.009 . 0.557 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 1 O4'-C1'-N19 112.674 4.474 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.956 2.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.7 t -163.65 174.96 11.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.445 1.498 . . . . 0.0 111.232 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.9 t -146.4 13.38 1.22 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.619 1.567 . . . . 0.0 112.649 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -80.03 1.67 78.75 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.834 1.207 . . . . 0.0 115.19 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 28.6 p -69.47 -9.97 56.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.563 1.545 . . . . 0.0 114.455 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 90.3 p -77.91 -13.31 59.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.556 1.143 . . . . 0.0 113.697 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 85.1 -8.17 71.79 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.3 1.428 . . . . 0.0 113.931 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 83.4 mt 58.08 -166.54 0.15 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.309 2.244 . . . . 0.0 113.428 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.0 p -142.49 163.54 32.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.33 2.252 . . . . 0.0 109.955 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -85.42 -8.92 58.15 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 387' ' ' SER . 1.8 tt0 -166.48 170.51 12.79 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.794 2.037 . . . . 0.0 110.222 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' SER . . . . . 0.414 ' H ' ' HG2' ' A' ' 386' ' ' GLN . 23.2 t -151.59 -177.16 5.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.314 1.846 . . . . 0.0 109.62 169.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.71 -11.97 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.939 1.296 . . . . 0.0 111.518 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.34 3.76 4.24 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 126.352 1.93 . . . . 0.0 115.758 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.68 -14.93 62.65 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.845 2.058 . . . . 0.0 113.402 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.28 125.31 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -66.65 126.42 28.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.229 1.012 . . . . 0.0 112.351 -172.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -59.3 -16.84 24.33 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -95.55 -28.95 14.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 0.0 113.107 -174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.4 p -132.77 -12.47 2.96 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 65.52 17.85 11.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.007 1.723 . . . . 0.0 113.435 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.6 mt -91.71 151.27 20.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.11 1.364 . . . . 0.0 111.191 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.8 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.455 -0.778 . . . . 0.0 111.514 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -66.32 141.88 57.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -81.06 152.95 27.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.219 1.007 . . . . 0.0 110.983 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 12.8 t -156.24 165.26 36.89 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.39 1.076 . . . . 0.0 112.484 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -55.73 -17.09 5.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.488 1.915 . . . . 0.0 115.58 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.63 21.24 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.443 1.897 . . . . 0.0 112.397 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -158.13 82.84 0.85 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.889 1.676 . . . . 0.0 109.769 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.1 t -169.16 160.69 9.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.865 1.666 . . . . 0.0 110.341 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.0 138.49 58.38 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.272 -0.892 . . . . 0.0 111.998 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.3 p -78.07 -7.2 56.64 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 123.92 -170.23 16.13 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.803 1.668 . . . . 0.0 113.695 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.36 164.21 29.12 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.138 3.225 . . . . 0.0 111.837 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.3 p -160.86 163.52 31.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.247 1.419 . . . . 0.0 111.906 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.0 p -134.35 4.93 3.46 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.341 1.448 . . . . 0.0 112.95 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.246 0 C4'-C3'-C2' 100.444 -2.256 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.251 1 O4'-C1'-N19 112.496 4.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.306 0 O5'-C5'-C4' 113.039 2.028 . 0.082 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.714 0 O4'-C1'-N19 111.277 3.077 . 0.413 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.081 1 O4'-C1'-N19 114.081 5.881 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 52.1 p -90.08 -9.26 49.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 65.5 p -164.51 161.13 21.07 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.533 1.533 . . . . 0.0 112.115 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.83 39.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.069 1.319 . . . . 0.0 113.455 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 t -159.9 146.21 15.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.873 1.269 . . . . 0.0 111.71 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 56.1 p -93.08 1.35 57.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.466 1.506 . . . . 0.0 113.338 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.54 -2.85 64.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.241 1.401 . . . . 0.0 115.584 -173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -154.24 123.19 6.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.874 1.67 . . . . 0.0 109.665 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.9 p -150.03 135.68 18.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.898 1.679 . . . . 0.0 110.19 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -84.75 -10.79 56.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.374 0.67 . . . . 0.0 112.642 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -168.11 146.72 4.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.889 2.476 . . . . 0.0 107.138 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.3 p -151.63 149.64 29.37 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.205 -0.934 . . . . 0.0 112.481 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 80.2 mt -73.35 134.55 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.09 5.63 34.94 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -50.49 -32.8 19.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.344 1.858 . . . . 0.0 114.471 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm -111.58 131.23 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.51 126.27 26.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.349 1.06 . . . . 0.0 112.083 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -73.38 -2.65 23.13 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -114.56 -25.98 8.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.499 1.12 . . . . 0.0 113.333 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.3 p -121.0 -11.5 8.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.123 1.369 . . . . 0.0 114.262 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t30 65.75 17.04 10.75 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 113.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.4 mt -89.53 144.53 25.96 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.195 1.398 . . . . 0.0 111.02 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t -70.59 137.28 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.444 -0.785 . . . . 0.0 111.097 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.24 145.41 55.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -110.05 177.75 4.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.566 1.946 . . . . 0.0 109.048 170.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.7 m -146.34 147.46 31.36 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.282 -0.887 . . . . 0.0 110.794 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.37 35.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.27 -17.85 63.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.56 1.144 . . . . 0.0 112.908 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -160.8 165.08 30.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.065 2.146 . . . . 0.0 110.564 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 68.1 m -144.66 -27.87 0.49 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.574 1.549 . . . . 0.0 113.542 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 152.44 8.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.901 1.68 . . . . 0.0 112.536 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.4 t -152.33 126.13 8.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.049 1.34 . . . . 0.0 109.445 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 71.97 -164.75 54.22 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.709 0.671 . . . . 0.0 112.758 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.88 138.98 82.63 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.051 3.167 . . . . 0.0 112.11 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 45.1 p -137.37 1.56 2.41 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 39.0 m 64.89 1.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.791 2.037 . . . . 0.0 114.761 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 C-N-CA 127.499 2.476 . . . . 0.0 112.71 -178.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.202 0 O4'-C1'-N19 110.557 2.357 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.218 1 O4'-C1'-N19 113.209 5.009 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.517 0 O5'-C5'-C4' 113.685 2.489 . 0.475 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.384 0 C5'-C4'-O4' 113.631 3.165 . 0.178 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.222 1 O4'-C1'-N19 115.373 7.173 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 P-O3'-C3' 121.891 1.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.4 t 65.67 -164.86 0.24 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.77 1.628 . . . . 0.0 112.952 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.2 m -134.35 138.11 44.65 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.278 1.831 . . . . 0.0 110.507 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.91 9.67 86.0 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.939 0.78 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 7.8 t -68.54 -16.98 64.05 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 118.503 1.151 . . . . 0.0 113.36 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.4 p -76.39 -5.39 47.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.347 1.459 . . . . 0.0 113.903 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.71 136.24 9.27 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.415 1.96 . . . . 0.0 112.804 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.67 -16.88 2.0 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.923 1.689 . . . . 0.0 113.881 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.2 p -137.79 21.25 2.87 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.63 2.372 . . . . 0.0 111.534 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.17 143.35 15.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 109.293 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.48 14.51 24.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.288 1.435 . . . . 0.0 112.443 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 14.6 t -156.36 -174.12 4.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 109.741 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 47.8 mt -75.97 91.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.944 -1.097 . . . . 0.0 110.269 -173.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.87 -67.55 2.65 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.881 1.705 . . . . 0.0 112.652 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.72 -40.84 0.33 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.835 3.254 . . . . 0.0 114.343 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.04 127.47 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.11 114.77 8.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.523 1.129 . . . . 0.0 110.696 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -77.47 6.65 6.63 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -106.23 -25.88 11.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.413 1.085 . . . . 0.0 112.646 172.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -126.68 -5.46 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.275 5.3 p30 64.79 3.42 2.02 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.817 2.847 . . . . 0.0 116.206 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.72 155.89 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.894 1.278 . . . . 0.0 111.958 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -73.75 136.39 43.64 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.538 -0.726 . . . . 0.0 109.382 167.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -76.62 148.59 36.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -72.41 166.25 22.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.64 1.576 . . . . 0.0 112.631 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -137.75 165.76 25.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.865 2.066 . . . . 0.0 109.858 170.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -67.68 164.29 19.63 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.64 1.45 2.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.464 1.506 . . . . 0.0 114.507 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.39 -4.48 42.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.853 1.261 . . . . 0.0 114.096 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.6 m -69.32 -10.67 58.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.803 1.241 . . . . 0.0 113.939 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -69.76 130.73 43.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.728 1.211 . . . . 0.0 111.777 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.9 m -77.21 -18.93 57.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.83 47.09 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.299 1.428 . . . . 0.0 113.554 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.83 148.7 73.9 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.403 3.402 . . . . 0.0 113.336 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.8 p -78.11 -0.93 30.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.72 1.208 . . . . 0.0 113.698 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.4 m -73.69 -6.11 44.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.62 1.568 . . . . 0.0 114.374 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.639 1.59 . . . . 0.0 112.871 178.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.274 0 O4'-C1'-N19 110.774 2.574 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.29 1 O4'-C1'-N19 114.979 6.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O5'-C5'-C4' 113.301 2.215 . 0.495 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.524 0 C5'-C4'-O4' 113.541 3.101 . 0.191 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.002 1 O4'-C1'-N19 114.624 6.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.3 p -85.48 -12.94 50.62 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -147.29 145.12 29.27 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.901 1.68 . . . . 0.0 111.071 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.32 -174.03 44.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.788 1.185 . . . . 0.0 113.211 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.2 t -161.22 147.39 14.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.097 1.359 . . . . 0.0 111.448 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 34.3 p -87.32 -5.7 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.117 1.367 . . . . 0.0 113.662 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.7 142.07 3.31 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.171 1.367 . . . . 0.0 113.087 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.91 -5.73 45.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 14.0 t -155.48 134.67 12.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.508 1.923 . . . . 0.0 109.407 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -176.42 170.01 2.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.775 2.03 . . . . 0.0 110.071 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.4 156.48 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 110.916 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 45.3 m -84.29 155.72 22.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.096 1.358 . . . . 0.0 113.006 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.8 mm -69.05 141.24 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.806 0.842 . . . . 0.0 109.957 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.51 2.83 21.05 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.858 1.218 . . . . 0.0 115.909 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.71 -16.89 64.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.03 1.332 . . . . 0.0 114.127 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm -119.63 131.07 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.17 123.15 19.13 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.592 -0.693 . . . . 0.0 111.165 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.56 -14.71 53.97 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -90.19 -28.0 19.17 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 112.711 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.1 p -133.19 -11.78 2.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.96 1.304 . . . . 0.0 114.405 -169.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 61.92 25.97 15.65 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.008 1.723 . . . . 0.0 113.571 -174.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.51 146.02 24.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.105 1.362 . . . . 0.0 111.335 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t -71.6 139.1 49.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.579 -0.7 . . . . 0.0 112.38 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -72.1 143.15 49.13 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -94.42 -167.62 1.69 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.126 0.97 . . . . 0.0 112.726 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.0 p -142.16 176.83 8.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.473 2.309 . . . . 0.0 109.152 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.77 -50.97 71.31 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.543 -1.348 . . . . 0.0 111.974 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.6 p30 175.26 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.79 2.836 . . . . 0.0 112.301 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -165.4 151.26 9.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.832 2.053 . . . . 0.0 110.116 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 56.6 p -72.07 -10.15 59.39 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.52 27.91 5.49 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.728 2.011 . . . . 0.0 111.617 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 97.6 p -65.81 158.97 26.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.386 1.074 . . . . 0.0 113.505 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 76.25 -162.08 52.25 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 123.954 0.788 . . . . 0.0 113.579 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.99 -11.76 13.53 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.857 3.038 . . . . 0.0 114.061 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 40.3 m 65.84 3.81 2.69 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.314 1.846 . . . . 0.0 114.828 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.8 t -164.01 162.52 23.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.308 1.843 . . . . 0.0 111.183 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 125.272 1.415 . . . . 0.0 112.819 -177.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.689 0 C4'-C3'-C2' 99.164 -3.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 1 O4'-C1'-N19 112.276 4.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 O5'-C5'-C4' 113.131 2.094 . 0.178 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 C5'-C4'-O4' 113.686 3.204 . 0.332 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.169 1 O4'-C1'-N19 113.7 5.5 . 0.011 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 111.873 3.673 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 45.7 t -163.79 149.31 11.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.377 1.471 . . . . 0.0 111.056 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.0 m -85.12 -6.55 59.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.872 0.869 . . . . 0.0 113.081 172.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.47 4.86 80.3 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.572 1.558 . . . . 0.0 114.774 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -161.24 176.2 11.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.069 1.748 . . . . 0.0 110.663 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 m 62.44 19.96 11.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.549 1.539 . . . . 0.0 113.92 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 106.61 119.63 4.53 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.368 1.937 . . . . 0.0 111.102 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.45 -5.64 55.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.561 1.145 . . . . 0.0 113.639 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.4 p -139.8 137.92 35.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.097 2.159 . . . . 0.0 109.687 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -167.01 177.26 6.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.5 1.52 . . . . 0.0 110.872 -172.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.53 172.02 16.14 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 110.708 174.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.7 m -54.4 115.82 2.31 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.45 134.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 120.92 -1.112 . . . . 0.0 110.123 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.09 56.9 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.552 1.072 . . . . 0.0 115.454 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.1 70.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm -115.58 131.64 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.57 126.76 28.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.733 1.213 . . . . 0.0 111.901 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.43 -6.49 40.69 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -114.5 -41.33 3.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.057 1.343 . . . . 0.0 112.255 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 66.1 p -100.99 -13.62 18.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.67 19.99 11.5 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.963 1.705 . . . . 0.0 113.065 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.51 146.23 23.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.89 1.276 . . . . 0.0 111.258 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t -67.09 146.52 54.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.526 -0.734 . . . . 0.0 111.842 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.09 144.18 16.01 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -48.99 125.77 11.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.206 1.002 . . . . 0.0 112.396 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.4 m -173.5 169.67 4.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.447 2.699 . . . . 0.0 109.327 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -76.46 -3.59 38.01 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -64.68 139.35 58.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.054 1.342 . . . . 0.0 111.865 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.67 140.38 12.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.826 1.251 . . . . 0.0 111.631 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 13.8 m -74.91 -6.81 51.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.77 -35.01 0.73 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.604 1.161 . . . . 0.0 113.423 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.8 m -87.61 -13.75 41.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.42 1.088 . . . . 0.0 113.105 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -79.82 -66.46 1.67 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.272 1.415 . . . . 0.0 112.589 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.26 148.79 39.46 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.729 2.952 . . . . 0.0 111.584 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.7 m -164.16 155.81 16.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.567 1.947 . . . . 0.0 110.797 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.2 m -77.42 -6.11 52.22 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.693 1.616 . . . . 0.0 112.999 -178.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.344 0 C4'-C3'-C2' 99.934 -2.766 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.661 1 O4'-C1'-N19 112.485 4.285 . 0.069 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 O4'-C1'-N19 110.778 2.578 . 0.215 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-O4' 113.544 3.103 . 0.634 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.028 1 O4'-C1'-N19 113.856 5.656 . 0.016 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.607 1 O4'-C1'-N19 113.966 5.766 . 0.03 2a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 32.9 t -163.79 155.6 16.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.414 1.485 . . . . 0.0 111.207 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.9 p -84.26 -7.9 59.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.605 1.162 . . . . 0.0 113.368 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.51 155.52 25.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.27 1.414 . . . . 0.0 112.939 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.4 m -148.16 148.57 30.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.462 1.505 . . . . 0.0 111.093 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.4 m -69.32 132.93 47.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.26 -0.9 . . . . 0.0 112.459 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -81.0 1.73 83.56 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.572 1.082 . . . . 0.0 114.716 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.3 tt -153.25 116.19 4.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.675 1.99 . . . . 0.0 107.715 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 53.6 p -119.6 -10.85 9.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.31 129.36 19.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.278 1.431 . . . . 0.0 108.917 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -160.33 -46.93 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.546 0.738 . . . . 0.0 111.891 -170.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.3 p -162.6 -177.69 5.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.525 1.13 . . . . 0.0 112.2 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 98.7 mt -73.33 -14.02 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.786 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 141.23 -31.22 2.18 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 126.885 2.183 . . . . 0.0 113.33 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.76 -31.53 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.197 2.999 . . . . 0.0 117.011 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.83 132.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.62 124.04 22.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.007 0.923 . . . . 0.0 111.709 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -80.67 9.44 6.18 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -116.03 -23.54 8.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.684 1.194 . . . . 0.0 113.185 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.8 p -126.14 -11.53 6.43 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 114.437 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 22.6 m120 67.0 15.49 10.16 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.79 2.036 . . . . 0.0 114.222 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.98 139.29 30.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.966 1.306 . . . . 0.0 110.945 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t -66.12 138.44 57.74 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.465 -0.772 . . . . 0.0 110.408 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -74.06 153.79 39.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -75.58 154.53 36.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.216 1.006 . . . . 0.0 111.493 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.3 p -158.65 165.28 34.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.012 2.125 . . . . 0.0 110.611 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.98 -19.64 57.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -165.57 157.8 15.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.208 1.803 . . . . 0.0 111.109 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -159.7 -43.23 0.05 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.811 2.044 . . . . 0.0 112.068 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 85.7 p -158.8 19.21 0.2 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.72 1.208 . . . . 0.0 113.669 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -75.95 71.87 2.78 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.679 -1.263 . . . . 0.0 112.706 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.1 t -159.74 174.13 14.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.431 1.893 . . . . 0.0 111.342 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.37 160.87 51.31 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.5 1.048 . . . . 0.0 113.596 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.21 155.8 46.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.076 3.184 . . . . 0.0 111.814 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.8 m -76.73 -3.48 38.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 80.9 p -164.36 164.76 22.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.11 1.764 . . . . 0.0 111.892 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.202 0 C-N-CA 124.948 1.261 . . . . 0.0 112.893 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 0 O4'-C1'-N19 109.987 1.787 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 113.274 5.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.617 0 C3'-C2'-C1' 103.705 2.45 . 0.354 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O4'-C1'-N19 111.084 2.884 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.225 2 O4'-C1'-N19 115.629 7.429 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 111.239 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.5 p -165.39 158.92 16.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.364 1.466 . . . . 0.0 111.792 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -142.88 144.93 32.66 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.941 1.296 . . . . 0.0 111.459 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.5 -179.33 34.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.06 1.314 . . . . 0.0 113.359 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.6 p -164.85 158.89 17.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 112.219 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.4 m -89.76 1.12 56.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.404 1.082 . . . . 0.0 113.748 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 167.15 -153.44 23.02 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.249 1.404 . . . . 0.0 113.278 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.38 163.16 28.49 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.839 1.656 . . . . 0.0 111.382 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.8 m -134.26 148.65 50.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.044 1.738 . . . . 0.0 109.436 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -149.99 152.42 34.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.98 1.312 . . . . 0.0 110.292 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -62.15 139.63 58.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.975 0.91 . . . . 0.0 111.726 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.3 t -163.27 -179.23 6.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.853 1.261 . . . . 0.0 111.588 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 77.5 mt -73.58 138.87 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.453 1.501 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 114.54 -2.81 23.4 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 125.197 1.379 . . . . 0.0 116.263 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.06 70.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.071 0.948 . . . . 0.0 112.493 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm -99.82 133.11 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.32 -35.1 78.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 114.444 -169.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.254 1.4 ptpp? 78.63 -17.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 131.26 3.824 . . . . 0.0 115.3 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.179 0.899 . . . . 0.0 111.063 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.8 p -108.6 -10.92 15.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.199 1.8 . . . . 0.0 113.647 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 65.99 9.25 6.01 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.625 1.97 . . . . 0.0 113.57 -171.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.8 mt -91.44 155.9 18.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.892 1.277 . . . . 0.0 111.83 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t -70.13 139.37 52.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.73 0.812 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -58.96 148.66 29.74 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -129.71 -154.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.143 2.177 . . . . 0.0 108.985 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.4 p -131.53 158.51 40.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.683 1.593 . . . . 0.0 110.794 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -62.3 141.38 58.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.833 0.853 . . . . 0.0 112.214 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -60.84 -18.94 58.78 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.71 131.15 23.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.707 1.603 . . . . 0.0 109.99 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.5 t -170.47 172.28 6.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.836 1.654 . . . . 0.0 111.069 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -153.24 119.75 5.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.669 1.587 . . . . 0.0 110.904 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 61.8 p -126.31 -1.7 6.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.987 1.315 . . . . 0.0 114.204 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.08 -163.21 38.94 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 125.379 1.466 . . . . 0.0 113.16 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -69.0 165.36 30.38 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.528 2.818 . . . . 0.0 111.335 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.9 m -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.8 m -166.42 157.8 13.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.475 2.31 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.975 -179.558 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.308 0 C4'-C3'-C2' 100.476 -2.224 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.233 1 O4'-C1'-N19 114.496 6.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 110.977 2.777 . 0.387 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 C5'-C4'-O4' 113.472 3.052 . 0.325 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C3'-C2'-C1' 104.703 3.559 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 O4'-C1'-N19 111.971 3.771 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.5 m -80.43 -8.72 59.65 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 18.4 m -163.99 154.42 15.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.08 2.152 . . . . 0.0 110.512 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.67 -2.74 89.86 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 124.451 1.024 . . . . 0.0 114.877 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 93.3 p -165.87 171.35 12.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.244 1.818 . . . . 0.0 111.28 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.3 p -83.99 -0.22 50.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.781 1.232 . . . . 0.0 113.846 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.89 -159.08 25.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.109 1.814 . . . . 0.0 112.527 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.99 126.06 28.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.885 0.874 . . . . 0.0 110.215 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.8 m -65.17 121.94 15.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.146 1.378 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -145.52 142.86 29.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.656 1.583 . . . . 0.0 109.317 -172.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -9.8 58.93 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.291 0.636 . . . . 0.0 112.61 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -76.01 8.6 3.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.949 1.699 . . . . 0.0 114.722 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.52 122.27 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 127.627 2.371 . . . . 0.0 108.662 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 8.78 80.36 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.394 0.997 . . . . 0.0 114.951 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -76.23 -14.33 60.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.519 1.528 . . . . 0.0 114.224 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.61 126.5 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.25 124.11 22.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.084 0.553 . . . . 0.0 111.106 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -62.35 -14.37 39.09 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -92.36 -27.06 17.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.757 1.223 . . . . 0.0 112.975 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -128.77 -15.59 4.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.117 1.367 . . . . 0.0 113.926 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.4 t30 64.43 24.68 13.21 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.872 2.069 . . . . 0.0 113.538 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.9 mt -102.14 152.04 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.107 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t -70.09 137.12 50.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.477 -0.764 . . . . 0.0 111.438 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -77.82 165.97 23.5 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.6 mtp-105 -68.86 143.93 54.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.874 0.87 . . . . 0.0 111.444 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.7 p -80.32 143.61 33.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.927 0.891 . . . . 0.0 111.416 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -131.04 4.76 4.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.49 171.08 12.85 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.176 1.39 . . . . 0.0 110.821 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.65 140.36 23.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.838 1.255 . . . . 0.0 112.318 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 30.5 t -165.51 139.3 4.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.068 2.147 . . . . 0.0 108.828 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -128.96 1.17 5.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -168.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.2 p -168.1 164.26 13.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.0 1.32 . . . . 0.0 112.438 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -171.64 168.7 41.82 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.943 1.258 . . . . 0.0 113.5 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.7 147.0 34.73 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.929 3.086 . . . . 0.0 111.562 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.4 p -165.06 162.85 20.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.461 1.504 . . . . 0.0 111.925 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.7 m -135.79 10.29 3.37 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.318 1.047 . . . . 0.0 113.712 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 C-N-CA 125.33 1.443 . . . . 0.0 112.999 -177.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 100.627 -2.073 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 1 O4'-C1'-N19 113.645 5.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.195 0 O4'-C1'-N19 110.768 2.568 . 0.053 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 P-O3'-C3' 124.286 3.822 . 0.422 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.027 1 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.205 3.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 75.1 p -164.47 166.43 20.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.395 1.478 . . . . 0.0 111.809 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.2 t -162.32 176.97 10.01 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.442 1.497 . . . . 0.0 111.127 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.93 -150.62 16.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.788 1.661 . . . . 0.0 112.58 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.0 m 70.2 9.67 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.15 1.78 . . . . 0.0 114.543 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 71.7 m -146.51 159.37 43.5 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.309 1.844 . . . . 0.0 111.326 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 98.31 -151.58 19.63 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.88 1.228 . . . . 0.0 112.892 -178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.6 tp -156.09 150.23 25.42 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.594 1.558 . . . . 0.0 110.86 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.0 t -158.27 160.92 37.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.235 1.814 . . . . 0.0 110.809 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.13 -5.59 49.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.04 1.336 . . . . 0.0 112.655 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.16 141.92 4.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.533 1.533 . . . . 0.0 111.069 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.7 t -65.78 149.86 49.47 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.645 -0.659 . . . . 0.0 111.602 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.6 mt -116.71 136.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.086 1.754 . . . . 0.0 109.084 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 16.94 63.24 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 123.746 0.689 . . . . 0.0 113.65 -170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.7 -16.15 60.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 114.719 -169.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt -129.4 132.95 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -63.63 127.43 31.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.529 1.131 . . . . 0.0 111.527 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -70.41 -10.3 58.72 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -105.04 -38.99 6.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 62.2 p -103.04 -16.04 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.0 t30 63.05 21.33 12.83 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.487 1.915 . . . . 0.0 113.749 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.79 143.49 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.9 1.28 . . . . 0.0 110.794 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t -66.55 135.16 53.76 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -65.11 149.82 49.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -163.02 1.62 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.536 1.534 . . . . 0.0 109.858 169.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.6 m -131.99 161.99 31.81 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.958 0.903 . . . . 0.0 111.292 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -87.66 131.47 34.43 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.267 -0.896 . . . . 0.0 111.073 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -160.13 136.57 8.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.236 1.414 . . . . 0.0 110.647 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.82 -11.98 59.51 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 54.2 m -124.77 0.91 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.427 1.491 . . . . 0.0 113.743 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -139.1 133.44 31.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.271 1.428 . . . . 0.0 111.65 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.0 p -167.09 162.36 15.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.521 1.528 . . . . 0.0 111.48 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.89 -175.52 55.01 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.226 0.917 . . . . 0.0 113.713 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.25 149.28 35.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.85 3.033 . . . . 0.0 111.289 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m -77.43 -4.59 46.15 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 t -164.97 169.15 16.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.267 1.827 . . . . 0.0 111.201 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.405 1.479 . . . . 0.0 112.836 -178.67 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 C5'-C4'-O4' 106.369 -2.022 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.112 1 O4'-C1'-N19 114.071 5.871 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O5'-C5'-C4' 114.976 3.412 . 0.391 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 123.587 3.239 . 0.406 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.109 1 O4'-C1'-N19 113.9 5.7 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 O4'-C1'-N19 111.472 3.272 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -65.41 150.4 48.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.375 1.07 . . . . 0.0 112.756 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.3 t -161.24 169.99 21.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.71 1.204 . . . . 0.0 111.7 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.41 -136.32 24.76 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.522 1.058 . . . . 0.0 111.351 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 84.0 p -82.96 -12.06 57.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.7 m 63.19 1.08 0.85 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.045 2.138 . . . . 0.0 114.591 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -90.71 -9.68 64.08 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.247 1.403 . . . . 0.0 114.726 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.9 mt -142.38 141.12 32.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.404 1.882 . . . . 0.0 110.04 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.6 p -147.81 155.51 41.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.426 1.89 . . . . 0.0 110.508 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -147.44 137.96 23.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -64.45 -23.76 67.39 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.546 -0.721 . . . . 0.0 112.083 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.6 p -67.1 -0.04 3.0 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 26.7 mt -128.85 -41.13 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.471 2.708 . . . . 0.0 110.909 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -88.37 -14.7 61.53 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 126.677 2.084 . . . . 0.0 116.196 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -126.03 -8.09 6.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.738 1.269 . . . . 0.0 113.976 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.24 127.1 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.0 124.23 23.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.304 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -61.16 -15.1 30.1 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.3 -27.92 19.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 112.925 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.6 p -133.01 -13.63 2.77 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.69 19.74 11.88 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.8 mt -90.79 151.12 21.31 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.272 1.429 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t -71.58 136.96 47.66 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.602 -0.686 . . . . 0.0 110.481 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.98 152.29 40.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.51 133.94 55.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.012 1.325 . . . . 0.0 111.123 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 72.0 m -148.9 141.36 24.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.645 1.578 . . . . 0.0 110.368 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.49 134.36 45.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.517 -0.74 . . . . 0.0 111.693 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -165.2 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.019 1.328 . . . . 0.0 113.103 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.2 148.44 16.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.468 1.507 . . . . 0.0 111.132 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.4 t -164.28 169.2 17.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 111.364 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -155.69 -45.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.104 1.362 . . . . 0.0 112.94 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.3 p -170.37 166.6 8.55 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.545 1.538 . . . . 0.0 111.611 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -162.32 172.01 38.33 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.748 1.165 . . . . 0.0 113.701 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.32 156.05 46.18 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.05 3.167 . . . . 0.0 111.88 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 25.0 m -158.91 144.8 16.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.269 1.828 . . . . 0.0 110.735 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.6 p -92.54 -6.32 49.89 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 125.484 1.516 . . . . 0.0 112.857 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.338 0 O4'-C1'-N19 110.86 2.66 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.302 1 O4'-C1'-N19 113.713 5.513 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 O5'-C5'-C4' 113.043 2.031 . 0.249 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 C5'-C4'-O4' 113.319 2.942 . 0.388 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.139 1 O4'-C1'-N19 113.487 5.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 111.527 3.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.8 p -166.14 179.54 5.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.677 1.591 . . . . 0.0 111.359 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.6 m -71.24 -5.21 30.36 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.847 -1.158 . . . . 0.0 113.991 173.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.72 174.86 50.64 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.421 . . . . 0.0 113.589 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -2.32 58.45 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.1 m -69.65 138.05 52.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.005 1.322 . . . . 0.0 113.05 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.94 67.06 3.3 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.125 1.345 . . . . 0.0 112.971 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.5 7.22 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.396 1.479 . . . . 0.0 114.347 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.5 p -76.67 -12.98 60.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.495 1.518 . . . . 0.0 113.579 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -159.61 149.94 18.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.606 1.962 . . . . 0.0 108.726 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -77.92 144.05 37.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.724 -0.61 . . . . 0.0 110.03 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.7 m -67.22 139.78 57.4 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.336 -0.853 . . . . 0.0 111.499 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 65.1 mt -96.43 104.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.108 0.963 . . . . 0.0 109.408 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.29 0.7 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.966 1.746 . . . . 0.0 113.111 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.67 -8.4 11.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.661 1.584 . . . . 0.0 115.054 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.32 142.08 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -68.18 122.83 19.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 111.945 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.38 -9.13 46.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -99.38 -31.27 11.76 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.884 1.273 . . . . 0.0 112.622 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.3 p -132.97 -7.54 3.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 55.0 t30 66.61 18.69 10.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.188 1.795 . . . . 0.0 113.873 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.41 147.65 22.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.079 1.352 . . . . 0.0 111.042 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t -65.62 140.47 58.51 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.163 -0.96 . . . . 0.0 112.107 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.4 144.1 47.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.6 -124.82 2.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.111 1.364 . . . . 0.0 110.209 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.1 t -160.39 163.09 33.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.173 1.789 . . . . 0.0 110.513 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.33 -11.06 55.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.151 0.98 . . . . 0.0 113.249 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.59 127.96 34.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -151.63 1.79 0.38 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.919 1.288 . . . . 0.0 113.615 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.7 p -171.76 162.64 6.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.649 1.58 . . . . 0.0 111.83 -172.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.58 -28.32 63.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.302 -0.874 . . . . 0.0 113.032 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -168.28 162.18 12.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.762 2.025 . . . . 0.0 110.566 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -81.39 170.97 52.84 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.42 1.009 . . . . 0.0 113.708 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.21 118.53 5.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.724 2.95 . . . . 0.0 110.583 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 50.5 m 66.01 -9.49 0.28 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.21 2.204 . . . . 0.0 115.394 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 14.9 t -168.48 153.64 6.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.921 2.088 . . . . 0.0 110.649 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.322 1.439 . . . . 0.0 113.031 -177.029 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.47 0 C5'-C4'-C3' 112.306 -2.129 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.491 1 O4'-C1'-N19 114.063 5.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O5'-C5'-C4' 113.494 2.353 . 0.413 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 0 O5'-C5'-C4' 113.66 2.472 . 0.409 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.084 1 O4'-C1'-N19 113.758 5.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C4'-C3'-C2' 100.739 -1.961 . 0.35 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 40.7 t -163.42 149.92 12.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.142 1.377 . . . . 0.0 111.278 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.5 m -81.6 -5.1 57.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.447 1.099 . . . . 0.0 113.344 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.52 -176.44 36.76 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.345 1.45 . . . . 0.0 113.36 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 46.4 p -92.12 0.88 57.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.07 1.348 . . . . 0.0 114.532 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p -160.65 171.05 19.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.403 1.481 . . . . 0.0 112.402 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 96.93 -163.13 22.22 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.005 1.288 . . . . 0.0 113.624 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.4 179.34 6.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.629 1.972 . . . . 0.0 111.113 -175.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.7 p -67.91 168.82 10.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.166 1.787 . . . . 0.0 112.148 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -152.02 152.06 31.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.712 1.605 . . . . 0.0 109.274 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.52 156.43 35.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.777 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.2 m -88.07 19.41 3.66 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 113.686 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 24.6 mt -129.68 123.7 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.417 1.887 . . . . 0.0 109.325 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.03 -33.24 55.32 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 124.02 0.819 . . . . 0.0 113.384 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.46 -30.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.175 2.99 . . . . 0.0 117.997 168.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.55 132.71 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.5 132.21 52.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 113.042 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -69.31 -11.19 60.6 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -113.24 -43.59 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 112.091 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.5 p -98.98 -14.65 19.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 60.76 24.14 14.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.84 1.656 . . . . 0.0 113.361 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.24 142.05 27.99 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 110.887 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t -66.32 138.97 57.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -63.36 149.23 46.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -60.46 148.33 37.96 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.611 -0.681 . . . . 0.0 110.876 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.1 t -162.89 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -156.56 155.0 31.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -164.85 149.04 9.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.418 1.887 . . . . 0.0 110.695 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.72 116.41 2.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.2 m -70.64 -11.37 60.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.173 . . . . 0.0 113.882 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? 42.27 -130.79 0.56 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.098 2.159 . . . . 0.0 114.067 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.4 m -78.5 0.14 27.21 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.904 1.281 . . . . 0.0 114.411 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.48 -162.11 49.0 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 124.328 0.966 . . . . 0.0 112.9 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.3 158.96 47.85 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.729 2.952 . . . . 0.0 111.59 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.3 p -79.94 -3.15 46.98 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.6 t -163.5 161.63 24.21 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.158 1.783 . . . . 0.0 111.175 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.26 1.41 . . . . 0.0 112.852 -178.011 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 C4'-C3'-C2' 100.546 -2.154 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.121 1 O4'-C1'-N19 114.16 5.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.372 0 C4'-C3'-C2' 100.465 -2.235 . 0.594 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 0 O4'-C1'-N19 111.958 3.758 . 0.452 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.009 1 O4'-C1'-N19 113.117 4.917 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 111.246 3.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.216 0.531 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt . . . . . 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt . . . . . 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.362 0.601 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.51 0.672 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.386 0.612 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLN . . . . . 0.647 HE22 ' N ' ' A' ' 441' ' ' SER . 65.0 tp60 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 441' ' ' SER . . . . . 0.647 ' N ' HE22 ' A' ' 410' ' ' GLN . 45.8 t . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.517 0.675 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.527 0.68 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.521 0.677 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.229 0.538 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.434 0.635 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.509 0.671 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.166 0.508 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.4 0.619 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 98.6 p -165.05 174.15 10.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.251 1.421 . . . . 0.0 111.911 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.3 m -75.87 1.36 15.29 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.68 -34.42 1.85 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.895 1.712 . . . . 0.0 114.958 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.2 t -160.84 145.71 14.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.528 1.531 . . . . 0.0 111.462 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 69.1 m -79.54 -9.07 59.55 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -93.1 -1.14 67.37 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.281 1.42 . . . . 0.0 114.227 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 30.7 tp -77.91 146.45 35.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.855 1.262 . . . . 0.0 111.821 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.3 p -82.78 15.43 2.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.938 2.095 . . . . 0.0 113.531 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -147.78 175.38 10.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.893 2.477 . . . . 0.0 108.993 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.56 172.63 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.648 0.779 . . . . 0.0 112.683 -173.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 70.4 m -57.93 142.51 46.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.589 1.156 . . . . 0.0 112.2 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.4 67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.189 0.996 . . . . 0.0 109.925 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -102.74 6.15 51.78 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 125.145 1.355 . . . . 0.0 114.202 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -119.57 -17.12 8.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.124 1.369 . . . . 0.0 114.526 -169.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm -104.5 134.36 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.21 119.9 12.29 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.306 1.042 . . . . 0.0 111.049 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.63 -10.93 30.09 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -93.19 -29.47 15.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 112.869 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.5 p -133.0 -10.89 2.98 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.85 24.8 12.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.231 1.812 . . . . 0.0 113.715 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.5 mt -101.28 148.25 25.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 111.122 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t -71.15 143.16 50.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -72.47 150.09 43.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -74.41 145.42 43.72 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.446 1.498 . . . . 0.0 111.29 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.7 p -168.87 154.45 6.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.241 1.816 . . . . 0.0 110.875 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -67.61 131.17 45.11 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.846 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -157.11 31.36 0.29 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.444 1.498 . . . . 0.0 111.32 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -163.15 170.58 17.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.983 1.713 . . . . 0.0 112.343 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -145.86 164.95 30.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.683 1.593 . . . . 0.0 111.756 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -144.76 156.99 44.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.89 1.676 . . . . 0.0 111.842 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.5 m -64.94 146.49 54.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.525 1.13 . . . . 0.0 112.967 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.07 -74.15 0.95 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.652 1.12 . . . . 0.0 112.715 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 138.99 26.41 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.509 2.806 . . . . 0.0 111.065 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 61.5 p -103.68 -2.73 26.07 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.948 1.299 . . . . 0.0 113.729 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 64.4 p -117.76 -0.57 11.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.633 1.573 . . . . 0.0 114.406 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.075 1.321 . . . . 0.0 113.114 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 0 C5'-C4'-C3' 112.455 -2.03 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.313 1 O4'-C1'-N19 114.577 6.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 O5'-C5'-C4' 113.467 2.334 . 0.441 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.466 0 C5'-C4'-O4' 113.327 2.948 . 0.232 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.026 1 O4'-C1'-N19 114.206 6.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 O4'-C1'-N19 111.53 3.33 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 48.2 p -89.83 -8.13 52.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.0 t -163.78 154.52 15.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.582 1.553 . . . . 0.0 111.555 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.38 2.67 85.15 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.114 1.34 . . . . 0.0 113.846 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 69.2 m -138.7 163.82 31.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.6 t -158.29 170.68 21.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.981 1.313 . . . . 0.0 111.631 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 88.06 -179.12 46.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.332 1.444 . . . . 0.0 113.14 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 40.3 tp -157.94 143.23 16.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.909 1.284 . . . . 0.0 111.08 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -116.87 8.63 13.61 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.377 1.871 . . . . 0.0 113.708 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -143.59 168.76 19.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.016 1.727 . . . . 0.0 110.816 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -67.62 -7.72 28.73 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.345 1.458 . . . . 0.0 114.665 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.0 p -165.99 165.1 18.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.514 1.926 . . . . 0.0 110.27 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.7 mt -81.24 74.05 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.182 -0.949 . . . . 0.0 109.294 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 74.43 13.41 81.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.013 1.292 . . . . 0.0 114.925 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.66 -27.74 0.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 128.624 2.77 . . . . 0.0 116.519 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm -111.79 122.59 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 124.72 23.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.107 0.563 . . . . 0.0 110.945 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -80.2 4.41 17.6 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -96.69 -29.6 13.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.686 1.195 . . . . 0.0 111.569 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.8 p -126.74 -13.93 5.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.313 1.845 . . . . 0.0 114.016 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.4 t30 67.03 22.72 9.92 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.133 2.173 . . . . 0.0 113.51 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.17 144.67 26.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.051 1.341 . . . . 0.0 112.219 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t -71.62 139.1 49.17 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -77.0 166.57 23.14 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -81.92 164.05 21.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.529 1.932 . . . . 0.0 112.74 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.7 m -81.61 135.59 35.55 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.376 1.071 . . . . 0.0 109.863 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -83.37 37.63 0.57 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -151.53 167.31 28.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.463 1.505 . . . . 0.0 112.651 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.35 14.77 16.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.331 1.852 . . . . 0.0 113.45 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.1 m -67.03 115.84 7.19 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.285 1.034 . . . . 0.0 112.377 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.24 -22.48 44.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 5.1 t 63.21 -160.85 0.3 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.604 1.562 . . . . 0.0 112.381 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 98.7 -159.45 20.31 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 125.493 1.521 . . . . 0.0 113.47 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -56.25 145.18 78.67 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.589 3.526 . . . . 0.0 113.645 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 77.4 p -148.4 13.42 0.96 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.4 m 68.9 6.09 5.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.539 1.936 . . . . 0.0 115.373 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.167 1.365 . . . . 0.0 113.271 177.701 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.25 0 C5'-C4'-C3' 112.108 -2.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 1 O4'-C1'-N19 114.048 5.848 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.346 0 C4'-C3'-C2' 100.471 -2.229 . 0.455 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 C5'-C4'-O4' 113.127 2.805 . 0.349 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.227 1 O4'-C1'-N19 113.951 5.751 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.048 0 O4'-C1'-N19 111.243 3.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 79.9 p -163.0 172.71 14.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.352 1.061 . . . . 0.0 112.416 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -46.59 132.41 10.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.179 1.792 . . . . 0.0 114.179 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.01 -8.46 76.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.51 1.052 . . . . 0.0 113.942 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.0 p -141.28 -49.8 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.581 1.19 . . . . 0.0 112.177 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.8 m 60.27 11.42 2.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.348 1.859 . . . . 0.0 115.111 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.92 -159.62 28.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.325 1.917 . . . . 0.0 112.201 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.4 mt -104.8 -6.79 19.96 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.2 p -148.92 151.06 33.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.358 1.863 . . . . 0.0 111.13 -174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 72.78 148.24 0.09 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.257 2.623 . . . . 0.0 113.169 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -89.23 134.75 33.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.972 0.909 . . . . 0.0 110.341 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 61.3 m -124.21 147.79 47.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.077 1.351 . . . . 0.0 110.377 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mm -84.79 61.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 122.611 1.196 . . . . 0.0 111.482 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -116.18 19.54 13.31 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.635 2.064 . . . . 0.0 112.095 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.3 -17.0 25.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.579 1.951 . . . . 0.0 114.536 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt -138.75 142.18 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 125.91 26.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.843 0.857 . . . . 0.0 111.989 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -75.47 -3.01 31.5 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -115.86 -25.85 7.59 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.609 1.164 . . . . 0.0 113.24 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.4 p -123.05 -8.5 8.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.362 1.465 . . . . 0.0 114.05 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 65.63 18.4 11.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.355 1.862 . . . . 0.0 113.692 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.29 126.33 31.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.581 1.152 . . . . 0.0 110.878 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t -69.42 137.38 52.67 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.752 -0.592 . . . . 0.0 111.421 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -57.86 150.82 19.31 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -40.84 125.47 2.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.732 1.613 . . . . 0.0 114.26 -172.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.8 t -165.96 12.59 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.881 1.272 . . . . 0.0 113.339 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.68 156.41 45.04 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.417 1.487 . . . . 0.0 112.251 -170.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.6 159.07 35.04 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.685 0.794 . . . . 0.0 112.398 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.58 157.35 39.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.57 1.948 . . . . 0.0 109.749 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.3 m -56.31 -24.46 43.58 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -63.29 -23.96 67.65 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.607 1.163 . . . . 0.0 113.105 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 34.1 m -102.5 4.69 38.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.386 1.874 . . . . 0.0 112.829 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 100.57 144.09 15.18 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.111 1.815 . . . . 0.0 113.05 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.31 146.82 87.88 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.865 3.044 . . . . 0.0 112.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 36.0 p -79.16 -3.29 44.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.446 1.098 . . . . 0.0 113.758 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 47.2 p -87.84 -5.78 58.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 114.463 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 124.996 1.284 . . . . 0.0 113.275 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.31 0 C4'-C3'-C2' 100.305 -2.395 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.327 1 O4'-C1'-N19 112.412 4.212 . 0.052 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.96 3.76 . 0.236 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.368 0 C3'-C2'-C1' 104.922 3.803 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 1 O4'-C1'-N19 114.424 6.224 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.426 0 O4'-C1'-N19 111.176 2.976 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.9 m -68.26 -14.32 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -77.72 1.2 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.931 1.292 . . . . 0.0 113.869 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 65.55 26.5 71.93 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.43 1.014 . . . . 0.0 114.043 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.2 t 62.45 20.99 12.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.284 1.434 . . . . 0.0 112.496 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.1 m 69.49 11.07 7.94 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.024 2.129 . . . . 0.0 113.563 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -84.05 5.22 80.63 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.661 1.601 . . . . 0.0 114.666 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.6 158.51 36.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.309 1.444 . . . . 0.0 111.794 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 t -156.86 177.91 10.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.408 1.483 . . . . 0.0 111.811 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.89 3.56 22.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.98 1.712 . . . . 0.0 113.977 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -148.39 149.39 31.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 111.406 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 83.0 p -128.81 176.79 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.27 1.428 . . . . 0.0 111.585 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 51.5 mt -73.66 -10.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.498 1.119 . . . . 0.0 111.985 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.56 59.16 1.24 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 127.545 2.498 . . . . 0.0 113.502 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.64 -29.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.736 2.814 . . . . 0.0 112.263 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.99 118.33 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -64.8 112.36 3.22 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.131 0.972 . . . . 0.0 110.635 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.43 -5.84 21.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.56 -21.99 22.6 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.175 0.99 . . . . 0.0 112.763 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.6 p -132.68 -13.63 2.9 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.7 t30 67.58 21.3 9.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.403 2.281 . . . . 0.0 113.904 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -101.78 152.0 21.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.375 1.47 . . . . 0.0 111.121 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t -71.77 140.74 49.61 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.304 -0.873 . . . . 0.0 111.211 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -64.9 139.83 58.8 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.68 165.73 16.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.665 0.786 . . . . 0.0 112.205 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.5 p -157.33 161.91 39.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.956 1.302 . . . . 0.0 111.959 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -159.89 146.24 15.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.814 1.245 . . . . 0.0 111.744 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.99 156.25 37.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -159.9 -42.04 0.05 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.582 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 8.6 t -165.15 161.3 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.28 1.432 . . . . 0.0 111.319 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -69.61 153.71 43.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.401 1.08 . . . . 0.0 113.556 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 39.5 p -82.94 -12.38 57.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.69 1.196 . . . . 0.0 113.938 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.98 -163.34 37.79 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.5 1.524 . . . . 0.0 113.376 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.37 165.14 33.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.732 2.955 . . . . 0.0 111.62 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.7 m -73.15 24.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.248 1.819 . . . . 0.0 114.567 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.3 t -158.14 -178.81 7.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.541 1.936 . . . . 0.0 111.007 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.441 1.496 . . . . 0.0 112.754 -178.671 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.353 0 C3'-C2'-C1' 99.601 -2.11 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.208 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O5'-C5'-C4' 113.368 2.263 . 0.506 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 C5'-C4'-O4' 113.459 3.042 . 0.41 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.247 1 O4'-C1'-N19 112.877 4.677 . 0.023 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 O4'-C1'-N19 110.741 2.541 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 83.4 p -164.08 167.29 20.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.281 1.433 . . . . 0.0 111.774 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -162.82 165.77 24.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.583 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.84 -87.18 1.16 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 124.313 0.959 . . . . 0.0 111.618 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.4 m -67.41 -14.73 63.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.723 1.209 . . . . 0.0 113.889 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.7 p -91.46 -4.59 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.429 1.492 . . . . 0.0 113.701 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.98 60.17 4.21 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.894 1.712 . . . . 0.0 112.717 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.92 14.52 0.47 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.013 1.725 . . . . 0.0 114.059 -171.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.3 p -59.78 -43.68 94.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.864 1.665 . . . . 0.0 113.64 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.19 -14.96 3.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.967 1.307 . . . . 0.0 112.98 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -176.14 173.51 2.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.345 2.658 . . . . 0.0 109.927 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.4 p -85.19 170.14 13.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.333 1.053 . . . . 0.0 112.109 168.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.22 133.6 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.382 . . . . 0.0 109.561 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 132.52 69.13 0.09 OUTLIER Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.564 1.554 . . . . 0.0 111.01 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -150.97 12.29 0.67 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.931 1.292 . . . . 0.0 114.054 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.18 141.38 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.65 121.99 15.8 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.954 0.902 . . . . 0.0 111.091 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -72.24 -1.81 16.58 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -114.69 -36.55 4.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.931 1.293 . . . . 0.0 112.575 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 45.2 p -105.41 -13.36 15.67 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.3 t30 65.32 16.65 10.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.534 1.934 . . . . 0.0 113.769 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.46 140.51 29.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t -70.18 137.87 51.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -64.51 158.18 24.76 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -74.67 37.5 0.11 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -168.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.8 m -77.71 -10.86 59.76 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.707 -1.246 . . . . 0.0 113.99 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 166.68 20.38 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.693 1.197 . . . . 0.0 114.223 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.65 156.98 40.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.89 1.676 . . . . 0.0 112.519 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.44 -38.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.467 1.107 . . . . 0.0 113.907 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 61.0 p -77.96 -20.34 52.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -135.05 -11.7 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 113.801 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 22.6 t -175.59 160.88 2.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.421 2.688 . . . . 0.0 108.382 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 137.62 -159.46 24.91 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.626 1.108 . . . . 0.0 113.556 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.14 163.71 34.5 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.992 3.128 . . . . 0.0 112.225 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 72.1 m -144.0 150.49 38.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.47 1.508 . . . . 0.0 111.315 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.2 m -77.15 -5.61 49.76 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.65 1.595 . . . . 0.0 113.072 -178.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.241 0 O4'-C1'-N19 111.041 2.841 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.356 1 O4'-C1'-N19 112.738 4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.416 0 O5'-C5'-C4' 113.229 2.164 . 0.478 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-O4' 113.238 2.884 . 0.339 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.932 3 C3'-C2'-C1' 106.044 5.049 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.617 2.419 0 O4'-C1'-N19 111.771 3.571 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 64.2 m -145.89 146.49 31.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.871 1.269 . . . . 0.0 111.519 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.9 p -165.92 156.25 12.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.347 1.459 . . . . 0.0 111.565 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.25 -166.83 28.92 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.669 1.128 . . . . 0.0 112.749 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.5 p -77.72 -3.91 43.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.652 1.181 . . . . 0.0 113.585 173.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 22.9 t -164.51 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.461 1.904 . . . . 0.0 111.798 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.12 26.98 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.456 1.027 . . . . 0.0 113.031 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.72 166.99 24.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.04 2.136 . . . . 0.0 110.631 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.2 m -76.17 81.13 2.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.413 1.485 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -166.45 163.61 17.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 0.0 110.803 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.51 162.04 38.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.043 1.337 . . . . 0.0 109.925 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.7 t -150.23 -165.46 2.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.594 1.557 . . . . 0.0 110.36 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 44.4 mm -77.38 145.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.56 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 124.42 0.16 8.69 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.183 1.373 . . . . 0.0 116.132 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.4 -15.08 60.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.996 1.319 . . . . 0.0 113.701 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.92 132.69 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.5 124.83 24.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.431 0.693 . . . . 0.0 111.318 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -62.64 -12.28 22.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -96.77 -28.31 14.33 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 113.027 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -131.82 -12.54 3.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 62.68 19.72 11.56 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.879 1.672 . . . . 0.0 113.976 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.84 139.85 32.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.399 1.08 . . . . 0.0 110.576 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t -76.07 138.75 41.02 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.737 -0.602 . . . . 0.0 111.251 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.8 146.06 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -69.88 141.77 53.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.036 1.334 . . . . 0.0 112.005 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.3 t -101.81 143.01 32.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.001 1.321 . . . . 0.0 109.395 168.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -142.19 143.71 33.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.334 1.054 . . . . 0.0 112.392 -169.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -155.34 165.3 37.05 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.165 1.786 . . . . 0.0 111.377 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.29 136.15 14.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.108 1.363 . . . . 0.0 110.935 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 28.7 t -173.0 154.15 2.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.676 1.59 . . . . 0.0 110.949 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.1 -30.12 61.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.449 1.099 . . . . 0.0 112.238 168.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.0 m -113.75 6.81 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.053 1.341 . . . . 0.0 113.507 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 79.71 -157.21 41.57 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.607 1.099 . . . . 0.0 113.868 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.45 148.53 42.45 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.699 3.599 . . . . 0.0 113.627 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.3 m -59.74 132.72 54.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.99 1.316 . . . . 0.0 113.816 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 46.0 p -86.57 -6.2 58.94 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 C-N-CA 125.671 1.605 . . . . 0.0 112.929 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.477 3.277 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.164 2 C5'-C4'-C3' 108.915 -4.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 C5'-C4'-C3' 112.522 -1.985 . 0.514 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.342 0 C5'-C4'-O4' 113.621 3.158 . 0.147 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.013 1 O4'-C1'-N19 113.842 5.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 1 O4'-C1'-N19 114.297 6.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.079 -0.409 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 72.7 p -164.2 162.47 22.7 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.433 1.493 . . . . 0.0 111.739 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -163.71 164.66 23.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.291 1.436 . . . . 0.0 111.31 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.97 -166.36 46.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 0.0 113.809 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 m 69.9 -5.03 1.32 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.346 2.259 . . . . 0.0 115.353 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 m -169.55 153.86 5.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.5 2.32 . . . . 0.0 110.614 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -83.3 157.77 35.27 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.211 0.91 . . . . 0.0 112.404 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.9 tp -159.11 136.37 9.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.003 1.321 . . . . 0.0 110.81 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.5 p -63.67 131.09 46.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.103 1.361 . . . . 0.0 110.979 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -88.65 149.23 23.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.934 0.894 . . . . 0.0 110.432 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -152.52 130.71 11.96 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.984 0.914 . . . . 0.0 110.489 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.2 p -86.54 155.71 20.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.316 1.046 . . . . 0.0 112.965 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 85.4 mt -88.36 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.798 1.239 . . . . 0.0 110.703 -174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.73 15.31 27.16 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.912 1.244 . . . . 0.0 115.462 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.0 -7.53 59.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.44 128.6 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.86 122.08 16.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.825 0.85 . . . . 0.0 110.976 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -80.08 4.46 17.13 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -108.12 -23.75 11.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.438 1.095 . . . . 0.0 112.774 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.3 p -124.8 -12.48 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.44 1.496 . . . . 0.0 114.118 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.4 t30 66.38 17.69 10.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.899 2.08 . . . . 0.0 113.603 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.14 142.67 27.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.894 1.277 . . . . 0.0 111.712 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t -70.55 143.6 51.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.616 -0.678 . . . . 0.0 111.16 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 162.81 22.46 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -70.57 167.01 19.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.883 1.273 . . . . 0.0 113.685 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.2 t -137.4 135.69 37.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.869 1.268 . . . . 0.0 110.236 169.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.82 -21.28 29.92 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -161.36 146.26 13.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.847 1.259 . . . . 0.0 112.143 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.77 146.78 13.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.342 1.857 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 43.1 t -162.28 145.23 11.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.835 1.254 . . . . 0.0 111.737 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -82.03 -5.33 58.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.543 1.137 . . . . 0.0 112.716 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 25.6 p 71.32 8.88 6.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 128.19 2.596 . . . . 0.0 115.092 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.38 95.59 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-O 117.456 -1.747 . . . . 0.0 115.829 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.95 138.2 80.78 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.93 3.087 . . . . 0.0 112.96 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 69.2 m -75.73 -4.63 41.48 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 42.4 p -88.06 -4.74 58.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.868 1.667 . . . . 0.0 113.725 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 C-N-CA 125.627 1.584 . . . . 0.0 113.703 178.635 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 0 O4'-C1'-N19 110.494 2.294 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 O4'-C1'-N19 113.844 5.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.44 0 O5'-C5'-C4' 113.258 2.184 . 0.439 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.506 0 C5'-C4'-O4' 114.156 3.54 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C3'-C2'-C1' 104.91 3.789 . 0.01 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 1 O4'-C1'-N19 112.965 4.765 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.3 t -154.44 29.42 0.44 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.437 1.095 . . . . 0.0 112.346 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.7 m -75.99 -9.48 58.65 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.17 7.6 86.83 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 124.77 1.176 . . . . 0.0 115.017 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.3 p -70.11 -15.46 62.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 114.113 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 14.4 m -64.51 -18.01 64.42 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.802 -1.186 . . . . 0.0 113.855 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -102.96 0.72 48.03 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.376 1.465 . . . . 0.0 114.551 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 33.0 tp -65.33 -14.98 62.03 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.4 1.6 . . . . 0.0 114.71 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.6 p -91.92 0.54 57.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.022 2.129 . . . . 0.0 113.76 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -158.55 -164.78 1.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.343 1.457 . . . . 0.0 111.2 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -92.22 -7.79 47.24 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 58.9 p -170.25 -171.08 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.191 1.396 . . . . 0.0 111.883 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.6 mm -78.38 -5.78 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.642 -1.286 . . . . 0.0 112.179 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 133.67 17.69 1.05 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 125.778 1.656 . . . . 0.0 115.213 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.95 -42.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.512 3.525 . . . . 0.0 115.307 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -111.38 136.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.8 124.5 23.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 111.262 172.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -75.38 3.72 8.59 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -126.44 -33.2 2.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.02 1.328 . . . . 0.0 113.137 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 43.5 p -102.26 -9.87 20.04 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.279 8.0 p30 60.96 9.73 2.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.725 2.41 . . . . 0.0 115.316 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.84 147.71 29.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.631 1.172 . . . . 0.0 111.837 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t -74.54 138.53 43.15 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.423 0.689 . . . . 0.0 110.259 168.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.36 146.63 50.74 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.0 124.56 20.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 110.758 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.4 m -93.93 -13.66 26.85 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -162.18 154.92 19.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.035 1.334 . . . . 0.0 113.444 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.47 -31.09 12.53 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.21 155.42 24.93 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.606 1.163 . . . . 0.0 113.348 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.1 p -165.67 156.32 13.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.548 1.539 . . . . 0.0 111.621 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -162.4 158.44 23.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.594 1.558 . . . . 0.0 112.416 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.2 m -80.76 116.4 20.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.787 0.835 . . . . 0.0 111.185 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -90.31 167.33 32.67 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.463 1.03 . . . . 0.0 113.515 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.5 159.34 46.46 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.032 3.155 . . . . 0.0 111.517 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 79.7 p -165.21 -47.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.383 1.073 . . . . 0.0 112.718 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.7 m 68.29 9.7 7.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.64 1.976 . . . . 0.0 114.619 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.563 1.554 . . . . 0.0 112.824 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.303 0 C5'-C4'-C3' 112.317 -2.122 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.307 1 O4'-C1'-N19 113.757 5.557 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 110.363 2.163 . 0.601 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-O4' 113.413 3.009 . 0.557 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 1 O4'-C1'-N19 112.674 4.474 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.956 2.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.7 t -163.65 174.96 11.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.445 1.498 . . . . 0.0 111.232 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.9 t -146.4 13.38 1.22 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.619 1.567 . . . . 0.0 112.649 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -80.03 1.67 78.75 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.834 1.207 . . . . 0.0 115.19 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 28.6 p -69.47 -9.97 56.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.563 1.545 . . . . 0.0 114.455 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 90.3 p -77.91 -13.31 59.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.556 1.143 . . . . 0.0 113.697 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 85.1 -8.17 71.79 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.3 1.428 . . . . 0.0 113.931 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 83.4 mt 58.08 -166.54 0.15 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.309 2.244 . . . . 0.0 113.428 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.0 p -142.49 163.54 32.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.33 2.252 . . . . 0.0 109.955 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -85.42 -8.92 58.15 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.48 170.51 12.79 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.794 2.037 . . . . 0.0 110.222 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.2 t -151.59 -177.16 5.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.314 1.846 . . . . 0.0 109.62 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.71 -11.97 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.939 1.296 . . . . 0.0 111.518 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.34 3.76 4.24 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 126.352 1.93 . . . . 0.0 115.758 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.68 -14.93 62.65 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.845 2.058 . . . . 0.0 113.402 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.28 125.31 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -66.65 126.42 28.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.229 1.012 . . . . 0.0 112.351 -172.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -59.3 -16.84 24.33 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -95.55 -28.95 14.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 0.0 113.107 -174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.4 p -132.77 -12.47 2.96 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 65.52 17.85 11.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.007 1.723 . . . . 0.0 113.435 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.6 mt -91.71 151.27 20.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.11 1.364 . . . . 0.0 111.191 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.8 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.455 -0.778 . . . . 0.0 111.514 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -66.32 141.88 57.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -81.06 152.95 27.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.219 1.007 . . . . 0.0 110.983 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 12.8 t -156.24 165.26 36.89 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.39 1.076 . . . . 0.0 112.484 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -55.73 -17.09 5.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.488 1.915 . . . . 0.0 115.58 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.63 21.24 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.443 1.897 . . . . 0.0 112.397 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -158.13 82.84 0.85 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.889 1.676 . . . . 0.0 109.769 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.1 t -169.16 160.69 9.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.865 1.666 . . . . 0.0 110.341 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.0 138.49 58.38 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.272 -0.892 . . . . 0.0 111.998 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.3 p -78.07 -7.2 56.64 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 123.92 -170.23 16.13 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.803 1.668 . . . . 0.0 113.695 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.36 164.21 29.12 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.138 3.225 . . . . 0.0 111.837 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.3 p -160.86 163.52 31.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.247 1.419 . . . . 0.0 111.906 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.0 p -134.35 4.93 3.46 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.341 1.448 . . . . 0.0 112.95 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.246 0 C4'-C3'-C2' 100.444 -2.256 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.251 1 O4'-C1'-N19 112.496 4.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.306 0 O5'-C5'-C4' 113.039 2.028 . 0.082 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.714 0 O4'-C1'-N19 111.277 3.077 . 0.413 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . 0.458 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.537 2.081 1 O4'-C1'-N19 114.081 5.881 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . 0.458 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 52.1 p -90.08 -9.26 49.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 65.5 p -164.51 161.13 21.07 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.533 1.533 . . . . 0.0 112.115 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.83 39.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.069 1.319 . . . . 0.0 113.455 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 t -159.9 146.21 15.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.873 1.269 . . . . 0.0 111.71 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 56.1 p -93.08 1.35 57.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.466 1.506 . . . . 0.0 113.338 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.54 -2.85 64.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.241 1.401 . . . . 0.0 115.584 -173.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -154.24 123.19 6.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.874 1.67 . . . . 0.0 109.665 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.9 p -150.03 135.68 18.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.898 1.679 . . . . 0.0 110.19 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -84.75 -10.79 56.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.374 0.67 . . . . 0.0 112.642 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -168.11 146.72 4.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.889 2.476 . . . . 0.0 107.138 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.3 p -151.63 149.64 29.37 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.205 -0.934 . . . . 0.0 112.481 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 80.2 mt -73.35 134.55 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.09 5.63 34.94 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -50.49 -32.8 19.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.344 1.858 . . . . 0.0 114.471 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm -111.58 131.23 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.51 126.27 26.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.349 1.06 . . . . 0.0 112.083 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -73.38 -2.65 23.13 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -114.56 -25.98 8.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.499 1.12 . . . . 0.0 113.333 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.3 p -121.0 -11.5 8.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.123 1.369 . . . . 0.0 114.262 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t30 65.75 17.04 10.75 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 113.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.4 mt -89.53 144.53 25.96 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.195 1.398 . . . . 0.0 111.02 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t -70.59 137.28 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.444 -0.785 . . . . 0.0 111.097 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.24 145.41 55.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -110.05 177.75 4.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.566 1.946 . . . . 0.0 109.048 170.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.7 m -146.34 147.46 31.36 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.282 -0.887 . . . . 0.0 110.794 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.37 35.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.27 -17.85 63.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.56 1.144 . . . . 0.0 112.908 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -160.8 165.08 30.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.065 2.146 . . . . 0.0 110.564 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 68.1 m -144.66 -27.87 0.49 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.574 1.549 . . . . 0.0 113.542 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 152.44 8.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.901 1.68 . . . . 0.0 112.536 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.4 t -152.33 126.13 8.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.049 1.34 . . . . 0.0 109.445 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 71.97 -164.75 54.22 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.709 0.671 . . . . 0.0 112.758 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.88 138.98 82.63 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.051 3.167 . . . . 0.0 112.11 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 45.1 p -137.37 1.56 2.41 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 39.0 m 64.89 1.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.791 2.037 . . . . 0.0 114.761 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 C-N-CA 127.499 2.476 . . . . 0.0 112.71 -178.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.202 0 O4'-C1'-N19 110.557 2.357 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.218 1 O4'-C1'-N19 113.209 5.009 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.517 0 O5'-C5'-C4' 113.685 2.489 . 0.475 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.384 0 C5'-C4'-O4' 113.631 3.165 . 0.178 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.222 1 O4'-C1'-N19 115.373 7.173 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 P-O3'-C3' 121.891 1.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.4 t 65.67 -164.86 0.24 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.77 1.628 . . . . 0.0 112.952 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.2 m -134.35 138.11 44.65 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.278 1.831 . . . . 0.0 110.507 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.91 9.67 86.0 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.939 0.78 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 7.8 t -68.54 -16.98 64.05 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 118.503 1.151 . . . . 0.0 113.36 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.4 p -76.39 -5.39 47.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.347 1.459 . . . . 0.0 113.903 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.71 136.24 9.27 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.415 1.96 . . . . 0.0 112.804 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.67 -16.88 2.0 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.923 1.689 . . . . 0.0 113.881 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.2 p -137.79 21.25 2.87 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.63 2.372 . . . . 0.0 111.534 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.17 143.35 15.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 109.293 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.48 14.51 24.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.288 1.435 . . . . 0.0 112.443 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 14.6 t -156.36 -174.12 4.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 109.741 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 47.8 mt -75.97 91.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.944 -1.097 . . . . 0.0 110.269 -173.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.87 -67.55 2.65 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.881 1.705 . . . . 0.0 112.652 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.72 -40.84 0.33 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.835 3.254 . . . . 0.0 114.343 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.04 127.47 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.11 114.77 8.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.523 1.129 . . . . 0.0 110.696 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -77.47 6.65 6.63 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -106.23 -25.88 11.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.413 1.085 . . . . 0.0 112.646 172.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -126.68 -5.46 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.275 5.3 p30 64.79 3.42 2.02 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.817 2.847 . . . . 0.0 116.206 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.72 155.89 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.894 1.278 . . . . 0.0 111.958 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -73.75 136.39 43.64 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.538 -0.726 . . . . 0.0 109.382 167.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -76.62 148.59 36.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -72.41 166.25 22.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.64 1.576 . . . . 0.0 112.631 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -137.75 165.76 25.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.865 2.066 . . . . 0.0 109.858 170.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -67.68 164.29 19.63 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.64 1.45 2.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.464 1.506 . . . . 0.0 114.507 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.39 -4.48 42.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.853 1.261 . . . . 0.0 114.096 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.6 m -69.32 -10.67 58.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.803 1.241 . . . . 0.0 113.939 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -69.76 130.73 43.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.728 1.211 . . . . 0.0 111.777 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.9 m -77.21 -18.93 57.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.83 47.09 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.299 1.428 . . . . 0.0 113.554 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.83 148.7 73.9 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.403 3.402 . . . . 0.0 113.336 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.8 p -78.11 -0.93 30.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.72 1.208 . . . . 0.0 113.698 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.4 m -73.69 -6.11 44.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.62 1.568 . . . . 0.0 114.374 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.639 1.59 . . . . 0.0 112.871 178.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.274 0 O4'-C1'-N19 110.774 2.574 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.29 1 O4'-C1'-N19 114.979 6.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O5'-C5'-C4' 113.301 2.215 . 0.495 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.524 0 C5'-C4'-O4' 113.541 3.101 . 0.191 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.002 1 O4'-C1'-N19 114.624 6.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.3 p -85.48 -12.94 50.62 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -147.29 145.12 29.27 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.901 1.68 . . . . 0.0 111.071 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.32 -174.03 44.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.788 1.185 . . . . 0.0 113.211 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.2 t -161.22 147.39 14.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.097 1.359 . . . . 0.0 111.448 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 34.3 p -87.32 -5.7 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.117 1.367 . . . . 0.0 113.662 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.7 142.07 3.31 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.171 1.367 . . . . 0.0 113.087 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.91 -5.73 45.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 14.0 t -155.48 134.67 12.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.508 1.923 . . . . 0.0 109.407 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -176.42 170.01 2.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.775 2.03 . . . . 0.0 110.071 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.4 156.48 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 110.916 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 45.3 m -84.29 155.72 22.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.096 1.358 . . . . 0.0 113.006 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.8 mm -69.05 141.24 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.806 0.842 . . . . 0.0 109.957 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.51 2.83 21.05 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.858 1.218 . . . . 0.0 115.909 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.71 -16.89 64.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.03 1.332 . . . . 0.0 114.127 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm -119.63 131.07 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.17 123.15 19.13 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.592 -0.693 . . . . 0.0 111.165 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.56 -14.71 53.97 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -90.19 -28.0 19.17 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 112.711 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.1 p -133.19 -11.78 2.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.96 1.304 . . . . 0.0 114.405 -169.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 61.92 25.97 15.65 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.008 1.723 . . . . 0.0 113.571 -174.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.51 146.02 24.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.105 1.362 . . . . 0.0 111.335 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t -71.6 139.1 49.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.579 -0.7 . . . . 0.0 112.38 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -72.1 143.15 49.13 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -94.42 -167.62 1.69 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.126 0.97 . . . . 0.0 112.726 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.0 p -142.16 176.83 8.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.473 2.309 . . . . 0.0 109.152 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.77 -50.97 71.31 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.543 -1.348 . . . . 0.0 111.974 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.6 p30 175.26 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.79 2.836 . . . . 0.0 112.301 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -165.4 151.26 9.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.832 2.053 . . . . 0.0 110.116 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 56.6 p -72.07 -10.15 59.39 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.52 27.91 5.49 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.728 2.011 . . . . 0.0 111.617 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 97.6 p -65.81 158.97 26.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.386 1.074 . . . . 0.0 113.505 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 76.25 -162.08 52.25 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 123.954 0.788 . . . . 0.0 113.579 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.99 -11.76 13.53 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.857 3.038 . . . . 0.0 114.061 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 40.3 m 65.84 3.81 2.69 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.314 1.846 . . . . 0.0 114.828 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.8 t -164.01 162.52 23.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.308 1.843 . . . . 0.0 111.183 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 125.272 1.415 . . . . 0.0 112.819 -177.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.689 0 C4'-C3'-C2' 99.164 -3.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 1 O4'-C1'-N19 112.276 4.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 O5'-C5'-C4' 113.131 2.094 . 0.178 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 C5'-C4'-O4' 113.686 3.204 . 0.332 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.169 1 O4'-C1'-N19 113.7 5.5 . 0.011 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 111.873 3.673 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 45.7 t -163.79 149.31 11.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.377 1.471 . . . . 0.0 111.056 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.0 m -85.12 -6.55 59.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.872 0.869 . . . . 0.0 113.081 172.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.47 4.86 80.3 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.572 1.558 . . . . 0.0 114.774 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -161.24 176.2 11.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.069 1.748 . . . . 0.0 110.663 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 m 62.44 19.96 11.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.549 1.539 . . . . 0.0 113.92 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 106.61 119.63 4.53 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.368 1.937 . . . . 0.0 111.102 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.45 -5.64 55.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.561 1.145 . . . . 0.0 113.639 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.4 p -139.8 137.92 35.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.097 2.159 . . . . 0.0 109.687 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -167.01 177.26 6.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.5 1.52 . . . . 0.0 110.872 -172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.53 172.02 16.14 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 110.708 174.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.7 m -54.4 115.82 2.31 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.45 134.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 120.92 -1.112 . . . . 0.0 110.123 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.09 56.9 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.552 1.072 . . . . 0.0 115.454 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.1 70.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm -115.58 131.64 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.57 126.76 28.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.733 1.213 . . . . 0.0 111.901 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.43 -6.49 40.69 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -114.5 -41.33 3.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.057 1.343 . . . . 0.0 112.255 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 66.1 p -100.99 -13.62 18.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.67 19.99 11.5 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.963 1.705 . . . . 0.0 113.065 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.51 146.23 23.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.89 1.276 . . . . 0.0 111.258 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t -67.09 146.52 54.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.526 -0.734 . . . . 0.0 111.842 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.09 144.18 16.01 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -48.99 125.77 11.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.206 1.002 . . . . 0.0 112.396 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.4 m -173.5 169.67 4.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.447 2.699 . . . . 0.0 109.327 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -76.46 -3.59 38.01 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -64.68 139.35 58.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.054 1.342 . . . . 0.0 111.865 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.67 140.38 12.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.826 1.251 . . . . 0.0 111.631 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 13.8 m -74.91 -6.81 51.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.77 -35.01 0.73 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.604 1.161 . . . . 0.0 113.423 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.8 m -87.61 -13.75 41.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.42 1.088 . . . . 0.0 113.105 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -79.82 -66.46 1.67 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.272 1.415 . . . . 0.0 112.589 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.26 148.79 39.46 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.729 2.952 . . . . 0.0 111.584 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.7 m -164.16 155.81 16.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.567 1.947 . . . . 0.0 110.797 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.2 m -77.42 -6.11 52.22 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.693 1.616 . . . . 0.0 112.999 -178.944 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.344 0 C4'-C3'-C2' 99.934 -2.766 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.661 1 O4'-C1'-N19 112.485 4.285 . 0.069 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 O4'-C1'-N19 110.778 2.578 . 0.215 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-O4' 113.544 3.103 . 0.634 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . 0.467 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.028 1 O4'-C1'-N19 113.856 5.656 . 0.016 3b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . 0.467 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.607 1 O4'-C1'-N19 113.966 5.766 . 0.03 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 32.9 t -163.79 155.6 16.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.414 1.485 . . . . 0.0 111.207 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.9 p -84.26 -7.9 59.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.605 1.162 . . . . 0.0 113.368 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.51 155.52 25.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.27 1.414 . . . . 0.0 112.939 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.4 m -148.16 148.57 30.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.462 1.505 . . . . 0.0 111.093 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.4 m -69.32 132.93 47.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.26 -0.9 . . . . 0.0 112.459 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -81.0 1.73 83.56 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.572 1.082 . . . . 0.0 114.716 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.3 tt -153.25 116.19 4.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.675 1.99 . . . . 0.0 107.715 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 53.6 p -119.6 -10.85 9.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.31 129.36 19.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.278 1.431 . . . . 0.0 108.917 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -160.33 -46.93 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.546 0.738 . . . . 0.0 111.891 -170.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.3 p -162.6 -177.69 5.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.525 1.13 . . . . 0.0 112.2 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 98.7 mt -73.33 -14.02 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.786 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 141.23 -31.22 2.18 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 126.885 2.183 . . . . 0.0 113.33 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.76 -31.53 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.197 2.999 . . . . 0.0 117.011 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.83 132.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.62 124.04 22.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.007 0.923 . . . . 0.0 111.709 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -80.67 9.44 6.18 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -116.03 -23.54 8.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.684 1.194 . . . . 0.0 113.185 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.8 p -126.14 -11.53 6.43 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 114.437 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 22.6 m120 67.0 15.49 10.16 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.79 2.036 . . . . 0.0 114.222 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.98 139.29 30.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.966 1.306 . . . . 0.0 110.945 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t -66.12 138.44 57.74 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.465 -0.772 . . . . 0.0 110.408 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -74.06 153.79 39.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -75.58 154.53 36.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.216 1.006 . . . . 0.0 111.493 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.3 p -158.65 165.28 34.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.012 2.125 . . . . 0.0 110.611 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.98 -19.64 57.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -165.57 157.8 15.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.208 1.803 . . . . 0.0 111.109 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -159.7 -43.23 0.05 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.811 2.044 . . . . 0.0 112.068 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 85.7 p -158.8 19.21 0.2 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.72 1.208 . . . . 0.0 113.669 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -75.95 71.87 2.78 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.679 -1.263 . . . . 0.0 112.706 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.1 t -159.74 174.13 14.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.431 1.893 . . . . 0.0 111.342 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.37 160.87 51.31 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.5 1.048 . . . . 0.0 113.596 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.21 155.8 46.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.076 3.184 . . . . 0.0 111.814 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.8 m -76.73 -3.48 38.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 80.9 p -164.36 164.76 22.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.11 1.764 . . . . 0.0 111.892 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.202 0 C-N-CA 124.948 1.261 . . . . 0.0 112.893 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 0 O4'-C1'-N19 109.987 1.787 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 113.274 5.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.617 0 C3'-C2'-C1' 103.705 2.45 . 0.354 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O4'-C1'-N19 111.084 2.884 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.225 2 O4'-C1'-N19 115.629 7.429 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 111.239 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.5 p -165.39 158.92 16.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.364 1.466 . . . . 0.0 111.792 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -142.88 144.93 32.66 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.941 1.296 . . . . 0.0 111.459 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.5 -179.33 34.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.06 1.314 . . . . 0.0 113.359 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.6 p -164.85 158.89 17.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 112.219 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.4 m -89.76 1.12 56.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.404 1.082 . . . . 0.0 113.748 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 167.15 -153.44 23.02 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.249 1.404 . . . . 0.0 113.278 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.38 163.16 28.49 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.839 1.656 . . . . 0.0 111.382 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.8 m -134.26 148.65 50.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.044 1.738 . . . . 0.0 109.436 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -149.99 152.42 34.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.98 1.312 . . . . 0.0 110.292 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -62.15 139.63 58.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.975 0.91 . . . . 0.0 111.726 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.3 t -163.27 -179.23 6.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.853 1.261 . . . . 0.0 111.588 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 77.5 mt -73.58 138.87 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.453 1.501 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 114.54 -2.81 23.4 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 125.197 1.379 . . . . 0.0 116.263 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.06 70.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.071 0.948 . . . . 0.0 112.493 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm -99.82 133.11 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.32 -35.1 78.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 114.444 -169.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.254 1.4 ptpp? 78.63 -17.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 131.26 3.824 . . . . 0.0 115.3 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.179 0.899 . . . . 0.0 111.063 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.8 p -108.6 -10.92 15.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.199 1.8 . . . . 0.0 113.647 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 65.99 9.25 6.01 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.625 1.97 . . . . 0.0 113.57 -171.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.8 mt -91.44 155.9 18.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.892 1.277 . . . . 0.0 111.83 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t -70.13 139.37 52.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.73 0.812 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -58.96 148.66 29.74 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -129.71 -154.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.143 2.177 . . . . 0.0 108.985 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.4 p -131.53 158.51 40.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.683 1.593 . . . . 0.0 110.794 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -62.3 141.38 58.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.833 0.853 . . . . 0.0 112.214 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -60.84 -18.94 58.78 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.71 131.15 23.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.707 1.603 . . . . 0.0 109.99 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.5 t -170.47 172.28 6.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.836 1.654 . . . . 0.0 111.069 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -153.24 119.75 5.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.669 1.587 . . . . 0.0 110.904 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 61.8 p -126.31 -1.7 6.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.987 1.315 . . . . 0.0 114.204 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.08 -163.21 38.94 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 125.379 1.466 . . . . 0.0 113.16 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -69.0 165.36 30.38 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.528 2.818 . . . . 0.0 111.335 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.9 m -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.8 m -166.42 157.8 13.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.475 2.31 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.975 -179.558 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.308 0 C4'-C3'-C2' 100.476 -2.224 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.233 1 O4'-C1'-N19 114.496 6.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 110.977 2.777 . 0.387 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 C5'-C4'-O4' 113.472 3.052 . 0.325 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . 0.416 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C3'-C2'-C1' 104.703 3.559 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . 0.416 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 O4'-C1'-N19 111.971 3.771 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.5 m -80.43 -8.72 59.65 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 18.4 m -163.99 154.42 15.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.08 2.152 . . . . 0.0 110.512 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.67 -2.74 89.86 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 124.451 1.024 . . . . 0.0 114.877 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 93.3 p -165.87 171.35 12.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.244 1.818 . . . . 0.0 111.28 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.3 p -83.99 -0.22 50.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.781 1.232 . . . . 0.0 113.846 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.89 -159.08 25.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.109 1.814 . . . . 0.0 112.527 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.99 126.06 28.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.885 0.874 . . . . 0.0 110.215 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.8 m -65.17 121.94 15.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.146 1.378 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -145.52 142.86 29.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.656 1.583 . . . . 0.0 109.317 -172.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -9.8 58.93 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.291 0.636 . . . . 0.0 112.61 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -76.01 8.6 3.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.949 1.699 . . . . 0.0 114.722 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.52 122.27 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 127.627 2.371 . . . . 0.0 108.662 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 8.78 80.36 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.394 0.997 . . . . 0.0 114.951 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -76.23 -14.33 60.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.519 1.528 . . . . 0.0 114.224 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.61 126.5 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.25 124.11 22.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.084 0.553 . . . . 0.0 111.106 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -62.35 -14.37 39.09 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -92.36 -27.06 17.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.757 1.223 . . . . 0.0 112.975 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -128.77 -15.59 4.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.117 1.367 . . . . 0.0 113.926 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.4 t30 64.43 24.68 13.21 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.872 2.069 . . . . 0.0 113.538 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.9 mt -102.14 152.04 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.107 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t -70.09 137.12 50.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.477 -0.764 . . . . 0.0 111.438 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -77.82 165.97 23.5 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.6 mtp-105 -68.86 143.93 54.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.874 0.87 . . . . 0.0 111.444 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.7 p -80.32 143.61 33.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.927 0.891 . . . . 0.0 111.416 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -131.04 4.76 4.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.49 171.08 12.85 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.176 1.39 . . . . 0.0 110.821 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.65 140.36 23.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.838 1.255 . . . . 0.0 112.318 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 30.5 t -165.51 139.3 4.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.068 2.147 . . . . 0.0 108.828 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -128.96 1.17 5.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -168.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.2 p -168.1 164.26 13.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.0 1.32 . . . . 0.0 112.438 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -171.64 168.7 41.82 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.943 1.258 . . . . 0.0 113.5 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.7 147.0 34.73 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.929 3.086 . . . . 0.0 111.562 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.4 p -165.06 162.85 20.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.461 1.504 . . . . 0.0 111.925 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.7 m -135.79 10.29 3.37 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.318 1.047 . . . . 0.0 113.712 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 C-N-CA 125.33 1.443 . . . . 0.0 112.999 -177.793 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 100.627 -2.073 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 1 O4'-C1'-N19 113.645 5.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.195 0 O4'-C1'-N19 110.768 2.568 . 0.053 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 P-O3'-C3' 124.286 3.822 . 0.422 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.027 1 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.205 3.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 75.1 p -164.47 166.43 20.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.395 1.478 . . . . 0.0 111.809 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.2 t -162.32 176.97 10.01 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.442 1.497 . . . . 0.0 111.127 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.93 -150.62 16.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.788 1.661 . . . . 0.0 112.58 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.0 m 70.2 9.67 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.15 1.78 . . . . 0.0 114.543 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 71.7 m -146.51 159.37 43.5 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.309 1.844 . . . . 0.0 111.326 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 98.31 -151.58 19.63 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.88 1.228 . . . . 0.0 112.892 -178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.6 tp -156.09 150.23 25.42 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.594 1.558 . . . . 0.0 110.86 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.0 t -158.27 160.92 37.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.235 1.814 . . . . 0.0 110.809 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.13 -5.59 49.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.04 1.336 . . . . 0.0 112.655 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.16 141.92 4.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.533 1.533 . . . . 0.0 111.069 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.7 t -65.78 149.86 49.47 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.645 -0.659 . . . . 0.0 111.602 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.6 mt -116.71 136.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.086 1.754 . . . . 0.0 109.084 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 16.94 63.24 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 123.746 0.689 . . . . 0.0 113.65 -170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.7 -16.15 60.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 114.719 -169.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt -129.4 132.95 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -63.63 127.43 31.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.529 1.131 . . . . 0.0 111.527 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -70.41 -10.3 58.72 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -105.04 -38.99 6.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 62.2 p -103.04 -16.04 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.0 t30 63.05 21.33 12.83 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.487 1.915 . . . . 0.0 113.749 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.79 143.49 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.9 1.28 . . . . 0.0 110.794 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t -66.55 135.16 53.76 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -65.11 149.82 49.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -163.02 1.62 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.536 1.534 . . . . 0.0 109.858 169.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.6 m -131.99 161.99 31.81 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.958 0.903 . . . . 0.0 111.292 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -87.66 131.47 34.43 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.267 -0.896 . . . . 0.0 111.073 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -160.13 136.57 8.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.236 1.414 . . . . 0.0 110.647 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.82 -11.98 59.51 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 54.2 m -124.77 0.91 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.427 1.491 . . . . 0.0 113.743 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -139.1 133.44 31.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.271 1.428 . . . . 0.0 111.65 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.0 p -167.09 162.36 15.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.521 1.528 . . . . 0.0 111.48 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.89 -175.52 55.01 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.226 0.917 . . . . 0.0 113.713 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.25 149.28 35.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.85 3.033 . . . . 0.0 111.289 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m -77.43 -4.59 46.15 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 t -164.97 169.15 16.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.267 1.827 . . . . 0.0 111.201 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.405 1.479 . . . . 0.0 112.836 -178.67 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 C5'-C4'-O4' 106.369 -2.022 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.112 1 O4'-C1'-N19 114.071 5.871 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O5'-C5'-C4' 114.976 3.412 . 0.391 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 123.587 3.239 . 0.406 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.109 1 O4'-C1'-N19 113.9 5.7 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 O4'-C1'-N19 111.472 3.272 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -65.41 150.4 48.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.375 1.07 . . . . 0.0 112.756 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.3 t -161.24 169.99 21.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.71 1.204 . . . . 0.0 111.7 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.41 -136.32 24.76 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.522 1.058 . . . . 0.0 111.351 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 84.0 p -82.96 -12.06 57.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.7 m 63.19 1.08 0.85 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.045 2.138 . . . . 0.0 114.591 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -90.71 -9.68 64.08 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.247 1.403 . . . . 0.0 114.726 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.9 mt -142.38 141.12 32.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.404 1.882 . . . . 0.0 110.04 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.6 p -147.81 155.51 41.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.426 1.89 . . . . 0.0 110.508 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -147.44 137.96 23.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -64.45 -23.76 67.39 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.546 -0.721 . . . . 0.0 112.083 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.6 p -67.1 -0.04 3.0 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 26.7 mt -128.85 -41.13 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.471 2.708 . . . . 0.0 110.909 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -88.37 -14.7 61.53 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 126.677 2.084 . . . . 0.0 116.196 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -126.03 -8.09 6.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.738 1.269 . . . . 0.0 113.976 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.24 127.1 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.0 124.23 23.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.304 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -61.16 -15.1 30.1 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.3 -27.92 19.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 112.925 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.6 p -133.01 -13.63 2.77 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.69 19.74 11.88 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.8 mt -90.79 151.12 21.31 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.272 1.429 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t -71.58 136.96 47.66 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.602 -0.686 . . . . 0.0 110.481 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.98 152.29 40.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.51 133.94 55.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.012 1.325 . . . . 0.0 111.123 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 72.0 m -148.9 141.36 24.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.645 1.578 . . . . 0.0 110.368 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.49 134.36 45.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.517 -0.74 . . . . 0.0 111.693 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -165.2 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.019 1.328 . . . . 0.0 113.103 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.2 148.44 16.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.468 1.507 . . . . 0.0 111.132 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.4 t -164.28 169.2 17.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 111.364 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -155.69 -45.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.104 1.362 . . . . 0.0 112.94 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.3 p -170.37 166.6 8.55 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.545 1.538 . . . . 0.0 111.611 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -162.32 172.01 38.33 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.748 1.165 . . . . 0.0 113.701 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.32 156.05 46.18 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.05 3.167 . . . . 0.0 111.88 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 25.0 m -158.91 144.8 16.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.269 1.828 . . . . 0.0 110.735 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.6 p -92.54 -6.32 49.89 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 125.484 1.516 . . . . 0.0 112.857 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.338 0 O4'-C1'-N19 110.86 2.66 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.302 1 O4'-C1'-N19 113.713 5.513 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 O5'-C5'-C4' 113.043 2.031 . 0.249 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 C5'-C4'-O4' 113.319 2.942 . 0.388 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.139 1 O4'-C1'-N19 113.487 5.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 111.527 3.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.8 p -166.14 179.54 5.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.677 1.591 . . . . 0.0 111.359 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.6 m -71.24 -5.21 30.36 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.847 -1.158 . . . . 0.0 113.991 173.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.72 174.86 50.64 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.421 . . . . 0.0 113.589 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -2.32 58.45 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.1 m -69.65 138.05 52.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.005 1.322 . . . . 0.0 113.05 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.94 67.06 3.3 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.125 1.345 . . . . 0.0 112.971 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.5 7.22 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.396 1.479 . . . . 0.0 114.347 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.5 p -76.67 -12.98 60.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.495 1.518 . . . . 0.0 113.579 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -159.61 149.94 18.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.606 1.962 . . . . 0.0 108.726 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -77.92 144.05 37.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.724 -0.61 . . . . 0.0 110.03 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.7 m -67.22 139.78 57.4 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.336 -0.853 . . . . 0.0 111.499 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 65.1 mt -96.43 104.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.108 0.963 . . . . 0.0 109.408 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.29 0.7 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.966 1.746 . . . . 0.0 113.111 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.67 -8.4 11.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.661 1.584 . . . . 0.0 115.054 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.32 142.08 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -68.18 122.83 19.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 111.945 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.38 -9.13 46.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -99.38 -31.27 11.76 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.884 1.273 . . . . 0.0 112.622 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.3 p -132.97 -7.54 3.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 55.0 t30 66.61 18.69 10.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.188 1.795 . . . . 0.0 113.873 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.41 147.65 22.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.079 1.352 . . . . 0.0 111.042 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t -65.62 140.47 58.51 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.163 -0.96 . . . . 0.0 112.107 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.4 144.1 47.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.6 -124.82 2.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.111 1.364 . . . . 0.0 110.209 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.1 t -160.39 163.09 33.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.173 1.789 . . . . 0.0 110.513 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.33 -11.06 55.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.151 0.98 . . . . 0.0 113.249 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.59 127.96 34.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -151.63 1.79 0.38 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.919 1.288 . . . . 0.0 113.615 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.7 p -171.76 162.64 6.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.649 1.58 . . . . 0.0 111.83 -172.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.58 -28.32 63.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.302 -0.874 . . . . 0.0 113.032 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -168.28 162.18 12.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.762 2.025 . . . . 0.0 110.566 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -81.39 170.97 52.84 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.42 1.009 . . . . 0.0 113.708 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.21 118.53 5.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.724 2.95 . . . . 0.0 110.583 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 50.5 m 66.01 -9.49 0.28 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.21 2.204 . . . . 0.0 115.394 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 14.9 t -168.48 153.64 6.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.921 2.088 . . . . 0.0 110.649 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.322 1.439 . . . . 0.0 113.031 -177.029 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.47 0 C5'-C4'-C3' 112.306 -2.129 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.491 1 O4'-C1'-N19 114.063 5.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O5'-C5'-C4' 113.494 2.353 . 0.413 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 0 O5'-C5'-C4' 113.66 2.472 . 0.409 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.084 1 O4'-C1'-N19 113.758 5.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C4'-C3'-C2' 100.739 -1.961 . 0.35 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 40.7 t -163.42 149.92 12.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.142 1.377 . . . . 0.0 111.278 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.5 m -81.6 -5.1 57.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.447 1.099 . . . . 0.0 113.344 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.52 -176.44 36.76 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.345 1.45 . . . . 0.0 113.36 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 46.4 p -92.12 0.88 57.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.07 1.348 . . . . 0.0 114.532 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p -160.65 171.05 19.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.403 1.481 . . . . 0.0 112.402 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 96.93 -163.13 22.22 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.005 1.288 . . . . 0.0 113.624 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.4 179.34 6.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.629 1.972 . . . . 0.0 111.113 -175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.7 p -67.91 168.82 10.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.166 1.787 . . . . 0.0 112.148 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -152.02 152.06 31.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.712 1.605 . . . . 0.0 109.274 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.52 156.43 35.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.777 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.2 m -88.07 19.41 3.66 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 113.686 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 24.6 mt -129.68 123.7 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.417 1.887 . . . . 0.0 109.325 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.03 -33.24 55.32 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 124.02 0.819 . . . . 0.0 113.384 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.46 -30.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.175 2.99 . . . . 0.0 117.997 168.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.55 132.71 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.5 132.21 52.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 113.042 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -69.31 -11.19 60.6 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -113.24 -43.59 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 112.091 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.5 p -98.98 -14.65 19.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 60.76 24.14 14.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.84 1.656 . . . . 0.0 113.361 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.24 142.05 27.99 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 110.887 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t -66.32 138.97 57.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -63.36 149.23 46.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -60.46 148.33 37.96 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.611 -0.681 . . . . 0.0 110.876 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.1 t -162.89 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -156.56 155.0 31.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -164.85 149.04 9.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.418 1.887 . . . . 0.0 110.695 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.72 116.41 2.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.2 m -70.64 -11.37 60.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.173 . . . . 0.0 113.882 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? 42.27 -130.79 0.56 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.098 2.159 . . . . 0.0 114.067 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.4 m -78.5 0.14 27.21 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.904 1.281 . . . . 0.0 114.411 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.48 -162.11 49.0 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 124.328 0.966 . . . . 0.0 112.9 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.3 158.96 47.85 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.729 2.952 . . . . 0.0 111.59 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.3 p -79.94 -3.15 46.98 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.6 t -163.5 161.63 24.21 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.158 1.783 . . . . 0.0 111.175 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.26 1.41 . . . . 0.0 112.852 -178.011 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 C4'-C3'-C2' 100.546 -2.154 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.121 1 O4'-C1'-N19 114.16 5.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.372 0 C4'-C3'-C2' 100.465 -2.235 . 0.594 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 0 O4'-C1'-N19 111.958 3.758 . 0.452 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.009 1 O4'-C1'-N19 113.117 4.917 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 111.246 3.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.7 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp . . . . . 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.216 0.531 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm . . . . . 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.711 0.767 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt . . . . . 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt . . . . . 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 121.362 0.601 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.51 0.672 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 121.386 0.612 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.8 t . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.247 0.546 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 121.517 0.675 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.825 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp . . . . . 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.527 0.68 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 121.521 0.677 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt . . . . . 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.229 0.538 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.76 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.434 0.635 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp . . . . . 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.509 0.671 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt . . . . . 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.664 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm . . . . . 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 121.166 0.508 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.4 0.619 . . . . 0.0 112.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 117.997 2.591 . . . . 0.0 117.997 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.622 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 98.6 p -165.05 174.15 10.73 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.251 1.421 . . . . 0.0 111.911 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.3 m -75.87 1.36 15.29 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.68 -34.42 1.85 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.895 1.712 . . . . 0.0 114.958 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.2 t -160.84 145.71 14.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.528 1.531 . . . . 0.0 111.462 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 69.1 m -79.54 -9.07 59.55 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -93.1 -1.14 67.37 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 125.281 1.42 . . . . 0.0 114.227 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 30.7 tp -77.91 146.45 35.57 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.855 1.262 . . . . 0.0 111.821 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.3 p -82.78 15.43 2.67 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.938 2.095 . . . . 0.0 113.531 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -147.78 175.38 10.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.893 2.477 . . . . 0.0 108.993 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.56 172.63 14.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.648 0.779 . . . . 0.0 112.683 -173.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 70.4 m -57.93 142.51 46.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.589 1.156 . . . . 0.0 112.2 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.4 67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.189 0.996 . . . . 0.0 109.925 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -102.74 6.15 51.78 Favored Glycine 0 N--CA 1.472 1.049 0 C-N-CA 125.145 1.355 . . . . 0.0 114.202 173.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -119.57 -17.12 8.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.124 1.369 . . . . 0.0 114.526 -169.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -91.94 136.58 33.05 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.607 1.163 . . . . 0.0 111.616 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.52 87.06 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.567 1.08 . . . . 0.0 113.155 -170.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 9.2 t -86.59 -171.69 3.66 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.769 1.228 . . . . 0.0 111.419 172.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -157.55 7.59 0.16 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.906 1.682 . . . . 0.0 113.176 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -63.95 126.46 27.72 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.226 -0.921 . . . . 0.0 111.708 -176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -81.16 128.99 34.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.808 0.843 . . . . 0.0 109.909 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -71.78 166.59 53.12 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 123.765 0.698 . . . . 0.0 113.389 -178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.25 174.98 7.31 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.781 2.987 . . . . 0.0 112.395 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.87 121.05 7.77 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.65 1.18 . . . . 0.0 112.175 -174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.44 -3.42 73.31 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.869 1.223 . . . . 0.0 114.716 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -106.4 -2.81 21.73 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.383 1.473 . . . . 0.0 114.012 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.68 133.95 43.28 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.051 1.34 . . . . 0.0 111.261 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.5 151.19 38.99 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.372 1.469 . . . . 0.0 112.342 -175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -119.67 128.42 53.81 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.588 2.355 . . . . 0.0 108.978 169.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.44 138.22 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.295 2.238 . . . . 0.0 107.847 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -139.71 151.63 46.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.753 1.221 . . . . 0.0 111.346 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 84.06 23.95 0.12 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 129.241 3.016 . . . . 0.0 113.985 -175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.64 160.47 67.52 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 120.912 -1.117 . . . . 0.0 112.92 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.43 155.04 60.11 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.57 2.847 . . . . 0.0 111.292 167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -81.27 -12.18 59.17 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -100.42 3.84 43.37 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.952 1.701 . . . . 0.0 113.466 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.26 128.84 36.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.383 1.073 . . . . 0.0 110.906 179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.49 174.34 20.23 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.93 1.252 . . . . 0.0 113.9 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -61.42 -33.61 74.0 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.575 1.15 . . . . 0.0 112.684 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.36 -30.38 53.79 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.847 0.859 . . . . 0.0 112.052 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -68.09 -44.28 76.6 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.714 0.688 . . . . 0.0 110.546 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.69 -35.08 79.75 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.274 0.63 . . . . 0.0 112.038 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.42 -53.9 44.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.906 0.483 . . . . 0.0 111.528 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -66.42 -25.04 66.57 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.628 0.649 . . . . 0.0 112.665 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.93 -37.9 79.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.477 1.511 . . . . 0.0 112.512 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.62 -10.61 20.77 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.291 1.437 . . . . 0.0 114.583 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 22.7 mtt -43.52 -44.12 13.33 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 174.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -62.34 -16.16 49.63 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.227 2.618 . . . . 0.0 116.164 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -99.96 -2.53 34.39 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.98 -174.91 25.75 Favored Glycine 0 N--CA 1.472 1.05 0 C-N-CA 125.209 1.385 . . . . 0.0 114.343 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -81.44 124.28 29.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.127 0.971 . . . . 0.0 112.368 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.4 t -105.57 129.13 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 126.067 1.747 . . . . 0.0 109.906 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.4 t -87.21 -34.23 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 126.986 2.114 . . . . 0.0 111.356 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 47.8 t -165.87 133.73 2.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.937 1.295 . . . . 0.0 110.244 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.81 133.64 32.34 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.495 1.118 . . . . 0.0 109.71 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -151.84 131.19 12.87 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -170.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 47.2 t -96.72 135.37 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 167.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -76.7 111.34 12.11 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.538 0.608 . . . . 0.0 110.027 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 25.7 mm -104.5 134.36 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.301 1.44 . . . . 0.0 110.159 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.21 119.9 12.29 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.306 1.042 . . . . 0.0 111.049 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -64.63 -10.93 30.09 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -93.19 -29.47 15.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.619 1.168 . . . . 0.0 112.869 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.5 p -133.0 -10.89 2.98 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -169.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.85 24.8 12.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.231 1.812 . . . . 0.0 113.715 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.5 mt -101.28 148.25 25.34 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.618 1.567 . . . . 0.0 111.122 174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.0 t -71.15 143.16 50.64 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.066 0.936 . . . . 0.0 112.677 173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -85.51 13.2 7.16 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.654 1.582 . . . . 0.0 113.195 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.8 m 72.49 12.78 5.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.134 2.174 . . . . 0.0 114.362 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -133.88 149.46 51.33 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.131 0.973 . . . . 0.0 112.02 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.42 -177.81 28.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.298 1.427 . . . . 0.0 113.738 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -149.14 149.41 30.99 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.54 1.536 . . . . 0.0 112.34 -168.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.2 t -143.36 129.2 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.354 1.062 . . . . 0.0 109.374 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 54.3 m -109.21 111.14 22.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.721 1.608 . . . . 0.0 110.364 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -86.66 163.27 17.48 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 121.606 -0.684 . . . . 0.0 111.365 169.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -78.44 -8.6 58.68 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -153.34 158.66 32.73 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.169 1.388 . . . . 0.0 111.605 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.59 -20.56 7.95 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.711 2.274 . . . . 0.0 113.956 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.32 -37.99 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.732 1.151 . . . . 0.0 110.4 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.6 m -67.02 -38.2 85.51 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 118.656 0.662 . . . . 0.0 112.234 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.04 74.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.66 0.784 . . . . 0.0 112.206 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 43.4 mm-40 -57.31 -46.15 83.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.893 0.877 . . . . 0.0 112.293 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.08 -34.49 73.52 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.535 0.734 . . . . 0.0 112.68 175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -35.28 66.76 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.768 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.11 -48.11 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 120.084 1.311 . . . . 0.0 109.697 170.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 19.0 mm-40 -64.48 -24.84 67.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.534 1.134 . . . . 0.0 113.033 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.9 m -98.09 -27.07 14.37 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.444 1.275 . . . . 0.0 114.444 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.1 mmm -114.34 -17.01 11.91 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -169.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -69.51 113.03 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.659 1.118 . . . . 0.0 110.08 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 4.44 58.83 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.933 1.73 . . . . 0.0 114.81 -173.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -63.38 123.26 18.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.675 1.737 . . . . 0.0 110.788 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -85.57 129.49 34.81 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.385 0.539 . . . . 0.0 110.806 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.45 129.67 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.469 1.508 . . . . 0.0 110.16 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.73 -79.01 0.48 Allowed Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.519 1.056 . . . . 0.0 112.266 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 35.6 tpp -158.9 19.64 0.2 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.059 2.143 . . . . 0.0 112.067 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -150.31 159.72 44.24 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.584 1.553 . . . . 0.0 112.376 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -105.63 134.43 48.75 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.15 0.98 . . . . 0.0 112.055 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.07 141.11 49.24 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.998 1.319 . . . . 0.0 111.656 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -107.01 131.23 54.3 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.266 1.426 . . . . 0.0 108.593 169.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.7 t -141.34 137.45 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.019 0.928 . . . . 0.0 110.552 -172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -162.76 177.64 9.15 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.672 1.589 . . . . 0.0 110.906 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.63 146.42 54.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.156 0.583 . . . . 0.0 110.241 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -72.47 150.09 43.59 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 112.973 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -74.41 145.42 43.72 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.446 1.498 . . . . 0.0 111.29 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.7 p -168.87 154.45 6.33 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.241 1.816 . . . . 0.0 110.875 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -67.61 131.17 45.11 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.38 -0.825 . . . . 0.0 111.846 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -157.11 31.36 0.29 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.444 1.498 . . . . 0.0 111.32 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -163.15 170.58 17.61 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.983 1.713 . . . . 0.0 112.343 -169.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 87.7 p -145.86 164.95 30.34 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.683 1.593 . . . . 0.0 111.756 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -144.76 156.99 44.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.89 1.676 . . . . 0.0 111.842 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.5 m -64.94 146.49 54.9 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.525 1.13 . . . . 0.0 112.967 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.07 -74.15 0.95 Allowed Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.652 1.12 . . . . 0.0 112.715 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.04 138.99 26.41 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.509 2.806 . . . . 0.0 111.065 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 61.5 p -103.68 -2.73 26.07 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.948 1.299 . . . . 0.0 113.729 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 64.4 p -117.76 -0.57 11.75 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.633 1.573 . . . . 0.0 114.406 -171.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.18 0 C-N-CA 125.075 1.321 . . . . 0.0 113.114 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.332 0 C5'-C4'-C3' 112.455 -2.03 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.313 1 O4'-C1'-N19 114.577 6.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 O5'-C5'-C4' 113.467 2.334 . 0.441 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.466 0 C5'-C4'-O4' 113.327 2.948 . 0.232 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.026 1 O4'-C1'-N19 114.206 6.006 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.513 0 O4'-C1'-N19 111.53 3.33 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 48.2 p -89.83 -8.13 52.73 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -176.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 35.0 t -163.78 154.52 15.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.582 1.553 . . . . 0.0 111.555 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.38 2.67 85.15 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.114 1.34 . . . . 0.0 113.846 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 69.2 m -138.7 163.82 31.15 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.521 1.528 . . . . 0.0 112.237 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.6 t -158.29 170.68 21.7 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.981 1.313 . . . . 0.0 111.631 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 88.06 -179.12 46.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.332 1.444 . . . . 0.0 113.14 -172.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 40.3 tp -157.94 143.23 16.83 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.909 1.284 . . . . 0.0 111.08 -176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 41.6 p -116.87 8.63 13.61 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.377 1.871 . . . . 0.0 113.708 -172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -143.59 168.76 19.11 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.016 1.727 . . . . 0.0 110.816 -169.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -67.62 -7.72 28.73 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.345 1.458 . . . . 0.0 114.665 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 94.0 p -165.99 165.1 18.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.514 1.926 . . . . 0.0 110.27 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.7 mt -81.24 74.05 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.182 -0.949 . . . . 0.0 109.294 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 74.43 13.41 81.7 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.013 1.292 . . . . 0.0 114.925 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.66 -27.74 0.11 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 128.624 2.77 . . . . 0.0 116.519 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.76 128.55 33.57 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.516 1.526 . . . . 0.0 114.018 -170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.58 71.68 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.406 1.479 . . . . 0.0 113.193 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 33.1 t -79.49 155.68 28.16 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.682 1.193 . . . . 0.0 112.116 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 26.53 6.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.082 1.353 . . . . 0.0 111.438 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.29 82.76 0.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.152 0.981 . . . . 0.0 110.513 169.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 136.6 58.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.845 1.258 . . . . 0.0 110.648 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.61 -170.92 44.85 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 125.887 1.708 . . . . 0.0 114.175 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.9 173.28 14.28 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.939 3.093 . . . . 0.0 112.348 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.63 127.5 32.34 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.308 1.043 . . . . 0.0 111.799 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.15 -4.2 68.06 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.967 1.27 . . . . 0.0 114.936 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -95.55 0.46 53.05 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.0 1.4 . . . . 0.0 114.084 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -109.6 113.67 26.65 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.223 1.009 . . . . 0.0 111.949 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 29.4 mt -97.18 148.21 23.31 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.055 1.342 . . . . 0.0 112.17 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -117.24 127.16 53.82 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.303 2.241 . . . . 0.0 107.811 168.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.82 133.59 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 126.726 2.01 . . . . 0.0 108.061 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -127.83 157.55 40.13 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.157 1.383 . . . . 0.0 111.133 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 72.37 29.52 2.15 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.247 2.219 . . . . 0.0 113.997 -175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.73 155.7 68.77 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 120.844 -1.16 . . . . 0.0 111.76 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.72 149.44 87.64 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.035 2.49 . . . . 0.0 110.584 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -70.15 -19.47 63.2 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 121.517 -0.739 . . . . 0.0 112.57 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -95.22 -0.13 53.42 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.673 1.589 . . . . 0.0 113.975 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -71.77 126.42 29.67 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.541 1.136 . . . . 0.0 111.491 -175.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.91 170.49 29.23 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.668 1.128 . . . . 0.0 113.349 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -63.37 -33.43 75.52 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.036 0.934 . . . . 0.0 112.704 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -77.18 -24.34 51.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.294 1.438 . . . . 0.0 112.682 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -73.4 -40.73 64.08 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 119.208 0.913 . . . . 0.0 110.348 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.8 tp -63.77 -37.02 85.82 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.435 0.694 . . . . 0.0 111.469 172.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 34.1 tp -63.27 -53.11 58.01 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.823 -0.548 . . . . 0.0 111.646 173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -67.72 -21.22 65.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 5.7 tpp -73.07 -39.54 65.78 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.416 1.086 . . . . 0.0 112.326 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -104.86 -18.51 14.19 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -170.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 38.2 mtm -50.47 -38.31 38.97 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 171.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.49 -14.65 7.43 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 124.146 3.231 . . . . 0.0 116.521 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -105.92 -1.09 24.51 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.387 1.075 . . . . 0.0 113.851 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 146.18 177.36 20.78 Favored Glycine 0 N--CA 1.473 1.146 0 C-N-CA 125.168 1.366 . . . . 0.0 114.629 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -69.14 127.61 33.73 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.622 0.769 . . . . 0.0 111.901 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 77.8 t -105.46 122.86 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.616 1.567 . . . . 0.0 109.63 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.32 -35.52 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.225 1.81 . . . . 0.0 110.872 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.2 p -161.09 148.09 15.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.568 1.147 . . . . 0.0 111.794 176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -135.14 130.86 36.08 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.915 1.686 . . . . 0.0 109.039 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 54.3 tptt -146.92 106.51 3.93 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 92.7 t -83.23 131.3 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -76.52 113.45 14.15 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.649 -175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.1 mm -111.79 122.59 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 108.851 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -66.19 124.72 23.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.107 0.563 . . . . 0.0 110.945 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -80.2 4.41 17.6 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -96.69 -29.6 13.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.686 1.195 . . . . 0.0 111.569 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.8 p -126.74 -13.93 5.77 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 126.313 1.845 . . . . 0.0 114.016 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.4 t30 67.03 22.72 9.92 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.133 2.173 . . . . 0.0 113.51 -175.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.17 144.67 26.78 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.051 1.341 . . . . 0.0 112.219 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 40.7 t -71.62 139.1 49.17 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.388 0.614 . . . . 0.0 111.69 170.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -93.97 11.64 28.94 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.204 1.002 . . . . 0.0 113.101 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 99.3 m 64.95 21.36 12.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.941 1.696 . . . . 0.0 114.06 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.99 155.23 50.56 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.26 1.424 . . . . 0.0 110.844 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -162.0 -173.83 31.14 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.09 0.852 . . . . 0.0 113.937 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -142.28 150.48 40.9 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 125.467 1.507 . . . . 0.0 111.754 -171.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.5 t -140.27 123.29 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.332 1.053 . . . . 0.0 109.105 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.6 m -104.69 115.32 30.13 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.409 1.084 . . . . 0.0 110.757 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -86.43 163.88 17.32 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.767 0.794 . . . . 0.0 112.591 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -72.97 -13.53 61.26 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.208 1.003 . . . . 0.0 113.221 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.7 162.21 27.62 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.56 1.544 . . . . 0.0 111.971 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.23 -17.36 9.17 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.012 2.474 . . . . 0.0 114.751 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.9 t -72.79 -38.16 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 119.967 1.258 . . . . 0.0 109.916 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -60.46 -43.67 96.67 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.858 0.863 . . . . 0.0 112.039 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.98 -49.45 72.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.188 0.995 . . . . 0.0 112.313 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -57.34 -44.71 84.52 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.979 0.912 . . . . 0.0 112.818 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.31 79.51 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.737 0.815 . . . . 0.0 112.566 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.54 68.54 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.615 0.766 . . . . 0.0 112.867 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.26 -47.76 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.978 1.263 . . . . 0.0 109.611 171.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.74 -20.02 65.87 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.549 1.14 . . . . 0.0 113.261 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 62.2 m -100.15 -25.58 14.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -119.05 -15.54 9.25 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 -169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -69.52 113.84 7.19 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.955 1.252 . . . . 0.0 110.473 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.61 5.12 63.38 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.52 1.533 . . . . 0.0 114.653 -173.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -60.02 123.31 16.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.58 1.69 . . . . 0.0 111.245 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -78.4 127.66 32.52 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.432 0.693 . . . . 0.0 110.57 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.52 132.32 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.966 1.306 . . . . 0.0 110.058 -176.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 59.95 -121.39 26.51 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 94.5 mtp -106.35 16.1 25.21 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.624 1.57 . . . . 0.0 112.765 175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -142.64 -168.47 2.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.611 1.564 . . . . 0.0 112.993 -169.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.25 139.6 42.84 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.361 1.465 . . . . 0.0 111.409 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 70.6 mt -67.92 150.8 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.587 1.155 . . . . 0.0 111.503 171.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -124.02 130.72 53.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.734 1.214 . . . . 0.0 108.766 169.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.45 138.15 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.175 0.99 . . . . 0.0 110.461 -169.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -165.3 168.77 16.58 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.575 1.55 . . . . 0.0 110.743 -172.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.19 139.31 57.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.27 0.628 . . . . 0.0 109.768 169.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 10.8 pttp -77.0 166.57 23.14 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -81.92 164.05 21.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.529 1.932 . . . . 0.0 112.74 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.7 m -81.61 135.59 35.55 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.376 1.071 . . . . 0.0 109.863 168.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -83.37 37.63 0.57 Allowed 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -151.53 167.31 28.45 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.463 1.505 . . . . 0.0 112.651 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -115.35 14.77 16.85 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.331 1.852 . . . . 0.0 113.45 -174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 52.1 m -67.03 115.84 7.19 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.285 1.034 . . . . 0.0 112.377 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.24 -22.48 44.73 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -172.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 5.1 t 63.21 -160.85 0.3 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.604 1.562 . . . . 0.0 112.381 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 98.7 -159.45 20.31 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 125.493 1.521 . . . . 0.0 113.47 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -56.25 145.18 78.67 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 124.589 3.526 . . . . 0.0 113.645 -177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 77.4 p -148.4 13.42 0.96 Allowed 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -173.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.4 m 68.9 6.09 5.39 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.539 1.936 . . . . 0.0 115.373 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.167 1.365 . . . . 0.0 113.271 177.701 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.25 0 C5'-C4'-C3' 112.108 -2.261 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.272 1 O4'-C1'-N19 114.048 5.848 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.346 0 C4'-C3'-C2' 100.471 -2.229 . 0.455 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.433 0 C5'-C4'-O4' 113.127 2.805 . 0.349 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.227 1 O4'-C1'-N19 113.951 5.751 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.048 0 O4'-C1'-N19 111.243 3.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 111.676 -0.57 . . . . 0.0 111.676 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 79.9 p -163.0 172.71 14.61 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.352 1.061 . . . . 0.0 112.416 -174.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -46.59 132.41 10.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.179 1.792 . . . . 0.0 114.179 -176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.01 -8.46 76.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.51 1.052 . . . . 0.0 113.942 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.0 p -141.28 -49.8 0.42 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.581 1.19 . . . . 0.0 112.177 171.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.8 m 60.27 11.42 2.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.348 1.859 . . . . 0.0 115.111 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 151.92 -159.62 28.41 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 126.325 1.917 . . . . 0.0 112.201 -170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.4 mt -104.8 -6.79 19.96 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.2 p -148.92 151.06 33.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.358 1.863 . . . . 0.0 111.13 -174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 72.78 148.24 0.09 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 128.257 2.623 . . . . 0.0 113.169 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -89.23 134.75 33.91 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.972 0.909 . . . . 0.0 110.341 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 61.3 m -124.21 147.79 47.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.077 1.351 . . . . 0.0 110.377 176.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mm -84.79 61.23 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 122.611 1.196 . . . . 0.0 111.482 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -116.18 19.54 13.31 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.635 2.064 . . . . 0.0 112.095 168.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -92.3 -17.0 25.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.579 1.951 . . . . 0.0 114.536 -169.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -82.69 119.36 24.21 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.631 1.172 . . . . 0.0 113.534 -169.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 -1.19 82.06 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.055 1.312 . . . . 0.0 113.023 -174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 63.6 m -84.18 158.6 21.27 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.25 1.42 . . . . 0.0 111.698 -178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.99 41.57 3.13 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.587 1.155 . . . . 0.0 110.567 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -75.53 83.66 2.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.32 1.057 . . . . 0.0 109.406 169.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -67.02 142.79 57.09 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.346 1.058 . . . . 0.0 111.136 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -86.97 -171.51 47.67 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 125.766 1.651 . . . . 0.0 113.34 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.09 177.35 5.9 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.985 3.123 . . . . 0.0 112.471 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -56.7 123.13 13.87 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.301 1.04 . . . . 0.0 111.482 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.54 1.1 87.87 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.655 1.122 . . . . 0.0 114.716 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.39 6.31 40.17 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.091 1.446 . . . . 0.0 114.149 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -113.87 122.69 47.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.957 1.303 . . . . 0.0 110.793 -176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 71.0 mt -112.96 145.55 40.59 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.176 1.391 . . . . 0.0 112.21 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -112.37 131.24 55.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.336 2.254 . . . . 0.0 108.813 169.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.3 mp -121.86 138.96 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.277 2.231 . . . . 0.0 108.271 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -139.67 152.84 47.04 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.592 1.557 . . . . 0.0 111.749 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 81.63 24.26 0.25 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 129.075 2.95 . . . . 0.0 113.839 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.4 mt -66.25 145.43 98.98 Favored Pre-proline 0 CA--C 1.546 0.824 0 O-C-N 121.015 -1.053 . . . . 0.0 111.263 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.26 148.1 80.79 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.191 2.594 . . . . 0.0 111.034 168.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -75.43 -8.68 57.34 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.3 -2.2 46.38 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.521 1.528 . . . . 0.0 113.44 172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -75.17 125.9 29.91 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.837 1.255 . . . . 0.0 111.193 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -92.69 172.6 34.36 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.479 1.037 . . . . 0.0 113.553 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.58 -32.88 74.71 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.964 0.905 . . . . 0.0 112.433 177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -76.43 -28.56 56.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.127 0.971 . . . . 0.0 112.128 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -69.55 -40.55 76.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.9 . . . . 0.0 110.678 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -63.31 -39.24 94.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.432 0.693 . . . . 0.0 111.426 172.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 42.5 tp -62.84 -55.13 29.03 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.11 0.564 . . . . 0.0 111.787 174.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.47 -23.83 67.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.3 ttp -80.73 -25.17 38.24 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.684 0.793 . . . . 0.0 112.954 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -100.89 -12.81 18.68 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.467 1.507 . . . . 0.0 114.412 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 47.1 mtt -43.12 -46.62 14.44 Favored Pre-proline 0 N--CA 1.482 1.155 0 N-CA-C 116.593 2.071 . . . . 0.0 116.593 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.92 -4.39 15.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.124 1.883 . . . . 0.0 114.778 -169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -99.34 -2.9 35.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.508 1.123 . . . . 0.0 113.539 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 138.22 -171.23 23.5 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.498 1.523 . . . . 0.0 114.223 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -70.77 101.67 2.15 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.009 0.924 . . . . 0.0 111.601 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 81.5 t -77.77 129.94 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.559 1.143 . . . . 0.0 108.832 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 61.1 t -93.37 -40.6 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.12 1.368 . . . . 0.0 110.656 -178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 99.5 p -159.98 144.41 14.69 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.431 -0.793 . . . . 0.0 112.605 171.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -130.07 132.72 46.29 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.875 1.67 . . . . 0.0 109.664 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -150.13 110.25 4.14 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.461 0.704 . . . . 0.0 112.353 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.9 t -81.03 135.36 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.318 1.447 . . . . 0.0 108.275 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -86.37 124.84 33.16 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.009 0.909 . . . . 0.0 111.232 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 52.1 mt -138.75 142.18 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 127.033 2.133 . . . . 0.0 109.182 -168.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.32 125.91 26.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.843 0.857 . . . . 0.0 111.989 175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -75.47 -3.01 31.5 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -172.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -115.86 -25.85 7.59 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.609 1.164 . . . . 0.0 113.24 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.4 p -123.05 -8.5 8.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.362 1.465 . . . . 0.0 114.05 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 65.63 18.4 11.2 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.355 1.862 . . . . 0.0 113.692 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.29 126.33 31.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.581 1.152 . . . . 0.0 110.878 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.6 t -69.42 137.38 52.67 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 121.752 -0.592 . . . . 0.0 111.421 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -93.88 11.49 29.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.184 0.994 . . . . 0.0 113.345 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 45.8 m 68.44 10.59 7.95 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.237 1.815 . . . . 0.0 114.141 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -131.84 157.5 43.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.246 1.418 . . . . 0.0 111.462 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -164.62 -172.97 32.74 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.656 1.122 . . . . 0.0 113.478 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -143.4 152.16 41.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.662 1.185 . . . . 0.0 112.547 -171.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.0 t -145.54 126.71 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.617 1.167 . . . . 0.0 109.554 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 53.2 p -105.82 143.16 34.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.712 0.805 . . . . 0.0 112.177 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -116.23 163.65 15.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.629 1.572 . . . . 0.0 112.604 176.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.68 -18.97 64.36 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.304 1.042 . . . . 0.0 113.257 175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -158.34 162.43 26.81 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.543 1.537 . . . . 0.0 111.523 -177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.01 -16.88 11.0 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.73 2.287 . . . . 0.0 114.495 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.1 t -73.52 -39.92 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 120.077 1.308 . . . . 0.0 109.996 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 30.7 m -62.69 -40.97 98.8 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.6 0.76 . . . . 0.0 112.1 172.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.39 -47.19 77.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.646 0.778 . . . . 0.0 112.293 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -58.16 -42.17 85.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.869 0.868 . . . . 0.0 112.982 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.35 86.55 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.466 -0.772 . . . . 0.0 112.245 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.85 -33.94 72.95 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.599 -0.688 . . . . 0.0 112.647 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.5 mt -60.68 -50.0 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.611 1.096 . . . . 0.0 109.633 170.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -64.1 -31.29 72.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.136 0.975 . . . . 0.0 112.93 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 61.1 m -94.89 -12.81 26.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 1.6 mmt -115.7 -25.78 7.68 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -71.46 112.41 7.56 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.04 1.291 . . . . 0.0 110.555 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.53 1.26 64.19 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.708 1.623 . . . . 0.0 114.621 -172.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -64.67 122.81 17.73 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.407 1.604 . . . . 0.0 110.947 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -76.02 134.48 40.11 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.204 0.526 . . . . 0.0 111.045 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.6 tt -140.8 60.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-O 123.166 1.46 . . . . 0.0 109.973 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 94.63 -135.17 12.32 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.842 1.687 . . . . 0.0 111.615 -169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 63.8 mtt -83.21 30.27 0.47 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.217 1.407 . . . . 0.0 112.873 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -160.23 164.84 32.43 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.667 1.987 . . . . 0.0 111.874 -170.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -126.57 139.97 52.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 0.0 111.022 177.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 84.8 mt -65.28 143.23 57.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.266 1.026 . . . . 0.0 111.557 175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -114.74 125.47 53.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.028 1.331 . . . . 0.0 108.264 169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 25.7 t -142.47 138.24 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.251 1.02 . . . . 0.0 110.184 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -164.25 172.95 12.9 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.347 1.459 . . . . 0.0 110.652 -173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.81 145.63 55.44 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.022 0.529 . . . . 0.0 109.769 168.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -57.86 150.82 19.31 Favored 'General case' 0 CA--C 1.55 0.962 0 O-C-N 121.601 -0.687 . . . . 0.0 111.838 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.8 ptt-85 -40.84 125.47 2.31 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.732 1.613 . . . . 0.0 114.26 -172.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 1.8 t -165.96 12.59 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.881 1.272 . . . . 0.0 113.339 -173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -142.68 156.41 45.04 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.417 1.487 . . . . 0.0 112.251 -170.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -70.6 159.07 35.04 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.685 0.794 . . . . 0.0 112.398 175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -153.58 157.35 39.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.57 1.948 . . . . 0.0 109.749 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.3 m -56.31 -24.46 43.58 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -63.29 -23.96 67.65 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.607 1.163 . . . . 0.0 113.105 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 34.1 m -102.5 4.69 38.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.386 1.874 . . . . 0.0 112.829 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 100.57 144.09 15.18 Favored Glycine 0 CA--C 1.542 1.781 0 C-N-CA 126.111 1.815 . . . . 0.0 113.05 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.31 146.82 87.88 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.865 3.044 . . . . 0.0 112.86 173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 36.0 p -79.16 -3.29 44.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.446 1.098 . . . . 0.0 113.758 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 47.2 p -87.84 -5.78 58.43 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.806 1.642 . . . . 0.0 114.463 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.154 0 C-N-CA 124.996 1.284 . . . . 0.0 113.275 179.131 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.31 0 C4'-C3'-C2' 100.305 -2.395 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.327 1 O4'-C1'-N19 112.412 4.212 . 0.052 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.358 0 O4'-C1'-N19 111.96 3.76 . 0.236 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.368 0 C3'-C2'-C1' 104.922 3.803 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 1 O4'-C1'-N19 114.424 6.224 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.426 0 O4'-C1'-N19 111.176 2.976 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.9 m -68.26 -14.32 62.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 -172.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 17.7 m -77.72 1.2 20.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.931 1.292 . . . . 0.0 113.869 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 65.55 26.5 71.93 Favored Glycine 0 N--CA 1.473 1.11 0 C-N-CA 124.43 1.014 . . . . 0.0 114.043 173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.2 t 62.45 20.99 12.3 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.284 1.434 . . . . 0.0 112.496 -172.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.1 m 69.49 11.07 7.94 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.024 2.129 . . . . 0.0 113.563 -174.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -84.05 5.22 80.63 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.661 1.601 . . . . 0.0 114.666 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 84.4 mt -70.6 158.51 36.05 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.309 1.444 . . . . 0.0 111.794 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.9 t -156.86 177.91 10.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.408 1.483 . . . . 0.0 111.811 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -80.89 3.56 22.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.98 1.712 . . . . 0.0 113.977 -169.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -148.39 149.39 31.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.636 1.174 . . . . 0.0 111.406 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 83.0 p -128.81 176.79 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.27 1.428 . . . . 0.0 111.585 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 51.5 mt -73.66 -10.2 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.498 1.119 . . . . 0.0 111.985 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.56 59.16 1.24 Allowed Glycine 0 N--CA 1.474 1.185 0 C-N-CA 127.545 2.498 . . . . 0.0 113.502 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -166.64 -29.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.736 2.814 . . . . 0.0 112.263 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.22 126.07 30.27 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.954 0.902 . . . . 0.0 113.425 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.92 -1.25 88.98 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.406 1.479 . . . . 0.0 113.249 -175.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 35.9 t -85.04 149.02 25.86 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.333 1.066 . . . . 0.0 111.734 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 20.63 10.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.954 1.301 . . . . 0.0 111.918 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -67.55 89.22 0.23 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.372 1.069 . . . . 0.0 110.452 169.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -64.15 139.94 58.82 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.98 0.912 . . . . 0.0 110.89 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -80.99 -171.78 45.25 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 126.084 1.802 . . . . 0.0 113.85 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.34 171.91 17.12 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.899 3.066 . . . . 0.0 112.45 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.74 125.5 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.376 1.07 . . . . 0.0 111.578 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.88 -3.42 85.6 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 124.611 1.1 . . . . 0.0 114.565 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -101.21 -4.03 27.95 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.084 1.442 . . . . 0.0 113.998 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -99.64 125.65 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.564 1.146 . . . . 0.0 111.359 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 46.3 mt -106.88 144.86 32.91 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.955 1.302 . . . . 0.0 111.959 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -111.31 122.19 47.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.743 2.017 . . . . 0.0 107.728 168.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.84 130.81 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.549 1.94 . . . . 0.0 107.244 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -132.89 149.0 52.29 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 111.398 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.251 0.2 OUTLIER 88.2 25.05 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.269 3.028 . . . . 0.0 114.089 176.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.61 164.76 18.03 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 125.233 1.413 . . . . 0.0 112.142 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -59.4 152.0 64.27 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.507 2.805 . . . . 0.0 111.841 168.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -75.15 4.67 6.48 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.01 0.924 . . . . 0.0 113.322 -178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.61 8.67 4.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.738 2.015 . . . . 0.0 113.297 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -69.25 133.1 47.49 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.224 1.01 . . . . 0.0 111.763 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.89 163.7 30.85 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.439 1.019 . . . . 0.0 113.308 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -62.33 -34.26 76.28 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.189 0.996 . . . . 0.0 112.591 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -84.66 -19.89 32.16 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.519 1.128 . . . . 0.0 112.415 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -70.15 -41.21 74.15 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.374 0.988 . . . . 0.0 110.506 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.26 -41.19 99.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.593 0.757 . . . . 0.0 111.528 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.56 -49.93 71.5 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.137 0.575 . . . . 0.0 111.914 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -64.04 -24.67 67.79 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.813 0.733 . . . . 0.0 112.708 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.6 ttp -80.29 -26.65 38.78 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.266 1.026 . . . . 0.0 113.072 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.99 -17.94 16.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.273 1.429 . . . . 0.0 114.624 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 24.6 mtt -37.47 -43.03 1.22 Allowed Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.716 2.006 . . . . 0.0 116.38 173.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -60.36 -16.83 43.67 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.287 2.658 . . . . 0.0 116.432 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -101.47 -4.62 26.49 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.46 -166.35 30.14 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 124.754 1.169 . . . . 0.0 115.013 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -89.97 127.23 35.99 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.965 1.306 . . . . 0.0 112.61 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 56.7 t -109.53 127.93 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.788 2.035 . . . . 0.0 110.231 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 97.9 t -83.43 -36.18 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.355 1.862 . . . . 0.0 111.212 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.1 p -159.98 149.63 18.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.711 1.205 . . . . 0.0 111.18 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.64 134.65 17.98 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.695 1.198 . . . . 0.0 110.299 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -157.74 134.67 10.02 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.14 0.576 . . . . 0.0 112.338 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 63.7 t -97.62 137.75 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 168.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -74.53 110.03 8.5 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.4 mm -106.99 118.33 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.613 1.165 . . . . 0.0 108.439 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -64.8 112.36 3.22 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.131 0.972 . . . . 0.0 110.635 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -68.43 -5.84 21.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -89.56 -21.99 22.6 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.175 0.99 . . . . 0.0 112.763 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.6 p -132.68 -13.63 2.9 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.7 t30 67.58 21.3 9.49 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 127.403 2.281 . . . . 0.0 113.904 -178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.7 mt -101.78 152.0 21.39 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.375 1.47 . . . . 0.0 111.121 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 29.8 t -71.77 140.74 49.61 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.304 -0.873 . . . . 0.0 111.211 171.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -87.85 12.41 13.13 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.991 0.917 . . . . 0.0 112.862 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 70.8 m 69.48 17.08 8.1 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.844 2.057 . . . . 0.0 113.743 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.03 150.15 49.07 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.537 1.135 . . . . 0.0 111.28 173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.37 -177.33 26.79 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.681 1.61 . . . . 0.0 113.297 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -145.64 149.75 35.07 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.973 1.309 . . . . 0.0 111.844 -169.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 90.1 t -142.67 123.64 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.121 1.368 . . . . 0.0 108.198 177.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 69.7 m -107.61 111.77 24.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 110.795 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -81.25 164.67 22.09 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.805 0.812 . . . . 0.0 112.249 172.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -76.26 -10.52 59.47 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.64 0.776 . . . . 0.0 112.943 171.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -156.48 160.77 30.52 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.322 1.449 . . . . 0.0 111.758 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.33 -15.27 8.96 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.922 2.415 . . . . 0.0 114.427 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.5 t -76.36 -39.63 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.755 1.162 . . . . 0.0 110.202 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 52.9 m -66.71 -37.8 85.42 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.699 -0.625 . . . . 0.0 111.944 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.22 -48.97 77.61 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.938 0.895 . . . . 0.0 112.07 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -58.31 -45.08 88.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.471 -0.768 . . . . 0.0 112.764 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.33 -35.04 74.7 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.378 0.671 . . . . 0.0 112.333 176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.18 -41.42 67.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.517 -0.754 . . . . 0.0 112.462 174.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.17 -47.56 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 120.138 1.335 . . . . 0.0 109.968 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -68.28 -18.61 64.57 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.866 1.266 . . . . 0.0 112.93 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 63.1 m -100.78 -25.73 14.02 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.43 -16.28 12.47 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 -168.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -69.84 114.06 7.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.934 1.243 . . . . 0.0 110.213 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.33 6.07 64.87 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.578 1.561 . . . . 0.0 114.564 -171.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -60.06 123.5 17.32 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.605 1.702 . . . . 0.0 110.911 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -77.88 130.0 36.08 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.011 0.434 . . . . 0.0 110.216 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.32 111.84 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 125.038 1.335 . . . . 0.0 108.206 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.27 -126.65 28.59 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -168.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.4 12.71 32.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.359 1.464 . . . . 0.0 113.638 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -142.87 171.77 13.61 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.309 1.444 . . . . 0.0 113.268 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -121.78 141.64 51.01 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.908 1.283 . . . . 0.0 112.34 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 90.2 mt -77.5 146.32 36.47 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.097 1.359 . . . . 0.0 112.275 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -107.5 128.24 54.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.209 1.403 . . . . 0.0 108.041 168.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.3 t -141.38 136.16 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.908 0.883 . . . . 0.0 110.659 -170.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -164.79 177.71 7.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.66 1.584 . . . . 0.0 110.716 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.4 141.38 57.07 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.789 -0.569 . . . . 0.0 110.027 169.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -64.9 139.83 58.8 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.498 -0.751 . . . . 0.0 111.362 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -67.68 165.73 16.59 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.665 0.786 . . . . 0.0 112.205 176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 68.5 p -157.33 161.91 39.1 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.956 1.302 . . . . 0.0 111.959 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -159.89 146.24 15.96 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.814 1.245 . . . . 0.0 111.744 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -67.99 156.25 37.71 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.083 0.953 . . . . 0.0 112.402 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -159.9 -42.04 0.05 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.377 1.471 . . . . 0.0 112.582 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 8.6 t -165.15 161.3 19.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.28 1.432 . . . . 0.0 111.319 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -69.61 153.71 43.05 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.401 1.08 . . . . 0.0 113.556 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 39.5 p -82.94 -12.38 57.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.69 1.196 . . . . 0.0 113.938 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.98 -163.34 37.79 Favored Glycine 0 CA--C 1.542 1.778 0 C-N-CA 125.5 1.524 . . . . 0.0 113.376 174.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.37 165.14 33.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.732 2.955 . . . . 0.0 111.62 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 15.7 m -73.15 24.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.248 1.819 . . . . 0.0 114.567 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.3 t -158.14 -178.81 7.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.541 1.936 . . . . 0.0 111.007 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.441 1.496 . . . . 0.0 112.754 -178.671 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.353 0 C3'-C2'-C1' 99.601 -2.11 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.208 1 O4'-C1'-N19 114.079 5.879 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O5'-C5'-C4' 113.368 2.263 . 0.506 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 C5'-C4'-O4' 113.459 3.042 . 0.41 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.247 1 O4'-C1'-N19 112.877 4.677 . 0.023 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 0 O4'-C1'-N19 110.741 2.541 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 83.4 p -164.08 167.29 20.48 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.281 1.433 . . . . 0.0 111.774 -176.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -162.82 165.77 24.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.286 1.434 . . . . 0.0 111.583 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 78.84 -87.18 1.16 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 124.313 0.959 . . . . 0.0 111.618 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.4 m -67.41 -14.73 63.19 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.723 1.209 . . . . 0.0 113.889 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 51.7 p -91.46 -4.59 55.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.429 1.492 . . . . 0.0 113.701 173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.98 60.17 4.21 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 125.894 1.712 . . . . 0.0 112.717 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.92 14.52 0.47 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.013 1.725 . . . . 0.0 114.059 -171.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 32.3 p -59.78 -43.68 94.26 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.864 1.665 . . . . 0.0 113.64 -170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.19 -14.96 3.79 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.967 1.307 . . . . 0.0 112.98 172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -176.14 173.51 2.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.345 2.658 . . . . 0.0 109.927 176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 59.4 p -85.19 170.14 13.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.333 1.053 . . . . 0.0 112.109 168.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.22 133.6 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.154 1.382 . . . . 0.0 109.561 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 132.52 69.13 0.09 OUTLIER Glycine 0 N--CA 1.474 1.2 0 C-N-CA 125.564 1.554 . . . . 0.0 111.01 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -150.97 12.29 0.67 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.931 1.292 . . . . 0.0 114.054 -168.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -101.04 127.74 47.41 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.429 1.491 . . . . 0.0 113.431 -169.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.5 -3.58 84.52 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.19 1.376 . . . . 0.0 112.739 -170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.7 m -76.35 126.57 31.23 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.936 1.694 . . . . 0.0 111.232 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.32 4.1 54.04 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -55.35 107.74 0.35 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.822 1.249 . . . . 0.0 111.844 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.69 129.03 34.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.834 0.854 . . . . 0.0 109.646 -174.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.78 -172.15 43.27 Favored Glycine 0 CA--C 1.54 1.644 0 C-N-CA 125.092 1.329 . . . . 0.0 113.86 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.17 171.9 16.66 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.764 2.976 . . . . 0.0 112.375 -177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.11 124.55 19.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.372 1.069 . . . . 0.0 111.818 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.83 86.41 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.702 1.144 . . . . 0.0 114.731 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.25 1.44 49.65 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 118.957 1.379 . . . . 0.0 114.04 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -110.83 111.44 22.6 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.248 1.019 . . . . 0.0 111.762 -169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 31.7 mt -96.58 145.79 25.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.52 1.128 . . . . 0.0 112.534 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -112.54 124.77 53.26 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.353 2.261 . . . . 0.0 107.57 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.24 136.9 49.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.598 1.959 . . . . 0.0 107.848 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -135.17 159.3 41.96 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.938 1.695 . . . . 0.0 110.923 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 71.78 25.6 3.18 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 127.832 2.453 . . . . 0.0 114.153 -173.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.26 154.27 53.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 120.965 -1.084 . . . . 0.0 111.44 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -56.04 152.01 39.24 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.749 2.966 . . . . 0.0 112.783 169.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 0.36 4.62 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.446 1.499 . . . . 0.0 113.892 -175.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -137.45 10.12 2.94 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.494 1.917 . . . . 0.0 113.364 -175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -67.31 132.77 48.38 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.924 0.89 . . . . 0.0 112.083 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.56 166.2 31.53 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.453 1.025 . . . . 0.0 113.26 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -66.94 -34.14 77.12 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.924 0.89 . . . . 0.0 112.608 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -75.13 -28.84 60.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.069 0.948 . . . . 0.0 112.086 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -67.41 -37.72 83.52 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.754 0.706 . . . . 0.0 111.103 175.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.0 tp -68.23 -43.68 77.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.33 0.652 . . . . 0.0 111.41 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.94 -53.82 53.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.89 0.876 . . . . 0.0 112.462 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.93 -17.35 63.32 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -85.12 -26.74 26.7 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.749 1.22 . . . . 0.0 113.061 174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -100.84 -18.24 16.5 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.172 1.389 . . . . 0.0 114.247 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 21.0 mtt -43.35 -42.57 9.48 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -58.56 -17.9 37.07 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.68 2.92 . . . . 0.0 116.075 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -100.08 -1.99 35.44 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -172.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 140.95 -174.57 22.64 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 125.341 1.448 . . . . 0.0 113.959 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -71.51 102.86 2.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.448 0.699 . . . . 0.0 111.84 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 99.6 t -77.47 122.84 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 124.957 1.303 . . . . 0.0 108.955 169.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.17 -31.5 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.288 1.835 . . . . 0.0 111.03 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 92.3 p -162.7 147.23 11.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.938 1.295 . . . . 0.0 111.346 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -143.29 133.56 24.56 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.081 1.353 . . . . 0.0 110.238 178.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -152.91 116.47 4.72 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.369 0.667 . . . . 0.0 111.376 -170.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 73.4 t -89.79 134.68 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.117 1.367 . . . . 0.0 107.661 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -81.79 124.81 29.97 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.828 0.823 . . . . 0.0 109.918 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.18 141.38 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.969 2.107 . . . . 0.0 108.853 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -64.65 121.99 15.8 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.954 0.902 . . . . 0.0 111.091 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -72.24 -1.81 16.58 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -114.69 -36.55 4.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.931 1.293 . . . . 0.0 112.575 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 45.2 p -105.41 -13.36 15.67 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.3 t30 65.32 16.65 10.64 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.534 1.934 . . . . 0.0 113.769 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.46 140.51 29.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.822 1.249 . . . . 0.0 110.73 176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.3 t -70.18 137.87 51.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.882 0.849 . . . . 0.0 111.819 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -78.74 10.87 2.92 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.12 0.968 . . . . 0.0 112.745 169.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 89.1 m 66.07 13.47 9.11 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.226 1.81 . . . . 0.0 113.753 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -138.92 150.24 45.7 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.717 1.207 . . . . 0.0 112.113 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.03 -179.52 34.88 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.002 1.286 . . . . 0.0 113.421 -174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -138.9 149.48 44.88 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.814 1.246 . . . . 0.0 112.135 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.65 122.14 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.671 1.188 . . . . 0.0 109.025 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.1 m -99.32 123.32 43.51 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 110.388 172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -93.1 165.48 12.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.653 0.781 . . . . 0.0 112.117 169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -72.46 -14.3 61.65 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.942 0.897 . . . . 0.0 113.107 172.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -158.6 161.59 28.16 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.45 1.5 . . . . 0.0 111.592 -175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -80.75 -17.89 9.49 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.82 2.347 . . . . 0.0 114.304 -175.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.68 -39.42 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.968 1.258 . . . . 0.0 110.203 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.0 m -64.79 -39.2 93.21 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 173.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.16 70.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 112.047 173.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -57.58 -43.46 84.58 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.923 0.889 . . . . 0.0 113.031 174.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.25 81.12 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.652 0.781 . . . . 0.0 112.455 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.26 -35.2 68.71 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.679 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.96 -48.28 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 CA-C-N 120.067 1.303 . . . . 0.0 109.707 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -67.07 -20.86 65.89 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 113.175 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.5 m -99.64 -25.79 14.29 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.2 mmm -115.22 -17.06 11.45 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.28 113.93 7.92 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.856 1.207 . . . . 0.0 110.169 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 93.78 4.25 63.69 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 125.744 1.64 . . . . 0.0 114.572 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 122.78 16.18 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.407 1.603 . . . . 0.0 111.026 178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -79.74 127.05 31.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.485 0.714 . . . . 0.0 110.268 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.4 tt -147.25 134.26 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.985 1.314 . . . . 0.0 109.879 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.11 -119.92 20.51 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 76.2 mtm -110.04 17.74 20.75 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.652 1.581 . . . . 0.0 112.821 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -143.3 -172.58 3.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.564 1.546 . . . . 0.0 112.943 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 84.7 mtm180 -131.86 140.45 49.12 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.612 1.565 . . . . 0.0 111.601 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 76.4 mt -72.3 143.88 48.54 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.572 1.149 . . . . 0.0 112.334 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -107.08 129.97 54.74 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.421 1.488 . . . . 0.0 107.531 168.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.4 t -142.65 136.17 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.108 0.867 . . . . 0.0 110.453 -173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -165.95 176.43 7.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.724 1.61 . . . . 0.0 110.49 -175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 92.3 mt -67.93 141.81 56.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 167.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -64.51 158.18 24.76 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 121.337 -0.852 . . . . 0.0 112.471 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -74.67 37.5 0.11 Allowed 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -168.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.8 m -77.71 -10.86 59.76 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 120.707 -1.246 . . . . 0.0 113.99 175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.74 166.68 20.38 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.693 1.197 . . . . 0.0 114.223 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 53.6 p-10 -152.65 156.98 40.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.89 1.676 . . . . 0.0 112.519 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.44 -38.77 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.467 1.107 . . . . 0.0 113.907 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 61.0 p -77.96 -20.34 52.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -169.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -135.05 -11.7 2.22 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.047 1.339 . . . . 0.0 113.801 -175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 22.6 t -175.59 160.88 2.56 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 128.421 2.688 . . . . 0.0 108.382 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 137.62 -159.46 24.91 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.626 1.108 . . . . 0.0 113.556 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.14 163.71 34.5 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.992 3.128 . . . . 0.0 112.225 -177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 72.1 m -144.0 150.49 38.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.47 1.508 . . . . 0.0 111.315 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.2 m -77.15 -5.61 49.76 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -173.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.65 1.595 . . . . 0.0 113.072 -178.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.241 0 O4'-C1'-N19 111.041 2.841 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.356 1 O4'-C1'-N19 112.738 4.538 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.416 0 O5'-C5'-C4' 113.229 2.164 . 0.478 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-O4' 113.238 2.884 . 0.339 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.932 3 C3'-C2'-C1' 106.044 5.049 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.617 2.419 0 O4'-C1'-N19 111.771 3.571 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 64.2 m -145.89 146.49 31.11 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.871 1.269 . . . . 0.0 111.519 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.9 p -165.92 156.25 12.82 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.347 1.459 . . . . 0.0 111.565 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -100.25 -166.83 28.92 Favored Glycine 0 N--CA 1.471 1.011 0 C-N-CA 124.669 1.128 . . . . 0.0 112.749 174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.5 p -77.72 -3.91 43.56 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.652 1.181 . . . . 0.0 113.585 173.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 22.9 t -164.51 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.461 1.904 . . . . 0.0 111.798 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -71.55 138.12 26.98 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.456 1.027 . . . . 0.0 113.031 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.3 mt -146.72 166.99 24.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.04 2.136 . . . . 0.0 110.631 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 23.2 m -76.17 81.13 2.98 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.413 1.485 . . . . 0.0 110.261 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -166.45 163.61 17.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.188 1.795 . . . . 0.0 110.803 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.51 162.04 38.84 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.043 1.337 . . . . 0.0 109.925 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 9.7 t -150.23 -165.46 2.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.594 1.557 . . . . 0.0 110.36 171.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 44.4 mm -77.38 145.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.378 1.471 . . . . 0.0 110.56 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 124.42 0.16 8.69 Favored Glycine 0 N--CA 1.477 1.407 0 C-N-CA 125.183 1.373 . . . . 0.0 116.132 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.4 -15.08 60.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.996 1.319 . . . . 0.0 113.701 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -95.13 141.59 28.58 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.841 1.656 . . . . 0.0 111.027 172.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.39 22.88 55.78 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.672 -168.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 8.5 t -141.64 170.78 15.08 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.674 1.989 . . . . 0.0 110.252 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.05 22.76 1.38 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.694 1.198 . . . . 0.0 112.426 -173.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -62.08 107.05 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.739 0.816 . . . . 0.0 111.072 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -73.45 135.0 44.1 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.318 1.047 . . . . 0.0 110.377 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -82.88 -175.28 50.88 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.136 1.35 . . . . 0.0 113.335 177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -75.53 174.68 12.39 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.149 3.233 . . . . 0.0 112.433 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.07 127.87 34.13 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.583 1.153 . . . . 0.0 111.685 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 79.38 -2.9 69.43 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.748 1.166 . . . . 0.0 114.77 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -103.34 -1.05 29.33 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.129 1.464 . . . . 0.0 113.508 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -100.85 123.93 45.78 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.451 1.1 . . . . 0.0 111.129 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 25.4 mt -97.34 157.31 16.04 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.339 1.055 . . . . 0.0 112.406 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -130.19 130.06 44.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.297 1.839 . . . . 0.0 109.184 168.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.5 140.6 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 127.167 2.187 . . . . 0.0 108.067 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -138.06 154.82 49.24 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.075 1.35 . . . . 0.0 110.413 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 82.16 18.71 0.34 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 128.302 2.641 . . . . 0.0 114.194 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 75.2 mt -61.91 156.87 54.45 Favored Pre-proline 0 N--CA 1.476 0.855 0 O-C-N 121.088 -1.007 . . . . 0.0 111.565 173.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.21 149.2 65.37 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.24 2.626 . . . . 0.0 112.363 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -69.95 1.75 4.2 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -130.91 6.19 4.62 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.588 1.955 . . . . 0.0 113.254 -177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.17 129.5 40.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.341 1.056 . . . . 0.0 110.942 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -94.02 168.11 28.46 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.261 0.934 . . . . 0.0 113.763 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -58.92 -32.73 69.82 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.377 1.071 . . . . 0.0 112.556 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -82.27 -28.17 31.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.382 1.073 . . . . 0.0 112.606 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -67.82 -36.16 79.9 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.931 0.787 . . . . 0.0 111.073 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.95 -44.22 77.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.107 0.963 . . . . 0.0 111.204 171.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.28 -50.76 72.75 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.868 0.867 . . . . 0.0 112.306 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -64.06 -20.83 66.22 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.7 ttp -91.15 -27.09 18.75 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.52 1.128 . . . . 0.0 113.256 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -99.98 -14.08 18.83 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.181 1.392 . . . . 0.0 114.218 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.5 mtt -43.8 -42.23 10.62 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -61.19 -15.52 40.43 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.634 2.889 . . . . 0.0 116.443 -175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -99.85 -5.24 28.8 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -170.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.48 -170.97 25.99 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.965 1.269 . . . . 0.0 114.244 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -68.3 106.42 2.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.218 1.007 . . . . 0.0 111.807 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.7 t -85.97 120.16 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.281 1.432 . . . . 0.0 109.166 173.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.1 t -81.49 -34.68 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.1 1.76 . . . . 0.0 111.087 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.8 t -167.11 138.5 3.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.32 1.048 . . . . 0.0 111.306 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -133.66 137.66 45.47 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.709 1.203 . . . . 0.0 110.621 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -150.6 133.12 15.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.523 0.729 . . . . 0.0 112.278 -169.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 61.4 t -106.53 129.3 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.96 115.79 13.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.475 0.655 . . . . 0.0 109.987 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 55.6 mt -129.92 132.69 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 125.335 1.454 . . . . 0.0 109.917 -168.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -67.5 124.83 24.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.431 0.693 . . . . 0.0 111.318 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -62.64 -12.28 22.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -96.77 -28.31 14.33 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 113.027 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.9 p -131.82 -12.54 3.33 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 62.68 19.72 11.56 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.879 1.672 . . . . 0.0 113.976 -175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 98.1 mt -83.84 139.85 32.39 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.399 1.08 . . . . 0.0 110.576 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 20.9 t -76.07 138.75 41.02 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.737 -0.602 . . . . 0.0 111.251 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -79.54 9.74 4.62 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.93 1.292 . . . . 0.0 112.522 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 55.4 m 71.95 15.34 5.68 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.425 1.89 . . . . 0.0 113.329 173.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -133.17 148.62 52.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.247 1.419 . . . . 0.0 111.635 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.46 -179.65 28.22 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.836 1.208 . . . . 0.0 114.359 -173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -147.64 149.33 32.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.562 1.945 . . . . 0.0 111.542 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 59.7 t -143.28 123.03 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.364 1.066 . . . . 0.0 108.994 175.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.5 m -95.01 118.82 32.47 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.865 1.266 . . . . 0.0 110.596 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -96.34 164.7 12.53 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.125 168.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 23.5 p-10 -81.37 -3.84 53.95 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 172.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -159.86 160.36 27.25 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.49 1.516 . . . . 0.0 111.685 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.77 -14.87 8.66 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.081 2.521 . . . . 0.0 114.409 -174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 40.9 t -77.45 -37.99 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-N 119.774 1.17 . . . . 0.0 110.309 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.0 m -67.59 -37.85 83.18 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 121.58 -0.7 . . . . 0.0 111.974 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -60.17 -51.86 67.77 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.069 0.948 . . . . 0.0 111.728 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -56.36 -45.58 80.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.356 -0.84 . . . . 0.0 113.202 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.34 75.08 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.788 0.722 . . . . 0.0 112.657 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.08 -40.66 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.526 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.55 -47.34 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 120.201 1.364 . . . . 0.0 109.972 173.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -70.21 -14.28 62.55 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.946 1.298 . . . . 0.0 113.515 -174.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 9.8 t -106.35 -38.53 6.19 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 172.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 2.0 mmt -90.23 -19.85 23.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -170.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -69.65 116.38 9.99 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.651 1.114 . . . . 0.0 110.79 176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 88.89 5.66 73.48 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 126.046 1.784 . . . . 0.0 114.281 -172.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -63.24 127.58 31.94 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.485 1.643 . . . . 0.0 109.877 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -95.15 125.98 40.16 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 110.454 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.2 tt -135.16 119.85 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.062 1.345 . . . . 0.0 109.176 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.34 -98.65 0.4 Allowed Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -129.7 10.18 5.55 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.256 1.822 . . . . 0.0 112.429 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -114.35 135.55 53.96 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.723 1.609 . . . . 0.0 111.407 -171.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -97.17 123.24 40.89 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.031 0.832 . . . . 0.0 110.214 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.24 127.89 33.41 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.618 1.167 . . . . 0.0 112.219 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -84.09 130.65 34.85 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 167.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.32 136.97 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.962 0.905 . . . . 0.0 109.875 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -162.93 -179.99 7.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.84 1.656 . . . . 0.0 110.197 -169.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.74 155.45 33.2 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.914 0.864 . . . . 0.0 110.919 168.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -63.8 146.06 54.62 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.196 1.398 . . . . 0.0 113.212 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -69.88 141.77 53.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.036 1.334 . . . . 0.0 112.005 173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.3 t -101.81 143.01 32.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.001 1.321 . . . . 0.0 109.395 168.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -142.19 143.71 33.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.334 1.054 . . . . 0.0 112.392 -169.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -155.34 165.3 37.05 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.165 1.786 . . . . 0.0 111.377 178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.29 136.15 14.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.108 1.363 . . . . 0.0 110.935 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 28.7 t -173.0 154.15 2.74 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.676 1.59 . . . . 0.0 110.949 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -56.1 -30.12 61.6 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.449 1.099 . . . . 0.0 112.238 168.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.0 m -113.75 6.81 16.95 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.053 1.341 . . . . 0.0 113.507 -171.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 79.71 -157.21 41.57 Favored Glycine 0 CA--C 1.541 1.691 0 C-N-CA 124.607 1.099 . . . . 0.0 113.868 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -54.45 148.53 42.45 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 124.699 3.599 . . . . 0.0 113.627 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 20.3 m -59.74 132.72 54.85 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.99 1.316 . . . . 0.0 113.816 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 46.0 p -86.57 -6.2 58.94 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.203 0 C-N-CA 125.671 1.605 . . . . 0.0 112.929 178.511 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.477 3.277 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.164 2 C5'-C4'-C3' 108.915 -4.39 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 C5'-C4'-C3' 112.522 -1.985 . 0.514 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.342 0 C5'-C4'-O4' 113.621 3.158 . 0.147 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.013 1 O4'-C1'-N19 113.842 5.642 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.68 1 O4'-C1'-N19 114.297 6.097 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.079 -0.409 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 72.7 p -164.2 162.47 22.7 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.433 1.493 . . . . 0.0 111.739 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.5 t -163.71 164.66 23.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.291 1.436 . . . . 0.0 111.31 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 81.97 -166.36 46.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 0.0 113.809 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 m 69.9 -5.03 1.32 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 127.346 2.259 . . . . 0.0 115.353 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 m -169.55 153.86 5.31 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.5 2.32 . . . . 0.0 110.614 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -83.3 157.77 35.27 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.211 0.91 . . . . 0.0 112.404 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 57.9 tp -159.11 136.37 9.83 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.003 1.321 . . . . 0.0 110.81 -177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 7.5 p -63.67 131.09 46.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.103 1.361 . . . . 0.0 110.979 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -88.65 149.23 23.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.934 0.894 . . . . 0.0 110.432 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 63.9 tp60 -152.52 130.71 11.96 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.984 0.914 . . . . 0.0 110.489 -170.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 22.2 p -86.54 155.71 20.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.316 1.046 . . . . 0.0 112.965 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 85.4 mt -88.36 144.27 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.798 1.239 . . . . 0.0 110.703 -174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 101.73 15.31 27.16 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.912 1.244 . . . . 0.0 115.462 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -85.0 -7.53 59.1 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -116.68 135.71 53.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.022 1.329 . . . . 0.0 111.297 177.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.84 25.82 44.1 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.368 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.6 m -142.87 164.68 29.44 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.018 2.527 . . . . 0.0 109.67 -169.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.18 23.46 1.85 Allowed 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.402 -0.811 . . . . 0.0 113.081 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -62.63 111.77 2.22 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.783 0.833 . . . . 0.0 111.101 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.61 144.89 39.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.096 0.958 . . . . 0.0 111.655 -171.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -81.76 161.6 42.35 Favored Glycine 0 CA--C 1.538 1.515 0 CA-C-O 118.901 -0.944 . . . . 0.0 112.906 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -70.22 179.55 3.86 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.763 2.975 . . . . 0.0 112.0 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -55.31 125.87 22.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.409 1.084 . . . . 0.0 112.285 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 77.2 -3.25 58.83 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.009 1.29 . . . . 0.0 114.654 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.91 24.83 11.7 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.276 1.83 . . . . 0.0 112.874 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -136.59 136.87 39.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.196 1.398 . . . . 0.0 111.005 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.33 148.4 51.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.458 1.503 . . . . 0.0 112.555 -168.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -117.22 134.12 55.18 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.274 2.63 . . . . 0.0 108.453 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.43 137.72 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 127.521 2.329 . . . . 0.0 107.959 -177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -135.48 158.4 44.48 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.07 1.348 . . . . 0.0 111.136 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 74.82 27.92 1.19 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.586 2.354 . . . . 0.0 114.052 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 34.0 mt -68.77 158.62 85.33 Favored Pre-proline 0 N--CA 1.477 0.883 0 O-C-N 120.767 -1.208 . . . . 0.0 112.337 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.89 147.48 95.12 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.099 2.533 . . . . 0.0 110.157 167.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -77.36 -7.71 56.51 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.373 -0.83 . . . . 0.0 113.051 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.92 0.49 46.61 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.557 1.543 . . . . 0.0 113.595 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.74 132.09 39.1 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.812 1.245 . . . . 0.0 111.722 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.08 172.76 21.82 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.923 1.249 . . . . 0.0 113.902 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -60.63 -35.5 76.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.587 1.155 . . . . 0.0 112.546 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -81.94 -22.19 36.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.736 0.815 . . . . 0.0 112.332 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -71.98 -41.93 67.1 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.117 -0.989 . . . . 0.0 110.368 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.2 tp -64.17 -37.21 86.65 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.673 0.789 . . . . 0.0 111.538 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.41 -55.31 32.8 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.553 0.741 . . . . 0.0 111.776 173.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -63.12 -27.01 69.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 44.8 ttp -79.68 -24.65 41.62 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.961 0.904 . . . . 0.0 113.138 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -103.2 -13.16 16.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.35 1.46 . . . . 0.0 114.571 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 25.3 mtt -45.37 -42.84 21.06 Favored Pre-proline 0 CA--C 1.553 1.091 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -58.2 -10.2 7.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 124.485 3.456 . . . . 0.0 117.233 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -108.61 -1.82 19.27 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.62 -178.19 19.87 Favored Glycine 0 N--CA 1.472 1.084 0 C-N-CA 125.826 1.679 . . . . 0.0 113.498 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -70.61 113.03 7.31 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.112 -0.64 . . . . 0.0 111.224 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.12 124.8 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.624 1.169 . . . . 0.0 109.149 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.2 -42.39 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.162 1.385 . . . . 0.0 110.124 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 2.9 t -161.27 146.2 13.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.941 0.897 . . . . 0.0 111.236 175.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.04 136.25 40.1 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.862 1.265 . . . . 0.0 109.932 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -152.16 131.88 13.19 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -173.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.5 t -95.17 134.2 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 167.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -76.04 120.59 21.56 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.055 0.455 . . . . 0.0 110.486 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 32.5 mm -115.44 128.6 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.315 1.446 . . . . 0.0 109.286 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.86 122.08 16.52 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.825 0.85 . . . . 0.0 110.976 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -80.08 4.46 17.13 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -108.12 -23.75 11.84 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.438 1.095 . . . . 0.0 112.774 175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 80.3 p -124.8 -12.48 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.44 1.496 . . . . 0.0 114.118 -175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.4 t30 66.38 17.69 10.73 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.899 2.08 . . . . 0.0 113.603 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.14 142.67 27.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.894 1.277 . . . . 0.0 111.712 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.1 t -70.55 143.6 51.56 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.616 -0.678 . . . . 0.0 111.16 169.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.2 8.39 38.27 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.331 1.052 . . . . 0.0 113.216 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.7 m 62.95 18.08 10.57 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.807 1.643 . . . . 0.0 113.942 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -132.0 149.44 52.42 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.586 1.554 . . . . 0.0 110.721 173.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -153.79 -174.36 23.91 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 125.289 1.423 . . . . 0.0 113.138 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -149.34 149.28 30.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.244 1.418 . . . . 0.0 111.464 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.5 t -145.31 133.38 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.68 1.192 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.4 p -118.28 146.03 44.61 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.893 1.277 . . . . 0.0 112.421 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -124.49 163.78 21.14 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 126.027 1.731 . . . . 0.0 111.467 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -78.15 -8.36 58.18 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.71 0.804 . . . . 0.0 113.042 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -154.71 159.43 31.87 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 125.504 1.522 . . . . 0.0 111.51 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -80.85 -19.97 8.03 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.807 2.338 . . . . 0.0 113.999 -174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.8 t -70.98 -38.14 70.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.573 1.079 . . . . 0.0 110.282 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.8 m -65.51 -39.17 91.55 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.617 0.644 . . . . 0.0 112.396 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -66.52 -48.81 68.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.484 0.713 . . . . 0.0 112.043 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -57.22 -43.19 82.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.978 0.911 . . . . 0.0 113.04 173.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.75 81.64 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.7 0.8 . . . . 0.0 112.474 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.84 -35.72 72.58 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.711 -0.661 . . . . 0.0 112.417 175.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.64 -48.85 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 CA-C-N 119.95 1.25 . . . . 0.0 109.837 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.33 -23.45 66.36 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 113.163 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 54.5 m -99.06 -27.18 13.96 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.5 mmm -112.0 -18.15 12.7 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -70.95 111.91 6.71 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.593 1.088 . . . . 0.0 110.136 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.86 3.5 62.19 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.771 1.653 . . . . 0.0 114.773 -172.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.0 122.68 17.1 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 119.329 1.565 . . . . 0.0 110.913 178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -77.68 132.91 38.4 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.04 0.448 . . . . 0.0 110.753 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.8 tt -147.06 127.8 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.238 1.415 . . . . 0.0 109.552 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.33 -105.24 1.07 Allowed Glycine 0 CA--C 1.533 1.164 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -128.31 18.28 6.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.222 1.809 . . . . 0.0 112.308 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -146.21 177.23 9.15 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.033 1.733 . . . . 0.0 112.296 -172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -121.95 136.37 54.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.562 1.145 . . . . 0.0 111.983 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 83.7 mt -69.2 153.17 44.11 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.106 1.362 . . . . 0.0 112.326 175.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -127.11 127.91 45.38 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.248 1.819 . . . . 0.0 108.038 174.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.5 136.67 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.783 0.833 . . . . 0.0 110.993 -168.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -166.01 170.16 13.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.68 1.592 . . . . 0.0 110.745 -173.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.71 139.3 58.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.175 0.59 . . . . 0.0 110.667 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.03 162.81 22.46 Favored 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -70.57 167.01 19.4 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.883 1.273 . . . . 0.0 113.685 -177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 23.2 t -137.4 135.69 37.18 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.869 1.268 . . . . 0.0 110.236 169.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -84.82 -21.28 29.92 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -161.36 146.26 13.58 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.847 1.259 . . . . 0.0 112.143 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.77 146.78 13.17 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.342 1.857 . . . . 0.0 110.63 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 43.1 t -162.28 145.23 11.47 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.835 1.254 . . . . 0.0 111.737 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -82.03 -5.33 58.28 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.543 1.137 . . . . 0.0 112.716 171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 25.6 p 71.32 8.88 6.45 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 128.19 2.596 . . . . 0.0 115.092 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -65.16 -43.38 95.59 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-O 117.456 -1.747 . . . . 0.0 115.829 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.95 138.2 80.78 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.93 3.087 . . . . 0.0 112.96 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 69.2 m -75.73 -4.63 41.48 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 42.4 p -88.06 -4.74 58.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.868 1.667 . . . . 0.0 113.725 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 C-N-CA 125.627 1.584 . . . . 0.0 113.703 178.635 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.475 0 O4'-C1'-N19 110.494 2.294 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 1 O4'-C1'-N19 113.844 5.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.44 0 O5'-C5'-C4' 113.258 2.184 . 0.439 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.506 0 C5'-C4'-O4' 114.156 3.54 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 0 C3'-C2'-C1' 104.91 3.789 . 0.01 3b . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.865 1 O4'-C1'-N19 112.965 4.765 . 0.0 OUTLIER '7D dist 2a' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.839 -0.504 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.3 t -154.44 29.42 0.44 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.437 1.095 . . . . 0.0 112.346 -175.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 14.7 m -75.99 -9.48 58.65 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -169.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 77.17 7.6 86.83 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 124.77 1.176 . . . . 0.0 115.017 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 23.3 p -70.11 -15.46 62.98 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.793 1.237 . . . . 0.0 114.113 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 14.4 m -64.51 -18.01 64.42 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.802 -1.186 . . . . 0.0 113.855 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -102.96 0.72 48.03 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.376 1.465 . . . . 0.0 114.551 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 33.0 tp -65.33 -14.98 62.03 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 119.4 1.6 . . . . 0.0 114.71 -169.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 40.6 p -91.92 0.54 57.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.022 2.129 . . . . 0.0 113.76 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -158.55 -164.78 1.53 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.343 1.457 . . . . 0.0 111.2 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -92.22 -7.79 47.24 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 58.9 p -170.25 -171.08 1.05 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.191 1.396 . . . . 0.0 111.883 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 36.6 mm -78.38 -5.78 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 120.642 -1.286 . . . . 0.0 112.179 170.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 133.67 17.69 1.05 Allowed Glycine 0 N--CA 1.479 1.534 0 C-N-CA 125.778 1.656 . . . . 0.0 115.213 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 68.95 -42.52 0.49 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.512 3.525 . . . . 0.0 115.307 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -79.57 119.7 22.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.006 1.322 . . . . 0.0 112.759 -173.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.32 86.5 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.598 1.095 . . . . 0.0 112.916 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.8 t -76.3 139.13 40.94 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.988 0.894 . . . . 0.0 111.75 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.98 5.28 44.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.736 1.214 . . . . 0.0 111.25 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -77.11 88.63 3.6 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 120.987 -1.071 . . . . 0.0 112.051 -172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -61.47 138.49 58.27 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.843 1.257 . . . . 0.0 110.88 175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.28 -173.75 49.97 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.657 1.598 . . . . 0.0 113.537 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -75.13 172.31 16.6 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 124.011 3.14 . . . . 0.0 112.403 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -57.62 125.86 24.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.524 1.13 . . . . 0.0 111.597 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.43 -6.64 71.73 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.742 1.163 . . . . 0.0 114.664 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.67 -2.84 37.34 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 118.899 1.349 . . . . 0.0 113.687 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -99.59 123.44 43.86 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.624 1.17 . . . . 0.0 111.18 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 58.0 mt -104.42 144.04 32.2 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 125.291 1.437 . . . . 0.0 111.344 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -115.03 125.58 53.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.714 2.005 . . . . 0.0 108.683 169.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -115.21 135.17 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 127.146 2.178 . . . . 0.0 107.906 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -137.23 150.91 48.18 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.195 1.398 . . . . 0.0 111.342 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 84.24 21.3 0.14 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 128.924 2.89 . . . . 0.0 113.654 -173.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 82.3 mt -63.92 153.26 85.06 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.021 0.928 . . . . 0.0 111.845 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 148.23 68.22 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.42 2.747 . . . . 0.0 111.948 169.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -73.51 4.97 4.18 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -127.79 9.52 6.43 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.048 1.739 . . . . 0.0 113.239 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.51 131.85 43.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.957 0.903 . . . . 0.0 111.546 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.54 166.94 28.24 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.558 1.075 . . . . 0.0 113.264 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.17 -34.34 77.83 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.752 0.821 . . . . 0.0 112.556 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -72.79 -27.47 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.324 1.45 . . . . 0.0 112.322 174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -72.26 -41.49 66.67 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.922 0.783 . . . . 0.0 110.716 174.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -66.19 -35.9 81.65 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.542 0.737 . . . . 0.0 111.731 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.12 -51.74 59.5 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.737 -0.602 . . . . 0.0 111.833 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.31 -23.92 65.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.773 0.715 . . . . 0.0 112.642 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.3 ttm -69.01 -39.48 79.28 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.806 1.243 . . . . 0.0 112.781 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.23 -15.02 18.23 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 13.2 mtt -39.05 -42.6 1.88 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.419 1.888 . . . . 0.0 116.083 173.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -62.48 -16.89 55.0 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.247 2.631 . . . . 0.0 116.561 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -102.2 -3.55 27.21 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 -169.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 150.72 -167.45 30.42 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 124.716 1.151 . . . . 0.0 114.92 173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -77.32 103.43 7.25 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.442 0.697 . . . . 0.0 112.028 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.23 121.28 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.836 1.255 . . . . 0.0 109.525 174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.8 t -82.79 -32.83 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.786 1.635 . . . . 0.0 111.016 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.2 p -160.06 150.15 18.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.064 0.945 . . . . 0.0 112.125 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -139.66 129.08 24.18 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.743 1.617 . . . . 0.0 109.03 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -149.56 104.8 3.39 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.775 0.83 . . . . 0.0 111.652 -168.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.74 138.99 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 168.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -80.71 112.4 18.05 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.422 0.556 . . . . 0.0 110.073 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.5 mm -111.38 136.56 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.215 1.406 . . . . 0.0 110.553 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -67.8 124.5 23.49 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.737 1.215 . . . . 0.0 111.262 172.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -75.38 3.72 8.59 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -126.44 -33.2 2.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.02 1.328 . . . . 0.0 113.137 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 43.5 p -102.26 -9.87 20.04 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.279 8.0 p30 60.96 9.73 2.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.725 2.41 . . . . 0.0 115.316 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.5 mt -81.84 147.71 29.2 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.631 1.172 . . . . 0.0 111.837 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.8 t -74.54 138.53 43.15 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.423 0.689 . . . . 0.0 110.259 168.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -81.81 13.9 2.98 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.511 1.124 . . . . 0.0 113.585 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.1 m 75.34 8.19 3.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.702 2.401 . . . . 0.0 114.495 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -133.26 149.52 51.96 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.287 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -160.11 179.04 35.91 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.866 1.222 . . . . 0.0 113.647 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -138.96 149.06 44.31 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.991 1.316 . . . . 0.0 112.304 -169.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.6 t -139.56 125.47 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.761 1.225 . . . . 0.0 108.407 173.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 52.2 m -111.98 123.9 51.24 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.797 0.839 . . . . 0.0 111.28 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -92.94 168.06 11.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 112.393 173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -81.43 -3.89 54.21 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 170.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -158.15 160.04 29.91 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 125.407 1.483 . . . . 0.0 111.498 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.61 -17.06 7.56 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.874 2.383 . . . . 0.0 114.128 -175.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.94 -37.72 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-N 119.837 1.199 . . . . 0.0 110.408 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 65.2 m -66.99 -38.25 85.69 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.791 0.723 . . . . 0.0 111.886 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.31 -50.16 72.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.985 0.914 . . . . 0.0 111.938 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -59.3 -43.83 92.57 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 112.914 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.72 78.94 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.776 0.831 . . . . 0.0 112.499 175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.89 -37.42 70.14 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 118.575 -0.726 . . . . 0.0 112.607 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.7 mt -58.22 -47.0 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 120.063 1.302 . . . . 0.0 109.957 173.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -66.51 -20.54 66.06 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.741 1.216 . . . . 0.0 113.191 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.7 m -100.53 -23.76 14.62 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.6 mmm -118.13 -16.38 9.77 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.27 111.56 5.27 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.926 1.239 . . . . 0.0 110.579 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.11 10.5 56.05 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.65 2.072 . . . . 0.0 114.574 -172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -60.35 119.42 7.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.886 1.843 . . . . 0.0 110.108 175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -81.92 130.04 34.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.106 0.479 . . . . 0.0 110.631 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.95 104.6 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 125.052 1.341 . . . . 0.0 107.862 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.14 -117.71 10.1 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 95.3 mtp -101.26 -2.5 31.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.098 1.359 . . . . 0.0 113.422 174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -92.08 153.61 19.27 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.901 1.28 . . . . 0.0 111.498 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -123.72 123.13 39.84 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.976 0.91 . . . . 0.0 109.888 168.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 89.2 mt -71.5 122.92 21.31 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 124.207 1.003 . . . . 0.0 111.512 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -85.28 126.38 33.66 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -136.8 135.27 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.21 1.004 . . . . 0.0 109.947 -173.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.51 176.69 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.336 1.454 . . . . 0.0 110.617 -170.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.3 mt -69.93 149.7 47.51 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.682 0.753 . . . . 0.0 110.708 168.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.36 146.63 50.74 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.598 1.159 . . . . 0.0 113.019 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.0 124.56 20.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.565 1.546 . . . . 0.0 110.758 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.4 m -93.93 -13.66 26.85 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -162.18 154.92 19.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.035 1.334 . . . . 0.0 113.444 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.47 -31.09 12.53 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -82.21 155.42 24.93 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.606 1.163 . . . . 0.0 113.348 -178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 78.1 p -165.67 156.32 13.4 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.548 1.539 . . . . 0.0 111.621 177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -162.4 158.44 23.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.594 1.558 . . . . 0.0 112.416 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.2 m -80.76 116.4 20.74 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.787 0.835 . . . . 0.0 111.185 177.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -90.31 167.33 32.67 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 124.463 1.03 . . . . 0.0 113.515 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.5 159.34 46.46 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.032 3.155 . . . . 0.0 111.517 176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 79.7 p -165.21 -47.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.383 1.073 . . . . 0.0 112.718 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 24.7 m 68.29 9.7 7.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 126.64 1.976 . . . . 0.0 114.619 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.563 1.554 . . . . 0.0 112.824 179.77 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.303 0 C5'-C4'-C3' 112.317 -2.122 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.307 1 O4'-C1'-N19 113.757 5.557 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.47 0 O4'-C1'-N19 110.363 2.163 . 0.601 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-O4' 113.413 3.009 . 0.557 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.274 1 O4'-C1'-N19 112.674 4.474 . 0.0 OUTLIER '7D dist 3b' 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.956 2.756 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.624 0 N-CA-C 112.056 -0.417 . . . . 0.0 112.056 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.7 t -163.65 174.96 11.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.445 1.498 . . . . 0.0 111.232 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 7.9 t -146.4 13.38 1.22 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.619 1.567 . . . . 0.0 112.649 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -80.03 1.67 78.75 Favored Glycine 0 N--CA 1.474 1.187 0 C-N-CA 124.834 1.207 . . . . 0.0 115.19 -175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 28.6 p -69.47 -9.97 56.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.563 1.545 . . . . 0.0 114.455 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 90.3 p -77.91 -13.31 59.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.556 1.143 . . . . 0.0 113.697 170.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 85.1 -8.17 71.79 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.3 1.428 . . . . 0.0 113.931 -170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 83.4 mt 58.08 -166.54 0.15 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 127.309 2.244 . . . . 0.0 113.428 175.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 60.0 p -142.49 163.54 32.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.33 2.252 . . . . 0.0 109.955 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -85.42 -8.92 58.15 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.48 170.51 12.79 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.794 2.037 . . . . 0.0 110.222 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.2 t -151.59 -177.16 5.93 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.314 1.846 . . . . 0.0 109.62 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 88.5 mt -80.71 -11.97 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.939 1.296 . . . . 0.0 111.518 174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.34 3.76 4.24 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 126.352 1.93 . . . . 0.0 115.758 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -70.68 -14.93 62.65 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.845 2.058 . . . . 0.0 113.402 169.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -78.98 125.43 29.36 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.468 1.507 . . . . 0.0 114.363 -174.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.38 -11.53 60.88 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.265 1.888 . . . . 0.0 113.089 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 47.1 m -76.38 162.9 27.49 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.391 1.476 . . . . 0.0 113.077 -173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.93 31.58 4.17 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.782 1.233 . . . . 0.0 111.536 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -75.8 83.67 2.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.229 1.011 . . . . 0.0 110.029 170.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -61.58 140.8 58.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.04 1.336 . . . . 0.0 110.974 -177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.55 -177.02 51.6 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.275 1.416 . . . . 0.0 113.49 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.28 176.19 8.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.055 3.17 . . . . 0.0 112.505 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.03 123.62 15.01 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.586 1.154 . . . . 0.0 111.874 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -4.37 79.64 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.953 1.263 . . . . 0.0 114.797 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.01 -5.21 48.11 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 118.969 1.385 . . . . 0.0 114.077 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -99.64 128.07 45.74 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.186 0.995 . . . . 0.0 111.18 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 49.1 mt -115.14 143.37 45.32 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.195 1.398 . . . . 0.0 111.886 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -104.57 125.59 50.86 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.558 1.943 . . . . 0.0 107.995 168.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.1 137.46 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 126.775 2.03 . . . . 0.0 107.555 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -147.72 150.42 34.27 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.359 1.064 . . . . 0.0 111.813 -172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 78.48 28.82 0.45 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 128.86 2.864 . . . . 0.0 113.325 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 53.4 mt -62.05 155.81 61.88 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.109 1.364 . . . . 0.0 112.226 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.26 151.63 77.76 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.396 2.731 . . . . 0.0 111.666 168.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -67.71 -23.47 65.28 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.387 0.675 . . . . 0.0 112.544 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.35 -0.21 57.62 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.241 1.417 . . . . 0.0 114.047 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -80.56 124.43 28.95 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.053 0.941 . . . . 0.0 111.672 -172.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -97.06 175.27 30.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.789 1.185 . . . . 0.0 113.733 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -64.47 -35.02 79.58 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.546 1.138 . . . . 0.0 112.657 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -76.67 -30.85 56.95 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.414 1.086 . . . . 0.0 111.859 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -68.74 -39.7 80.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.695 0.68 . . . . 0.0 110.832 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.8 tp -62.44 -41.9 99.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.586 0.754 . . . . 0.0 111.259 172.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.75 -50.92 69.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.21 0.604 . . . . 0.0 111.879 175.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -66.93 -21.07 66.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.1 ttp -82.85 -26.69 31.4 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.104 0.962 . . . . 0.0 113.184 174.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -106.39 -21.68 13.02 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 41.0 mtm -51.23 -36.96 30.76 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 173.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -53.89 -15.65 7.52 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.172 3.248 . . . . 0.0 116.424 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -101.95 -3.77 27.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.334 1.053 . . . . 0.0 113.697 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.89 -175.95 24.24 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.121 1.343 . . . . 0.0 115.018 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -67.72 119.64 12.78 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.76 1.224 . . . . 0.0 111.55 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 84.2 t -106.18 117.34 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.785 1.634 . . . . 0.0 109.61 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.4 -29.88 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.245 1.818 . . . . 0.0 111.508 -176.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 95.0 p -158.45 149.99 21.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.461 1.104 . . . . 0.0 112.127 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.47 130.92 23.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.679 1.592 . . . . 0.0 109.184 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 37.0 tttp -149.37 121.14 8.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.105 0.562 . . . . 0.0 111.917 -168.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 79.9 t -96.62 135.57 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.315 1.446 . . . . 0.0 108.102 171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -81.44 115.12 20.62 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.56 0.744 . . . . 0.0 111.059 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 40.2 mm -115.28 125.31 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.847 1.659 . . . . 0.0 109.137 -177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -66.65 126.42 28.9 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.229 1.012 . . . . 0.0 112.351 -172.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -59.3 -16.84 24.33 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -95.55 -28.95 14.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.947 1.299 . . . . 0.0 113.107 -174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.4 p -132.77 -12.47 2.96 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -169.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 65.52 17.85 11.07 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 126.007 1.723 . . . . 0.0 113.435 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.6 mt -91.71 151.27 20.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.11 1.364 . . . . 0.0 111.191 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.8 t -75.05 139.46 42.86 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.455 -0.778 . . . . 0.0 111.514 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -89.94 11.68 19.74 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.417 0.687 . . . . 0.0 112.668 169.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.4 m 67.11 17.95 10.43 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.172 1.789 . . . . 0.0 113.814 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -131.87 159.24 39.15 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.192 1.397 . . . . 0.0 111.574 173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -167.53 -169.94 31.71 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.873 1.225 . . . . 0.0 113.931 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -135.75 149.01 49.03 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.596 1.558 . . . . 0.0 111.859 -172.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 85.8 t -137.83 120.82 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.486 1.114 . . . . 0.0 108.271 170.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.9 m -108.63 111.27 23.0 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.589 1.155 . . . . 0.0 110.644 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -83.86 164.35 19.52 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.842 0.83 . . . . 0.0 112.835 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -71.62 -15.45 62.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.321 1.048 . . . . 0.0 113.098 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -158.27 161.09 29.28 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.327 1.451 . . . . 0.0 111.796 -175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.81 -18.17 9.27 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.92 2.414 . . . . 0.0 114.399 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 47.8 t -73.94 -39.38 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.014 1.279 . . . . 0.0 110.227 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 56.4 m -64.75 -39.2 93.24 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.343 0.657 . . . . 0.0 112.044 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.03 -48.71 75.27 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.835 0.854 . . . . 0.0 112.26 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -58.19 -43.67 87.67 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 112.779 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -62.31 -35.2 78.33 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.677 0.791 . . . . 0.0 112.514 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.4 66.11 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 118.589 -0.72 . . . . 0.0 112.754 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.9 mt -59.76 -48.32 88.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 120.082 1.31 . . . . 0.0 109.631 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -66.23 -20.7 66.2 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.456 1.103 . . . . 0.0 113.14 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.1 m -99.64 -26.04 14.21 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.2 mmm -117.49 -16.1 10.21 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -169.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -71.63 115.23 10.58 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.002 1.274 . . . . 0.0 110.458 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 89.3 5.32 72.8 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.618 1.58 . . . . 0.0 114.41 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -60.68 124.66 21.07 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.344 1.572 . . . . 0.0 111.254 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -80.0 126.5 31.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.691 0.796 . . . . 0.0 110.108 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.59 133.89 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.837 1.255 . . . . 0.0 109.778 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.05 -120.88 24.69 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -109.24 16.88 22.11 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.759 1.624 . . . . 0.0 112.397 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -143.55 -170.24 3.25 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.644 1.578 . . . . 0.0 113.046 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -134.44 142.67 47.19 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.454 1.502 . . . . 0.0 111.759 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.28 150.81 38.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.906 1.283 . . . . 0.0 112.441 175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -117.53 129.44 55.79 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.96 1.304 . . . . 0.0 107.83 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.28 134.35 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.419 1.088 . . . . 0.0 109.353 -170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -162.75 167.33 23.13 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.371 1.069 . . . . 0.0 111.0 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.94 135.63 57.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.586 0.707 . . . . 0.0 110.126 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -66.32 141.88 57.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.463 1.105 . . . . 0.0 112.266 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -81.06 152.95 27.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.219 1.007 . . . . 0.0 110.983 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 12.8 t -156.24 165.26 36.89 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.39 1.076 . . . . 0.0 112.484 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -55.73 -17.09 5.17 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.488 1.915 . . . . 0.0 115.58 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -135.63 21.24 3.34 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.443 1.897 . . . . 0.0 112.397 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -158.13 82.84 0.85 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.889 1.676 . . . . 0.0 109.769 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.1 t -169.16 160.69 9.88 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.865 1.666 . . . . 0.0 110.341 -170.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.0 138.49 58.38 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.272 -0.892 . . . . 0.0 111.998 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 36.3 p -78.07 -7.2 56.64 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 123.92 -170.23 16.13 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.803 1.668 . . . . 0.0 113.695 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.36 164.21 29.12 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 124.138 3.225 . . . . 0.0 111.837 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.3 p -160.86 163.52 31.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.247 1.419 . . . . 0.0 111.906 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.0 p -134.35 4.93 3.46 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -171.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.156 0 C-N-CA 125.341 1.448 . . . . 0.0 112.95 -179.015 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.246 0 C4'-C3'-C2' 100.444 -2.256 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.251 1 O4'-C1'-N19 112.496 4.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.306 0 O5'-C5'-C4' 113.039 2.028 . 0.082 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.714 0 O4'-C1'-N19 111.277 3.077 . 0.413 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . 0.458 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 C5'--C4' 1.537 2.081 1 O4'-C1'-N19 114.081 5.881 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . 0.458 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.56 1 O4'-C1'-N19 112.589 4.389 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.576 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 52.1 p -90.08 -9.26 49.08 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 65.5 p -164.51 161.13 21.07 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.533 1.533 . . . . 0.0 112.115 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.44 -165.83 39.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.069 1.319 . . . . 0.0 113.455 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 38.0 t -159.9 146.21 15.93 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.873 1.269 . . . . 0.0 111.71 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 56.1 p -93.08 1.35 57.27 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.466 1.506 . . . . 0.0 113.338 174.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -74.54 -2.85 64.9 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.241 1.401 . . . . 0.0 115.584 -173.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 62.8 tp -154.24 123.19 6.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.874 1.67 . . . . 0.0 109.665 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 34.9 p -150.03 135.68 18.36 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.898 1.679 . . . . 0.0 110.19 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -84.75 -10.79 56.9 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.374 0.67 . . . . 0.0 112.642 173.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -168.11 146.72 4.49 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.889 2.476 . . . . 0.0 107.138 174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.3 p -151.63 149.64 29.37 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.205 -0.934 . . . . 0.0 112.481 175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 80.2 mt -73.35 134.55 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 107.09 5.63 34.94 Favored Glycine 0 N--CA 1.473 1.163 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 -171.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -50.49 -32.8 19.16 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.344 1.858 . . . . 0.0 114.471 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -76.65 115.23 16.22 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.214 1.406 . . . . 0.0 112.322 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.57 2.21 85.01 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.154 1.359 . . . . 0.0 113.027 -173.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 41.0 t -82.15 155.76 24.83 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.212 1.006 . . . . 0.0 111.832 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.64 29.96 6.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 110.949 174.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.33 81.93 0.76 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.11 0.964 . . . . 0.0 110.096 169.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -63.92 141.97 58.58 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.788 1.235 . . . . 0.0 110.847 -175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.27 -176.21 51.34 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 125.29 1.424 . . . . 0.0 113.365 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.02 174.92 10.54 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.962 3.108 . . . . 0.0 112.334 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.66 123.78 16.07 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.345 1.058 . . . . 0.0 111.816 -178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.31 -4.95 79.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.838 1.209 . . . . 0.0 114.815 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.4 -4.25 54.06 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.037 1.419 . . . . 0.0 113.928 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -101.95 131.71 48.19 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.668 1.187 . . . . 0.0 111.266 -178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 57.1 mt -116.09 149.16 39.4 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 125.581 1.552 . . . . 0.0 112.146 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -115.35 129.55 56.63 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 127.26 2.224 . . . . 0.0 108.565 168.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.47 137.82 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.992 2.117 . . . . 0.0 107.958 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -139.08 151.6 46.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.113 1.365 . . . . 0.0 111.557 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 83.85 21.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 129.378 3.071 . . . . 0.0 113.908 -174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.64 159.1 36.02 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 124.185 0.994 . . . . 0.0 112.207 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.81 155.28 33.31 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.025 3.15 . . . . 0.0 113.032 169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -11.44 60.19 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.936 1.294 . . . . 0.0 113.406 -174.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.08 9.68 10.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.444 1.898 . . . . 0.0 113.466 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.12 130.7 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.811 0.844 . . . . 0.0 112.016 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.16 166.25 30.79 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 124.459 1.028 . . . . 0.0 113.236 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.44 -33.86 76.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.867 0.867 . . . . 0.0 112.669 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -75.8 -27.56 58.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.13 0.972 . . . . 0.0 112.047 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -68.39 -39.17 81.8 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.116 0.871 . . . . 0.0 110.938 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.3 tp -67.62 -36.98 81.83 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.464 0.706 . . . . 0.0 111.903 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 65.1 tp -64.01 -51.1 65.81 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.765 -0.584 . . . . 0.0 111.619 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -66.7 -24.38 66.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttm -70.59 -38.71 74.08 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.837 1.255 . . . . 0.0 112.666 171.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -100.4 -12.29 19.52 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 14.0 mtt -43.76 -42.63 11.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 126.494 1.918 . . . . 0.0 115.963 171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -62.55 -14.35 39.06 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.388 2.726 . . . . 0.0 115.974 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -105.34 -0.38 26.24 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.16 -171.39 25.65 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.706 1.146 . . . . 0.0 115.124 174.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -78.53 118.96 21.16 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.867 1.267 . . . . 0.0 112.754 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 85.0 t -102.93 129.62 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 125.599 1.559 . . . . 0.0 110.865 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 52.8 t -88.96 -36.16 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 126.489 1.916 . . . . 0.0 111.137 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 98.9 p -160.16 155.82 25.68 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.817 1.247 . . . . 0.0 112.098 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -148.85 133.97 18.24 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.724 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -154.57 119.41 4.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 122.915 0.486 . . . . 0.0 112.11 -169.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.4 t -89.46 138.56 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.183 1.393 . . . . 0.0 107.522 171.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -81.09 112.01 18.07 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.292 0.568 . . . . 0.0 110.397 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 33.6 mm -111.58 131.23 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.688 1.595 . . . . 0.0 109.789 -175.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.51 126.27 26.95 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.349 1.06 . . . . 0.0 112.083 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -73.38 -2.65 23.13 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -114.56 -25.98 8.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.499 1.12 . . . . 0.0 113.333 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 81.3 p -121.0 -11.5 8.9 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.123 1.369 . . . . 0.0 114.262 -174.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 54.0 t30 65.75 17.04 10.75 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.071 1.748 . . . . 0.0 113.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.4 mt -89.53 144.53 25.96 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.195 1.398 . . . . 0.0 111.02 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.9 t -70.59 137.28 49.88 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.444 -0.785 . . . . 0.0 111.097 169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -80.85 16.05 1.58 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.674 0.79 . . . . 0.0 112.872 169.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.6 m 66.62 16.25 10.34 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.356 1.862 . . . . 0.0 113.369 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -136.11 149.64 48.77 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.706 1.203 . . . . 0.0 111.994 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.85 -179.19 32.56 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.623 1.106 . . . . 0.0 113.957 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -138.73 146.18 41.17 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.608 1.563 . . . . 0.0 111.61 -169.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.0 t -140.34 129.26 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.544 1.138 . . . . 0.0 108.821 174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.8 m -115.47 111.4 20.71 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.709 1.204 . . . . 0.0 110.836 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -83.81 169.34 15.28 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.809 0.843 . . . . 0.0 111.993 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -80.44 -7.22 59.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -162.25 161.89 20.27 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.55 1.54 . . . . 0.0 111.613 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.99 -18.11 9.06 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.889 2.393 . . . . 0.0 114.563 -172.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.13 -37.17 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 120.199 1.363 . . . . 0.0 110.299 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 42.6 m -65.39 -40.73 93.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.112 0.565 . . . . 0.0 111.816 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.95 -47.16 81.53 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.881 0.872 . . . . 0.0 112.115 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -59.84 -44.06 94.27 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.851 0.86 . . . . 0.0 112.735 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.3 77.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.704 0.802 . . . . 0.0 112.497 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.02 -36.68 67.02 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 0.0 112.733 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.69 -47.8 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 119.908 1.231 . . . . 0.0 109.69 171.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -66.35 -20.37 66.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.546 1.138 . . . . 0.0 113.287 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.1 m -100.24 -25.9 14.1 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.8 mmm -117.37 -19.06 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -169.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -69.9 110.0 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.777 1.171 . . . . 0.0 109.762 172.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 100.02 5.97 54.36 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.407 1.479 . . . . 0.0 114.803 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.62 125.84 25.59 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.881 1.841 . . . . 0.0 110.228 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -84.63 128.86 34.82 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.96 0.8 . . . . 0.0 110.119 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.1 tt -127.74 116.08 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.387 1.075 . . . . 0.0 108.239 171.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.81 -116.82 9.42 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.6 mmt -110.95 12.78 22.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.499 1.52 . . . . 0.0 113.398 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -132.08 154.4 49.47 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.806 1.243 . . . . 0.0 113.705 -175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -106.44 126.25 52.02 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.75 1.62 . . . . 0.0 110.635 -172.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.7 mt -71.69 130.38 41.0 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.277 1.031 . . . . 0.0 111.545 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -95.04 130.29 41.78 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.071 1.349 . . . . 0.0 108.388 169.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.5 t -141.18 135.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.14 0.976 . . . . 0.0 110.176 -176.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -161.79 170.89 18.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.311 1.444 . . . . 0.0 110.704 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.9 mt -62.52 140.73 58.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.362 0.601 . . . . 0.0 110.699 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 11.8 ttpp -66.24 145.41 55.79 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.515 0.726 . . . . 0.0 112.862 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -110.05 177.75 4.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.566 1.946 . . . . 0.0 109.048 170.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 66.7 m -146.34 147.46 31.36 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.282 -0.887 . . . . 0.0 110.794 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -79.37 35.23 0.27 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.27 -17.85 63.11 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.56 1.144 . . . . 0.0 112.908 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -160.8 165.08 30.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.065 2.146 . . . . 0.0 110.564 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 68.1 m -144.66 -27.87 0.49 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.574 1.549 . . . . 0.0 113.542 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.46 152.44 8.6 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.901 1.68 . . . . 0.0 112.536 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.4 t -152.33 126.13 8.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.049 1.34 . . . . 0.0 109.445 173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 71.97 -164.75 54.22 Favored Glycine 0 CA--C 1.542 1.728 0 C-N-CA 123.709 0.671 . . . . 0.0 112.758 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -60.88 138.98 82.63 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.051 3.167 . . . . 0.0 112.11 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 45.1 p -137.37 1.56 2.41 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 39.0 m 64.89 1.64 1.5 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 126.791 2.037 . . . . 0.0 114.761 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 C-N-CA 127.499 2.476 . . . . 0.0 112.71 -178.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.202 0 O4'-C1'-N19 110.557 2.357 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.218 1 O4'-C1'-N19 113.209 5.009 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.517 0 O5'-C5'-C4' 113.685 2.489 . 0.475 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.384 0 C5'-C4'-O4' 113.631 3.165 . 0.178 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.222 1 O4'-C1'-N19 115.373 7.173 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 P-O3'-C3' 121.891 1.826 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 N-CA-C 112.066 -0.414 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.4 t 65.67 -164.86 0.24 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.77 1.628 . . . . 0.0 112.952 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 74.2 m -134.35 138.11 44.65 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.278 1.831 . . . . 0.0 110.507 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 80.91 9.67 86.0 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.939 0.78 . . . . 0.0 114.586 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 7.8 t -68.54 -16.98 64.05 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 118.503 1.151 . . . . 0.0 113.36 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 29.4 p -76.39 -5.39 47.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.347 1.459 . . . . 0.0 113.903 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 100.71 136.24 9.27 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.415 1.96 . . . . 0.0 112.804 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.67 -16.88 2.0 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.923 1.689 . . . . 0.0 113.881 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.2 p -137.79 21.25 2.87 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 127.63 2.372 . . . . 0.0 111.534 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.17 143.35 15.28 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.038 2.135 . . . . 0.0 109.293 -177.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.48 14.51 24.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.288 1.435 . . . . 0.0 112.443 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 14.6 t -156.36 -174.12 4.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.11 2.164 . . . . 0.0 109.741 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 47.8 mt -75.97 91.36 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 120.944 -1.097 . . . . 0.0 110.269 -173.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 76.87 -67.55 2.65 Favored Glycine 0 N--CA 1.469 0.841 0 C-N-CA 125.881 1.705 . . . . 0.0 112.652 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.72 -40.84 0.33 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 129.835 3.254 . . . . 0.0 114.343 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -87.0 142.96 27.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 111.054 169.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 77.2 23.34 68.75 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.516 0.579 . . . . 0.0 112.199 -169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 28.2 t -134.52 155.75 49.85 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.179 1.392 . . . . 0.0 111.906 -175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -133.83 21.04 3.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.094 1.358 . . . . 0.0 112.606 -171.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -65.2 98.1 0.3 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.847 0.859 . . . . 0.0 110.894 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -65.06 128.61 36.5 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.536 1.134 . . . . 0.0 110.685 -174.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -68.71 161.96 50.96 Favored Glycine 0 CA--C 1.541 1.684 0 CA-C-O 119.317 -0.713 . . . . 0.0 113.254 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.87 176.68 4.97 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.946 3.097 . . . . 0.0 112.156 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -54.74 121.1 7.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.409 1.084 . . . . 0.0 112.041 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.14 85.14 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.786 1.184 . . . . 0.0 114.731 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -113.71 -0.13 14.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.496 1.518 . . . . 0.0 114.257 -176.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -99.98 139.27 35.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.07 1.348 . . . . 0.0 111.162 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 74.0 mt -125.29 152.32 44.81 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.128 1.371 . . . . 0.0 112.625 -175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -120.91 133.47 55.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 127.683 2.393 . . . . 0.0 109.115 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.3 mp -122.49 138.74 51.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 127.34 2.256 . . . . 0.0 107.856 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -138.76 151.34 47.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.249 1.419 . . . . 0.0 111.156 177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 84.8 25.45 0.08 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 129.075 2.95 . . . . 0.0 113.755 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.86 159.3 79.94 Favored Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 120.945 -1.097 . . . . 0.0 111.929 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -58.26 148.88 76.62 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.544 2.829 . . . . 0.0 112.144 169.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -72.68 6.01 2.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -134.36 9.26 3.72 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.134 1.774 . . . . 0.0 113.14 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -72.24 135.81 46.15 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.464 1.105 . . . . 0.0 111.228 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.31 167.3 16.68 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.495 1.045 . . . . 0.0 113.849 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -57.3 -33.71 67.95 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.895 1.278 . . . . 0.0 112.486 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 69.2 tp60 -77.99 -29.47 49.69 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.563 1.545 . . . . 0.0 112.493 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -72.3 -40.59 67.41 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 121.607 -0.683 . . . . 0.0 110.794 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.6 tp -64.49 -39.5 93.91 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.652 0.781 . . . . 0.0 111.534 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 68.4 tp -59.01 -54.13 50.56 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.628 0.771 . . . . 0.0 111.781 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -69.66 -16.95 63.45 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 43.0 ttp -84.15 -28.74 27.2 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.195 0.998 . . . . 0.0 113.099 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -100.69 -11.37 20.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.301 1.441 . . . . 0.0 114.511 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 15.5 mtt -42.05 -43.47 7.1 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 116.098 1.888 . . . . 0.0 116.098 170.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -62.69 -14.65 41.52 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 123.164 2.576 . . . . 0.0 116.081 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -102.6 -1.32 30.52 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -169.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.58 -171.9 25.1 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 125.039 1.304 . . . . 0.0 114.404 175.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -74.23 103.91 4.82 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.734 0.813 . . . . 0.0 111.879 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -79.12 115.96 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.507 1.123 . . . . 0.0 110.11 177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -74.34 -37.85 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.259 1.823 . . . . 0.0 110.711 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.7 p -163.1 158.47 21.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.476 1.11 . . . . 0.0 111.67 173.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -145.5 142.69 29.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.821 1.248 . . . . 0.0 110.236 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -151.69 125.88 9.29 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.721 0.809 . . . . 0.0 111.679 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.21 134.51 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 166.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -76.78 107.52 9.16 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.207 0.527 . . . . 0.0 110.029 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 23.8 mm -99.04 127.47 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.61 1.164 . . . . 0.0 109.285 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -70.11 114.77 8.59 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.523 1.129 . . . . 0.0 110.696 177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -77.47 6.65 6.63 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -106.23 -25.88 11.79 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.413 1.085 . . . . 0.0 112.646 172.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -126.68 -5.46 6.39 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . 0.275 5.3 p30 64.79 3.42 2.02 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 128.817 2.847 . . . . 0.0 116.206 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.72 155.89 21.69 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.894 1.278 . . . . 0.0 111.958 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.7 t -73.75 136.39 43.64 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.538 -0.726 . . . . 0.0 109.382 167.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -81.63 12.47 3.81 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.196 0.998 . . . . 0.0 112.806 175.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.92 13.56 4.97 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.417 2.287 . . . . 0.0 114.157 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.51 149.21 52.6 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.87 1.268 . . . . 0.0 111.699 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -154.2 -177.69 27.85 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 125.134 1.35 . . . . 0.0 114.001 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -148.81 148.63 30.16 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.076 1.75 . . . . 0.0 111.792 -168.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 83.9 t -143.98 132.76 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.377 1.071 . . . . 0.0 109.003 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 56.5 m -110.77 126.84 55.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.176 1.391 . . . . 0.0 110.685 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -105.04 163.44 12.55 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.334 1.054 . . . . 0.0 111.704 169.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 52.2 p-10 -81.15 -10.07 59.7 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 -150.63 156.44 36.36 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.529 1.932 . . . . 0.0 110.658 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.44 -26.97 2.43 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.108 2.538 . . . . 0.0 113.537 -169.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 78.4 t -62.12 -35.18 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.13 0.877 . . . . 0.0 110.978 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.8 m -66.22 -41.06 90.63 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.14 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -69.13 -44.52 72.18 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.89 0.876 . . . . 0.0 112.0 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 58.6 mm-40 -57.28 -46.89 82.66 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.839 0.856 . . . . 0.0 112.125 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -59.57 -34.59 72.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.6 0.76 . . . . 0.0 112.785 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.85 -37.8 70.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 118.62 -0.705 . . . . 0.0 112.459 174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -59.62 -47.84 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 120.073 1.306 . . . . 0.0 109.849 171.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.76 -23.67 67.32 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.687 1.195 . . . . 0.0 113.215 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 57.6 m -100.14 -27.07 13.72 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -111.87 -17.34 12.94 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -169.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -70.75 110.61 5.64 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.709 1.141 . . . . 0.0 110.065 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.75 4.73 58.97 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 126.407 1.955 . . . . 0.0 114.542 -171.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -64.33 122.73 17.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.546 1.673 . . . . 0.0 110.522 175.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -87.27 130.32 34.64 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.02 0.438 . . . . 0.0 110.958 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.04 123.68 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.108 1.363 . . . . 0.0 110.115 -175.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.99 -72.08 0.71 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.023 1.297 . . . . 0.0 112.827 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -161.47 8.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 127.498 2.319 . . . . 0.0 113.947 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -145.6 162.05 38.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.895 1.678 . . . . 0.0 111.972 -171.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -112.36 131.92 55.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.815 0.846 . . . . 0.0 112.352 -172.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.5 mt -69.4 135.07 49.79 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.913 1.285 . . . . 0.0 112.478 -177.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -100.38 126.95 46.8 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.28 1.432 . . . . 0.0 108.001 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.2 t -140.34 136.68 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.882 0.873 . . . . 0.0 110.803 -170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.32 177.66 8.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.473 1.509 . . . . 0.0 111.227 -175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 93.3 mt -66.0 147.1 53.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.315 0.646 . . . . 0.0 110.56 169.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -76.62 148.59 36.84 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -72.41 166.25 22.95 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.64 1.576 . . . . 0.0 112.631 169.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 69.0 m -137.75 165.76 25.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.865 2.066 . . . . 0.0 109.858 170.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -67.68 164.29 19.63 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -137.64 1.45 2.34 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.464 1.506 . . . . 0.0 114.507 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -76.39 -4.48 42.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.853 1.261 . . . . 0.0 114.096 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.6 m -69.32 -10.67 58.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.803 1.241 . . . . 0.0 113.939 175.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -69.76 130.73 43.12 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.728 1.211 . . . . 0.0 111.777 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.9 m -77.21 -18.93 57.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.71 -174.83 47.09 Favored Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.299 1.428 . . . . 0.0 113.554 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.83 148.7 73.9 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.403 3.402 . . . . 0.0 113.336 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.8 p -78.11 -0.93 30.06 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.72 1.208 . . . . 0.0 113.698 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 16.4 m -73.69 -6.11 44.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.62 1.568 . . . . 0.0 114.374 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.639 1.59 . . . . 0.0 112.871 178.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.274 0 O4'-C1'-N19 110.774 2.574 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.29 1 O4'-C1'-N19 114.979 6.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O5'-C5'-C4' 113.301 2.215 . 0.495 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.524 0 C5'-C4'-O4' 113.541 3.101 . 0.191 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.002 1 O4'-C1'-N19 114.624 6.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.3 p -85.48 -12.94 50.62 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -147.29 145.12 29.27 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.901 1.68 . . . . 0.0 111.071 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -90.32 -174.03 44.82 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.788 1.185 . . . . 0.0 113.211 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.2 t -161.22 147.39 14.46 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.097 1.359 . . . . 0.0 111.448 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 34.3 p -87.32 -5.7 58.8 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.117 1.367 . . . . 0.0 113.662 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 157.7 142.07 3.31 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.171 1.367 . . . . 0.0 113.087 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 85.4 mt -74.91 -5.73 45.31 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -172.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 14.0 t -155.48 134.67 12.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.508 1.923 . . . . 0.0 109.407 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -176.42 170.01 2.58 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.775 2.03 . . . . 0.0 110.071 -169.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.4 156.48 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.8 1.24 . . . . 0.0 110.916 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 45.3 m -84.29 155.72 22.28 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.096 1.358 . . . . 0.0 113.006 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.8 mm -69.05 141.24 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.806 0.842 . . . . 0.0 109.957 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 115.51 2.83 21.05 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.858 1.218 . . . . 0.0 115.909 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -67.71 -16.89 64.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.03 1.332 . . . . 0.0 114.127 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -108.46 134.96 50.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.775 1.63 . . . . 0.0 109.2 169.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.77 28.83 30.88 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -150.88 163.97 37.41 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.856 2.062 . . . . 0.0 109.742 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -146.51 24.06 1.26 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.862 1.265 . . . . 0.0 112.186 -173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -58.09 109.09 0.68 Allowed 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.564 -0.71 . . . . 0.0 111.049 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -80.08 146.92 31.65 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.473 1.109 . . . . 0.0 110.943 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -89.25 -170.29 44.85 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 125.597 1.57 . . . . 0.0 113.15 176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -72.45 176.2 9.04 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.004 3.136 . . . . 0.0 112.529 -179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 125.46 22.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.312 1.045 . . . . 0.0 111.526 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.42 -2.28 88.04 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.675 1.131 . . . . 0.0 114.684 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.46 3.98 45.91 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.976 1.388 . . . . 0.0 113.969 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -114.56 127.02 55.57 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.851 1.26 . . . . 0.0 111.07 -174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 55.8 mt -111.54 152.16 27.85 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.381 1.472 . . . . 0.0 112.77 -173.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -122.51 128.03 50.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.99 2.116 . . . . 0.0 108.9 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.98 137.14 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 127.185 2.194 . . . . 0.0 107.961 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -134.98 154.66 51.64 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.625 1.57 . . . . 0.0 110.616 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 77.94 28.42 0.53 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 127.71 2.404 . . . . 0.0 113.673 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.84 161.34 38.47 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 120.954 -1.091 . . . . 0.0 112.185 173.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -58.41 152.34 54.94 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.565 2.843 . . . . 0.0 111.958 168.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 28.8 mp0 -70.95 1.29 5.8 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.453 1.501 . . . . 0.0 113.89 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.61 10.98 2.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.391 1.876 . . . . 0.0 113.102 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.38 131.49 44.19 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.444 1.098 . . . . 0.0 111.564 -175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -99.33 168.95 22.24 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.702 1.144 . . . . 0.0 113.494 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.37 -33.77 71.59 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.392 1.077 . . . . 0.0 112.388 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -81.38 -26.44 35.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.089 0.955 . . . . 0.0 112.577 178.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -68.65 -40.02 80.4 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.258 -0.902 . . . . 0.0 110.694 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.6 tp -67.56 -35.55 79.24 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.669 0.788 . . . . 0.0 111.873 173.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.89 -52.64 62.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.377 0.671 . . . . 0.0 111.694 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -62.72 -29.81 70.95 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.068 0.547 . . . . 0.0 112.057 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.1 ttm -71.86 -37.74 70.18 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.766 1.227 . . . . 0.0 113.05 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -100.45 -12.27 19.49 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 16.2 mtt -43.32 -43.26 10.56 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 169.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -62.4 -15.35 44.65 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.418 2.745 . . . . 0.0 115.965 -176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -101.66 -0.24 34.99 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -169.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 139.08 -165.78 25.59 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.088 1.328 . . . . 0.0 114.585 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -71.77 88.63 1.01 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.295 1.038 . . . . 0.0 112.356 -175.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 82.5 t -67.44 125.48 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.445 1.098 . . . . 0.0 109.5 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 84.4 t -79.94 -48.91 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.72 1.608 . . . . 0.0 109.551 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 96.8 p -160.07 158.99 31.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.001 0.921 . . . . 0.0 112.14 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -136.29 140.35 43.32 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.065 1.346 . . . . 0.0 109.819 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -153.7 125.26 7.61 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.153 0.581 . . . . 0.0 111.924 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -95.25 136.05 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.239 1.416 . . . . 0.0 108.101 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -78.48 120.02 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.636 0.774 . . . . 0.0 110.847 -176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.4 mm -119.63 131.07 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 126.399 1.88 . . . . 0.0 108.713 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -66.17 123.15 19.13 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.592 -0.693 . . . . 0.0 111.165 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -63.56 -14.71 53.97 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -90.19 -28.0 19.17 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.597 1.159 . . . . 0.0 112.711 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.1 p -133.19 -11.78 2.86 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.96 1.304 . . . . 0.0 114.405 -169.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 61.92 25.97 15.65 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.008 1.723 . . . . 0.0 113.571 -174.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.2 mt -94.51 146.02 24.39 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.105 1.362 . . . . 0.0 111.335 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.4 t -71.6 139.1 49.22 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.579 -0.7 . . . . 0.0 112.38 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -89.05 5.77 42.88 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.14 0.976 . . . . 0.0 113.066 171.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 62.2 m 65.68 18.86 11.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.048 1.739 . . . . 0.0 114.187 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -132.98 147.66 52.28 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.234 1.414 . . . . 0.0 111.067 174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -150.36 179.59 26.96 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 125.2 1.381 . . . . 0.0 113.846 -171.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -146.41 148.64 32.52 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.278 1.431 . . . . 0.0 112.121 -168.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 60.5 t -146.14 128.9 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.433 1.093 . . . . 0.0 109.067 178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.8 p -108.17 137.96 45.26 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.34 1.056 . . . . 0.0 111.329 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.27 166.84 11.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.586 1.554 . . . . 0.0 111.555 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -77.71 -7.19 56.14 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -162.26 161.95 20.18 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.648 1.579 . . . . 0.0 111.566 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.58 -15.82 9.56 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.996 2.464 . . . . 0.0 114.588 -172.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 33.6 t -75.2 -37.56 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 120.043 1.292 . . . . 0.0 110.397 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 40.7 m -66.72 -39.24 87.91 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.714 -0.616 . . . . 0.0 111.857 174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.52 -47.65 80.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.971 0.909 . . . . 0.0 111.954 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -57.73 -44.5 86.06 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.443 -0.786 . . . . 0.0 112.809 173.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.05 -37.53 80.12 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.646 0.657 . . . . 0.0 112.111 176.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.97 -39.02 76.22 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -59.72 -48.2 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.691 1.132 . . . . 0.0 109.781 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -68.38 -24.22 64.75 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.515 1.126 . . . . 0.0 113.026 -175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 41.7 m -96.74 -25.43 15.52 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.9 mmm -111.58 -18.38 12.82 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -171.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -70.22 113.7 7.65 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.993 1.27 . . . . 0.0 110.124 174.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.42 4.98 60.62 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.689 1.614 . . . . 0.0 114.601 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -62.75 118.17 7.32 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 119.441 1.621 . . . . 0.0 110.453 176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -82.86 131.94 35.18 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.85 0.46 . . . . 0.0 110.743 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.2 tt -145.04 116.94 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.805 1.242 . . . . 0.0 110.176 -173.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 74.19 -59.39 2.31 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.058 1.313 . . . . 0.0 112.693 -171.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 64.1 ttp -169.02 -40.42 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.854 2.461 . . . . 0.0 110.973 176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -71.2 170.77 12.31 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.692 1.597 . . . . 0.0 113.232 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -121.57 136.95 54.92 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.749 1.22 . . . . 0.0 112.0 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 71.0 mt -67.66 129.91 41.37 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.557 1.143 . . . . 0.0 111.546 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 34.3 tttp -94.91 123.31 38.31 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.701 1.601 . . . . 0.0 107.46 169.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -138.84 136.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.89 0.876 . . . . 0.0 110.173 -173.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -165.3 175.02 9.55 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.043 1.337 . . . . 0.0 111.156 -169.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.95 144.43 54.16 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.451 0.643 . . . . 0.0 109.905 168.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -72.1 143.15 49.13 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 0.0 112.045 177.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -94.42 -167.62 1.69 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.126 0.97 . . . . 0.0 112.726 174.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.0 p -142.16 176.83 8.66 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 127.473 2.309 . . . . 0.0 109.152 168.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -60.77 -50.97 71.31 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.543 -1.348 . . . . 0.0 111.974 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.6 p30 175.26 -25.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.79 2.836 . . . . 0.0 112.301 169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -165.4 151.26 9.55 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.832 2.053 . . . . 0.0 110.116 -177.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 56.6 p -72.07 -10.15 59.39 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -128.52 27.91 5.49 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.728 2.011 . . . . 0.0 111.617 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 97.6 p -65.81 158.97 26.35 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.386 1.074 . . . . 0.0 113.505 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 76.25 -162.08 52.25 Favored Glycine 0 CA--C 1.542 1.777 0 C-N-CA 123.954 0.788 . . . . 0.0 113.579 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.99 -11.76 13.53 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.857 3.038 . . . . 0.0 114.061 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 40.3 m 65.84 3.81 2.69 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.314 1.846 . . . . 0.0 114.828 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.8 t -164.01 162.52 23.24 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.308 1.843 . . . . 0.0 111.183 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.199 0 C-N-CA 125.272 1.415 . . . . 0.0 112.819 -177.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.689 0 C4'-C3'-C2' 99.164 -3.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.568 1 O4'-C1'-N19 112.276 4.076 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 O5'-C5'-C4' 113.131 2.094 . 0.178 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.468 0 C5'-C4'-O4' 113.686 3.204 . 0.332 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.169 1 O4'-C1'-N19 113.7 5.5 . 0.011 3b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 O4'-C1'-N19 111.873 3.673 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 45.7 t -163.79 149.31 11.0 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.377 1.471 . . . . 0.0 111.056 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 51.0 m -85.12 -6.55 59.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.872 0.869 . . . . 0.0 113.081 172.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -91.47 4.86 80.3 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.572 1.558 . . . . 0.0 114.774 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 8.4 t -161.24 176.2 11.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.069 1.748 . . . . 0.0 110.663 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 43.7 m 62.44 19.96 11.53 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 125.549 1.539 . . . . 0.0 113.92 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 106.61 119.63 4.53 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.368 1.937 . . . . 0.0 111.102 -172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.45 -5.64 55.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.561 1.145 . . . . 0.0 113.639 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.4 p -139.8 137.92 35.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 127.097 2.159 . . . . 0.0 109.687 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -167.01 177.26 6.4 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.5 1.52 . . . . 0.0 110.872 -172.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.53 172.02 16.14 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.087 1.355 . . . . 0.0 110.708 174.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.7 m -54.4 115.82 2.31 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 78.3 mt -66.45 134.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 O-C-N 120.92 -1.112 . . . . 0.0 110.123 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.09 56.9 Favored Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.552 1.072 . . . . 0.0 115.454 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.1 70.14 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -75.41 120.33 20.72 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.941 0.896 . . . . 0.0 112.658 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.8 3.08 89.61 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.089 1.328 . . . . 0.0 112.888 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 37.1 t -75.11 123.88 26.02 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.813 1.306 . . . . 0.0 111.579 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -79.2 -0.69 33.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.276 1.43 . . . . 0.0 111.933 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.89 132.35 47.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.168 -0.957 . . . . 0.0 111.341 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -91.36 144.3 25.73 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.889 0.876 . . . . 0.0 110.122 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -79.91 172.72 54.92 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.008 0.814 . . . . 0.0 112.956 172.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.98 167.35 24.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.206 2.604 . . . . 0.0 111.479 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.86 122.75 12.94 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 0.0 111.791 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.7 -7.69 78.59 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 124.492 1.044 . . . . 0.0 114.283 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.86 3.22 36.36 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.371 1.468 . . . . 0.0 113.022 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -119.4 126.46 51.41 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.589 1.956 . . . . 0.0 111.189 -170.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 72.4 mt -119.13 141.77 48.51 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.619 1.568 . . . . 0.0 112.174 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -109.07 129.67 55.47 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.273 2.229 . . . . 0.0 108.381 168.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.82 135.23 57.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.413 1.885 . . . . 0.0 108.08 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -131.65 163.48 28.02 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.259 1.824 . . . . 0.0 110.94 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 66.18 27.94 10.24 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.277 1.831 . . . . 0.0 113.565 -174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -60.15 152.17 63.33 Favored Pre-proline 0 N--CA 1.475 0.8 0 O-C-N 121.2 -0.938 . . . . 0.0 110.828 169.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.67 143.28 50.74 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.094 1.863 . . . . 0.0 108.0 167.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -75.56 14.96 0.53 Allowed 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.63 2.54 8.92 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.725 2.01 . . . . 0.0 113.49 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.69 131.12 40.62 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.987 0.915 . . . . 0.0 111.504 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -93.18 171.32 32.4 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.629 1.109 . . . . 0.0 113.12 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -63.58 -35.61 81.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.129 0.972 . . . . 0.0 112.586 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -81.5 -22.65 37.84 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.005 0.922 . . . . 0.0 112.188 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -72.64 -43.28 63.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.113 -0.992 . . . . 0.0 110.49 172.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.6 tp -60.47 -41.14 93.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.763 0.825 . . . . 0.0 111.33 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 67.0 tp -61.52 -52.7 63.39 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.776 0.83 . . . . 0.0 112.221 174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -63.18 -25.21 68.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.896 0.771 . . . . 0.0 112.802 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 46.4 ttp -79.71 -26.58 40.81 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.281 1.032 . . . . 0.0 113.18 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -101.37 -11.7 19.2 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.724 1.609 . . . . 0.0 114.536 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 27.1 mtt -45.41 -42.55 20.39 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 126.257 1.823 . . . . 0.0 115.406 172.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -58.78 -16.66 32.36 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 123.659 2.906 . . . . 0.0 116.368 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -99.92 -6.35 26.83 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -170.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.7 -166.68 26.14 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.905 1.24 . . . . 0.0 114.865 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -73.27 92.95 1.83 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.643 0.777 . . . . 0.0 112.318 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.8 t -68.53 123.57 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.92 0.888 . . . . 0.0 109.71 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.9 -33.21 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.541 2.336 . . . . 0.0 111.374 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.1 p -159.61 147.98 17.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.883 1.273 . . . . 0.0 111.01 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.55 128.87 17.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.6 1.56 . . . . 0.0 109.305 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -148.86 106.39 3.65 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.743 0.817 . . . . 0.0 111.789 -169.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 60.6 t -81.81 136.79 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -81.57 115.01 20.66 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.289 0.566 . . . . 0.0 110.381 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 34.9 mm -115.58 131.64 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.582 1.553 . . . . 0.0 109.676 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -59.57 126.76 28.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.733 1.213 . . . . 0.0 111.901 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -71.43 -6.49 40.69 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -114.5 -41.33 3.46 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.057 1.343 . . . . 0.0 112.255 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 66.1 p -100.99 -13.62 18.19 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.67 19.99 11.5 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.963 1.705 . . . . 0.0 113.065 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.6 mt -92.51 146.23 23.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.89 1.276 . . . . 0.0 111.258 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 30.5 t -67.09 146.52 54.21 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.526 -0.734 . . . . 0.0 111.842 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -97.1 14.37 25.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.413 1.085 . . . . 0.0 112.934 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.4 m 66.53 15.05 10.0 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.266 1.826 . . . . 0.0 114.154 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -135.46 154.44 51.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.915 1.286 . . . . 0.0 111.683 176.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -166.67 -168.73 29.3 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.685 1.136 . . . . 0.0 113.371 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -143.45 152.45 41.55 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.753 1.221 . . . . 0.0 112.202 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.32 132.88 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.43 1.492 . . . . 0.0 107.744 172.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 23.8 m -127.35 137.5 52.8 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.828 -0.545 . . . . 0.0 112.101 177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -107.14 169.75 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.075 1.75 . . . . 0.0 111.5 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -81.63 -2.16 49.21 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -157.3 158.4 30.86 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.902 1.281 . . . . 0.0 111.905 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.4 -17.7 8.77 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.989 2.46 . . . . 0.0 114.237 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.0 t -73.75 -38.58 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 119.466 1.03 . . . . 0.0 110.272 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 64.4 m -67.17 -37.9 84.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.646 0.657 . . . . 0.0 112.258 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.61 72.3 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.821 0.848 . . . . 0.0 112.182 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -56.51 -45.75 80.91 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.47 0.708 . . . . 0.0 112.845 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.02 72.45 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.653 0.661 . . . . 0.0 112.628 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.74 -42.23 64.3 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 118.408 -0.806 . . . . 0.0 112.15 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.26 -47.69 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 120.406 1.457 . . . . 0.0 109.917 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -70.65 -12.68 61.71 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.153 1.381 . . . . 0.0 113.418 -174.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 6.6 t -110.03 -27.7 9.07 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.5 mmm -106.0 -19.61 13.68 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -71.2 112.07 7.05 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.464 1.029 . . . . 0.0 110.017 172.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 92.29 8.17 63.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.32 1.438 . . . . 0.0 114.644 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -67.2 123.59 20.74 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 119.19 1.495 . . . . 0.0 110.499 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -83.75 132.71 34.82 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.261 0.624 . . . . 0.0 110.846 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.1 tt -146.56 119.44 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.85 1.26 . . . . 0.0 110.245 -172.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.71 -59.64 2.1 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.972 1.273 . . . . 0.0 112.756 -172.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 60.0 ttm -167.85 -40.98 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 127.683 2.393 . . . . 0.0 111.001 176.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -76.26 175.58 8.92 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.321 1.449 . . . . 0.0 113.279 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtt85 -117.89 138.61 52.0 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 0.0 112.482 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.6 148.45 51.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.206 1.403 . . . . 0.0 111.678 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -120.99 126.83 50.95 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.318 1.847 . . . . 0.0 107.799 173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.4 t -139.9 128.78 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-N 119.013 0.824 . . . . 0.0 110.09 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -147.98 166.17 28.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.588 1.555 . . . . 0.0 110.172 -172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.75 148.45 51.9 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.602 0.715 . . . . 0.0 110.44 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -53.09 144.18 16.01 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.199 1.399 . . . . 0.0 111.533 169.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -48.99 125.77 11.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.206 1.002 . . . . 0.0 112.396 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.4 m -173.5 169.67 4.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.447 2.699 . . . . 0.0 109.327 -175.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -76.46 -3.59 38.01 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -64.68 139.35 58.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.054 1.342 . . . . 0.0 111.865 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -159.67 140.38 12.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.826 1.251 . . . . 0.0 111.631 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 13.8 m -74.91 -6.81 51.22 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.278 1.585 . . . . 0.0 115.278 -173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.77 -35.01 0.73 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.604 1.161 . . . . 0.0 113.423 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.8 m -87.61 -13.75 41.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.42 1.088 . . . . 0.0 113.105 173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -79.82 -66.46 1.67 Allowed Glycine 0 CA--C 1.537 1.432 0 C-N-CA 125.272 1.415 . . . . 0.0 112.589 173.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.26 148.79 39.46 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.729 2.952 . . . . 0.0 111.584 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.7 m -164.16 155.81 16.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.567 1.947 . . . . 0.0 110.797 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 17.2 m -77.42 -6.11 52.22 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -174.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 125.693 1.616 . . . . 0.0 112.999 -178.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.344 0 C4'-C3'-C2' 99.934 -2.766 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.62 2.661 1 O4'-C1'-N19 112.485 4.285 . 0.069 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.416 0 O4'-C1'-N19 110.778 2.578 . 0.215 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C5'-C4'-O4' 113.544 3.103 . 0.634 0a . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . 0.467 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.429 -2.028 1 O4'-C1'-N19 113.856 5.656 . 0.016 3b . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . 0.467 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.422 -2.607 1 O4'-C1'-N19 113.966 5.766 . 0.03 2a . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.147 -0.381 . . . . 0.0 112.147 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 32.9 t -163.79 155.6 16.95 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.414 1.485 . . . . 0.0 111.207 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 53.9 p -84.26 -7.9 59.2 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.605 1.162 . . . . 0.0 113.368 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -88.51 155.52 25.99 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.27 1.414 . . . . 0.0 112.939 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.4 m -148.16 148.57 30.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.462 1.505 . . . . 0.0 111.093 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.4 m -69.32 132.93 47.2 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.26 -0.9 . . . . 0.0 112.459 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -81.0 1.73 83.56 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.572 1.082 . . . . 0.0 114.716 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 3.3 tt -153.25 116.19 4.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.675 1.99 . . . . 0.0 107.715 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 53.6 p -119.6 -10.85 9.53 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -169.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.31 129.36 19.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.278 1.431 . . . . 0.0 108.917 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -160.33 -46.93 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.546 0.738 . . . . 0.0 111.891 -170.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 54.3 p -162.6 -177.69 5.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.525 1.13 . . . . 0.0 112.2 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 98.7 mt -73.33 -14.02 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 124.36 1.064 . . . . 0.0 111.786 170.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 141.23 -31.22 2.18 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 126.885 2.183 . . . . 0.0 113.33 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.76 -31.53 0.15 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.197 2.999 . . . . 0.0 117.011 169.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -77.29 120.84 22.89 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.072 1.349 . . . . 0.0 113.015 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.72 -7.65 68.82 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.186 1.374 . . . . 0.0 113.103 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 26.8 m -70.02 151.06 45.98 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.424 1.112 . . . . 0.0 110.822 173.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -131.55 11.61 4.87 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 -171.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.71 127.37 32.41 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.361 169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -96.21 137.04 35.86 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 125.782 1.633 . . . . 0.0 110.365 -168.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -69.54 162.59 52.06 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.02 0.819 . . . . 0.0 113.567 -174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.55 178.48 2.65 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 124.117 3.211 . . . . 0.0 112.385 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -52.34 117.29 2.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.874 1.27 . . . . 0.0 112.17 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 81.24 -3.89 74.8 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.006 1.288 . . . . 0.0 115.098 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.96 -5.34 28.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.319 1.559 . . . . 0.0 114.296 -177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -99.94 146.2 26.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.371 1.468 . . . . 0.0 111.749 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 80.9 mt -135.86 147.24 48.14 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.833 1.653 . . . . 0.0 112.483 -171.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -121.09 132.84 55.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.564 1.945 . . . . 0.0 109.861 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.5 137.15 52.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 126.893 2.077 . . . . 0.0 108.174 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -132.21 154.79 49.24 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.077 1.351 . . . . 0.0 111.086 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 81.45 24.96 0.24 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.819 2.847 . . . . 0.0 113.85 -176.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 90.3 mt -63.12 158.87 52.29 Favored Pre-proline 0 CA--C 1.549 0.942 0 O-C-N 121.055 -1.028 . . . . 0.0 112.303 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -57.42 155.15 31.74 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 123.81 3.007 . . . . 0.0 113.051 169.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -69.32 -8.46 46.44 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.016 1.326 . . . . 0.0 113.716 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -131.18 10.31 4.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.2 1.8 . . . . 0.0 113.582 -173.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -66.99 131.68 46.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.062 0.945 . . . . 0.0 112.139 -172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -91.05 165.92 30.72 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.407 1.003 . . . . 0.0 113.284 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -65.48 -33.38 75.79 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.795 0.838 . . . . 0.0 112.455 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -77.8 -27.09 50.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 0.0 112.157 175.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -68.08 -39.19 82.95 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.254 0.934 . . . . 0.0 110.87 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.9 tp -65.75 -39.79 91.44 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.597 0.759 . . . . 0.0 111.478 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 43.7 tp -64.75 -50.34 67.23 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.391 0.676 . . . . 0.0 112.308 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -60.68 -23.13 64.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 41.5 ttp -88.36 -20.47 25.27 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.628 1.171 . . . . 0.0 113.601 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -112.24 -18.79 12.45 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 46.3 mtm -50.39 -38.33 38.43 Favored Pre-proline 0 N--CA 1.478 0.948 0 N-CA-C 115.702 1.742 . . . . 0.0 115.702 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.89 -15.76 10.44 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.999 3.132 . . . . 0.0 116.757 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -104.63 -2.43 25.07 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -173.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 151.54 -174.93 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 124.391 0.996 . . . . 0.0 115.337 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -81.72 114.48 20.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.303 1.041 . . . . 0.0 111.966 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 63.9 t -90.75 128.62 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 126.466 1.906 . . . . 0.0 110.01 -170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 85.4 t -84.33 -36.4 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.9 1.68 . . . . 0.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.9 p -161.53 154.43 20.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.161 0.984 . . . . 0.0 112.545 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.11 126.87 11.76 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.876 1.67 . . . . 0.0 109.481 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -151.72 111.53 4.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.357 0.663 . . . . 0.0 111.799 -170.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.0 t -84.69 135.25 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.113 1.365 . . . . 0.0 108.15 173.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -82.39 119.07 23.7 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.619 0.723 . . . . 0.0 110.664 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 31.7 mt -129.83 132.79 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.394 1.878 . . . . 0.0 108.996 -174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -67.62 124.04 22.14 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.007 0.923 . . . . 0.0 111.709 -178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -80.67 9.44 6.18 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -174.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -116.03 -23.54 8.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.684 1.194 . . . . 0.0 113.185 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.8 p -126.14 -11.53 6.43 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.462 1.505 . . . . 0.0 114.437 -175.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 22.6 m120 67.0 15.49 10.16 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.79 2.036 . . . . 0.0 114.222 177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 91.7 mt -87.98 139.29 30.67 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.966 1.306 . . . . 0.0 110.945 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 45.9 t -66.12 138.44 57.74 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.465 -0.772 . . . . 0.0 110.408 169.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -82.22 12.72 4.05 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.656 -0.653 . . . . 0.0 112.6 169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 73.7 m 66.51 18.75 10.85 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.458 1.903 . . . . 0.0 113.39 175.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -137.36 153.91 50.12 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.796 1.238 . . . . 0.0 111.685 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -161.12 177.73 37.36 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.024 0.821 . . . . 0.0 114.042 -176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -127.79 146.1 50.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.941 1.696 . . . . 0.0 111.018 -173.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 77.3 t -139.75 145.16 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.143 1.377 . . . . 0.0 107.712 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 9.8 m -139.35 134.01 31.91 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.526 -0.734 . . . . 0.0 112.105 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -100.99 170.01 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.509 1.523 . . . . 0.0 111.662 174.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -78.01 -8.38 58.1 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.711 0.804 . . . . 0.0 113.139 173.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.98 158.42 32.91 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.534 1.133 . . . . 0.0 112.435 -175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.88 -16.74 8.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.078 2.518 . . . . 0.0 114.225 -174.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.95 -38.72 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 120.041 1.291 . . . . 0.0 109.964 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.0 m -66.05 -37.84 86.84 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.3 -49.98 67.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.524 0.729 . . . . 0.0 112.259 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -57.31 -41.87 80.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.133 0.973 . . . . 0.0 112.222 174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -64.78 -37.29 87.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.714 0.806 . . . . 0.0 112.515 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -70.4 -37.07 74.41 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.524 0.602 . . . . 0.0 112.059 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.43 -47.86 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.669 1.122 . . . . 0.0 110.067 172.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -65.47 -24.76 67.24 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.006 . . . . 0.0 113.21 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 55.0 m -96.97 -25.05 15.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 95.6 mmm -117.26 -17.5 10.17 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 -169.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -71.04 111.51 6.46 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 119.729 1.149 . . . . 0.0 110.115 173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.96 4.07 58.9 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.82 1.676 . . . . 0.0 114.596 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -64.2 122.76 17.38 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.488 1.644 . . . . 0.0 110.947 178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -82.42 131.82 35.22 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.04 0.536 . . . . 0.0 110.801 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.09 119.7 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.772 1.229 . . . . 0.0 110.131 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 73.97 -61.55 2.13 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.774 1.178 . . . . 0.0 112.382 -170.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 46.8 tpp -168.57 -37.73 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.565 2.346 . . . . 0.0 111.495 175.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.18 168.78 18.42 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.3 1.44 . . . . 0.0 113.337 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -116.38 137.21 52.34 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.93 1.292 . . . . 0.0 112.157 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.02 145.89 48.01 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.339 1.456 . . . . 0.0 112.329 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -111.81 131.83 55.08 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.741 1.216 . . . . 0.0 108.022 168.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.8 t -137.93 137.6 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.133 0.973 . . . . 0.0 109.7 -174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -161.64 170.76 19.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.221 1.408 . . . . 0.0 110.668 -168.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 99.2 mt -67.95 150.8 48.05 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.69 0.757 . . . . 0.0 110.174 168.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -74.06 153.79 39.49 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.929 0.891 . . . . 0.0 113.298 -173.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -75.58 154.53 36.69 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.216 1.006 . . . . 0.0 111.493 173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.3 p -158.65 165.28 34.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 127.012 2.125 . . . . 0.0 110.611 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.98 -19.64 57.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.236 1.198 . . . . 0.0 114.236 -175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -165.57 157.8 15.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.208 1.803 . . . . 0.0 111.109 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -159.7 -43.23 0.05 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.811 2.044 . . . . 0.0 112.068 -176.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 85.7 p -158.8 19.21 0.2 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.72 1.208 . . . . 0.0 113.669 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -75.95 71.87 2.78 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 120.679 -1.263 . . . . 0.0 112.706 -174.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.1 t -159.74 174.13 14.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.431 1.893 . . . . 0.0 111.342 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.37 160.87 51.31 Favored Glycine 0 CA--C 1.542 1.767 0 C-N-CA 124.5 1.048 . . . . 0.0 113.596 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.21 155.8 46.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.076 3.184 . . . . 0.0 111.814 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.8 m -76.73 -3.48 38.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 80.9 p -164.36 164.76 22.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.11 1.764 . . . . 0.0 111.892 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.202 0 C-N-CA 124.948 1.261 . . . . 0.0 112.893 -179.316 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.173 0 O4'-C1'-N19 109.987 1.787 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 113.274 5.074 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.617 0 C3'-C2'-C1' 103.705 2.45 . 0.354 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O4'-C1'-N19 111.084 2.884 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.225 2 O4'-C1'-N19 115.629 7.429 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.818 0 O4'-C1'-N19 111.239 3.039 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 112.037 -0.425 . . . . 0.0 112.037 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.5 p -165.39 158.92 16.52 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.364 1.466 . . . . 0.0 111.792 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 69.9 m -142.88 144.93 32.66 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.941 1.296 . . . . 0.0 111.459 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.5 -179.33 34.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.06 1.314 . . . . 0.0 113.359 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.6 p -164.85 158.89 17.8 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.981 1.312 . . . . 0.0 112.219 -176.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.4 m -89.76 1.12 56.49 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.404 1.082 . . . . 0.0 113.748 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 167.15 -153.44 23.02 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 125.249 1.404 . . . . 0.0 113.278 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.7 mt -131.38 163.16 28.49 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.839 1.656 . . . . 0.0 111.382 -177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.8 m -134.26 148.65 50.85 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.044 1.738 . . . . 0.0 109.436 -174.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -149.99 152.42 34.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.98 1.312 . . . . 0.0 110.292 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -62.15 139.63 58.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.975 0.91 . . . . 0.0 111.726 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 8.3 t -163.27 -179.23 6.45 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.853 1.261 . . . . 0.0 111.588 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 77.5 mt -73.58 138.87 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.453 1.501 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 114.54 -2.81 23.4 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 125.197 1.379 . . . . 0.0 116.263 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -69.75 -32.06 70.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.071 0.948 . . . . 0.0 112.493 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -89.72 142.35 27.76 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.973 1.709 . . . . 0.0 110.795 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.59 23.6 60.01 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.745 -169.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.9 t -143.08 156.77 44.88 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.779 1.631 . . . . 0.0 111.276 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.51 27.9 2.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.415 1.486 . . . . 0.0 111.489 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -68.07 91.16 0.34 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.317 1.047 . . . . 0.0 110.971 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -63.92 137.83 58.2 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.993 1.317 . . . . 0.0 110.917 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.98 -167.43 43.05 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 126.04 1.781 . . . . 0.0 114.319 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.32 162.83 5.4 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 125.052 3.835 . . . . 0.0 114.577 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.04 127.37 31.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.312 0.645 . . . . 0.0 110.058 169.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 80.7 -8.03 56.69 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.573 1.082 . . . . 0.0 114.553 -174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -94.85 -5.34 45.26 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.829 1.314 . . . . 0.0 113.422 176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -99.38 126.57 45.29 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.471 1.109 . . . . 0.0 110.554 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 44.0 mt -106.05 148.85 27.29 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.608 1.563 . . . . 0.0 111.35 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -118.86 129.27 55.12 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.595 2.358 . . . . 0.0 108.733 169.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.84 138.82 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 126.779 2.032 . . . . 0.0 108.173 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -135.1 158.49 44.22 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.195 1.398 . . . . 0.0 111.451 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 74.85 28.5 1.12 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 127.905 2.482 . . . . 0.0 113.485 -176.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 67.9 mt -68.74 157.8 87.56 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 124.242 1.017 . . . . 0.0 111.641 170.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.44 152.23 55.9 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.721 2.947 . . . . 0.0 112.249 168.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -73.26 -3.64 28.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -117.22 7.58 12.99 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.727 1.611 . . . . 0.0 113.349 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.55 134.15 43.72 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.15 0.98 . . . . 0.0 111.718 -176.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -106.39 170.33 16.34 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.029 1.299 . . . . 0.0 113.745 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -60.15 -35.03 74.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.623 1.169 . . . . 0.0 112.596 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -78.3 -27.84 47.38 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.859 0.864 . . . . 0.0 112.247 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -69.99 -38.82 76.12 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.257 -0.902 . . . . 0.0 110.821 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.2 tp -68.41 -35.07 77.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.783 0.833 . . . . 0.0 111.853 172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.58 -50.51 66.93 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.76 -0.587 . . . . 0.0 111.554 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.81 -24.39 67.73 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.669 0.668 . . . . 0.0 112.766 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 56.3 ttm -75.17 -40.39 59.48 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.007 1.323 . . . . 0.0 113.042 173.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -100.57 -8.81 22.63 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 2.0 mmt -39.97 -46.86 5.29 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 -6.18 15.31 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.122 1.882 . . . . 0.0 115.228 -168.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -97.87 -2.71 40.17 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 147.77 -169.47 28.58 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.767 1.175 . . . . 0.0 114.748 174.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -79.76 117.48 20.69 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.545 0.738 . . . . 0.0 111.695 -175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.8 t -98.31 128.11 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.475 1.91 . . . . 0.0 109.772 -175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 58.3 t -87.16 -37.4 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.409 1.884 . . . . 0.0 110.776 176.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 88.5 p -163.18 158.31 21.55 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.647 1.179 . . . . 0.0 111.914 173.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.21 136.82 19.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.123 1.369 . . . . 0.0 110.146 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -155.25 137.78 15.06 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -169.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.24 133.72 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 107.505 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -78.35 113.38 16.28 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.999 0.52 . . . . 0.0 110.521 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.9 mm -99.82 133.11 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.781 1.232 . . . . 0.0 109.604 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -62.32 -35.1 78.02 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 114.444 -169.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . 0.254 1.4 ptpp? 78.63 -17.95 0.55 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 131.26 3.824 . . . . 0.0 115.3 -178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -87.61 -36.26 17.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 119.179 0.899 . . . . 0.0 111.063 175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.8 p -108.6 -10.92 15.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.199 1.8 . . . . 0.0 113.647 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 65.99 9.25 6.01 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.625 1.97 . . . . 0.0 113.57 -171.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 94.8 mt -91.44 155.9 18.11 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.892 1.277 . . . . 0.0 111.83 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.1 t -70.13 139.37 52.45 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.73 0.812 . . . . 0.0 110.797 168.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -78.6 14.63 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.412 1.085 . . . . 0.0 113.395 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 74.5 m 71.85 12.39 6.18 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.283 2.233 . . . . 0.0 113.794 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -134.42 151.11 50.98 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.263 1.025 . . . . 0.0 112.608 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -156.93 -175.22 27.61 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.111 1.338 . . . . 0.0 113.647 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -145.64 149.52 34.66 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.712 1.605 . . . . 0.0 111.796 -169.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 84.4 t -142.47 125.75 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.037 173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 70.5 m -106.76 115.94 31.07 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.796 1.238 . . . . 0.0 110.695 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -88.47 165.52 14.83 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.741 0.816 . . . . 0.0 112.152 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -74.06 -10.79 59.98 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.434 1.093 . . . . 0.0 113.016 173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -159.99 162.54 24.25 Favored Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 125.562 1.545 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.41 -17.07 9.1 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.938 2.426 . . . . 0.0 114.561 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.1 t -74.61 -38.82 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 120.026 1.285 . . . . 0.0 110.378 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 51.0 m -64.79 -39.45 93.62 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 112.18 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.52 -50.37 71.64 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.972 0.909 . . . . 0.0 112.017 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -57.67 -43.69 85.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.945 0.898 . . . . 0.0 113.033 175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.39 -36.38 80.1 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.762 0.825 . . . . 0.0 112.647 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.81 -35.95 67.43 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.652 -0.69 . . . . 0.0 112.689 176.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.75 -49.44 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 119.85 1.205 . . . . 0.0 109.676 171.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -65.17 -20.69 66.57 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.878 1.271 . . . . 0.0 113.208 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 60.5 m -100.1 -23.43 14.87 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 94.2 mmm -115.32 -12.03 11.83 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -62.01 126.76 28.46 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.592 1.087 . . . . 0.0 110.875 170.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.43 7.88 88.11 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-O 118.517 -1.157 . . . . 0.0 115.007 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -60.15 123.97 18.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.559 1.679 . . . . 0.0 110.676 177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -84.41 128.75 34.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.333 0.653 . . . . 0.0 109.712 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . 0.264 17.9 tt -129.6 68.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 123.446 1.593 . . . . 0.0 111.791 -174.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 81.72 -59.49 4.84 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 126.092 1.806 . . . . 0.0 112.116 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 25.8 ptp -143.24 11.11 1.73 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.342 1.457 . . . . 0.0 113.9 -176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -136.96 163.73 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.534 1.534 . . . . 0.0 111.726 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -120.86 117.75 28.18 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.93 172.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.62 140.68 56.88 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 122.091 0.948 . . . . 0.0 112.451 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -111.76 129.79 56.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.568 1.947 . . . . 0.0 107.994 173.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.1 t -141.04 134.04 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.532 0.733 . . . . 0.0 109.76 -174.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -161.87 173.05 15.08 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.441 1.496 . . . . 0.0 110.347 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 97.4 mt -67.75 149.49 49.88 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.751 0.786 . . . . 0.0 111.246 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -58.96 148.66 29.74 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.11 0.964 . . . . 0.0 112.846 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -129.71 -154.6 0.64 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.143 2.177 . . . . 0.0 108.985 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.4 p -131.53 158.51 40.74 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.683 1.593 . . . . 0.0 110.794 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -62.3 141.38 58.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.833 0.853 . . . . 0.0 112.214 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -60.84 -18.94 58.78 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -141.71 131.15 23.76 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.707 1.603 . . . . 0.0 109.99 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.5 t -170.47 172.28 6.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.836 1.654 . . . . 0.0 111.069 -175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -153.24 119.75 5.59 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.669 1.587 . . . . 0.0 110.904 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 61.8 p -126.31 -1.7 6.95 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.987 1.315 . . . . 0.0 114.204 -173.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -88.08 -163.21 38.94 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 125.379 1.466 . . . . 0.0 113.16 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -69.0 165.36 30.38 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.528 2.818 . . . . 0.0 111.335 175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.9 m -62.66 -25.21 68.02 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.8 m -166.42 157.8 13.14 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.475 2.31 . . . . 0.0 110.567 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.205 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.975 -179.558 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.308 0 C4'-C3'-C2' 100.476 -2.224 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.233 1 O4'-C1'-N19 114.496 6.296 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 0 O4'-C1'-N19 110.977 2.777 . 0.387 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.363 0 C5'-C4'-O4' 113.472 3.052 . 0.325 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . 0.416 " H2'" ' C8 ' ' B' ' 496' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.422 -2.547 0 C3'-C2'-C1' 104.703 3.559 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . 0.416 ' C8 ' " H2'" ' B' ' 495' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.845 0 O4'-C1'-N19 111.971 3.771 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.542 0 N-CA-C 111.792 -0.523 . . . . 0.0 111.792 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 18.5 m -80.43 -8.72 59.65 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -173.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 18.4 m -163.99 154.42 15.24 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 127.08 2.152 . . . . 0.0 110.512 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -83.67 -2.74 89.86 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 124.451 1.024 . . . . 0.0 114.877 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 93.3 p -165.87 171.35 12.82 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.244 1.818 . . . . 0.0 111.28 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 44.3 p -83.99 -0.22 50.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.781 1.232 . . . . 0.0 113.846 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 138.89 -159.08 25.4 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.109 1.814 . . . . 0.0 112.527 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.99 126.06 28.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.885 0.874 . . . . 0.0 110.215 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.8 m -65.17 121.94 15.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.146 1.378 . . . . 0.0 110.045 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -145.52 142.86 29.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.656 1.583 . . . . 0.0 109.317 -172.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.66 -9.8 58.93 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.291 0.636 . . . . 0.0 112.61 -177.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 28.4 p -76.01 8.6 3.05 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.949 1.699 . . . . 0.0 114.722 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.1 mt -121.52 122.27 66.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 127.627 2.371 . . . . 0.0 108.662 -172.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 8.78 80.36 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 124.394 0.997 . . . . 0.0 114.951 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -76.23 -14.33 60.14 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.519 1.528 . . . . 0.0 114.224 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -118.59 138.3 52.66 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.318 1.847 . . . . 0.0 110.337 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.54 31.81 35.89 Favored Glycine 0 CA--C 1.531 1.063 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.717 -169.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 22.8 t -133.96 172.57 12.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.706 1.603 . . . . 0.0 111.442 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -127.77 17.69 6.82 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.303 1.841 . . . . 0.0 111.078 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -78.45 77.85 4.93 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.6 -1.313 . . . . 0.0 112.685 -172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -67.13 136.21 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.833 1.253 . . . . 0.0 111.049 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.23 173.76 50.32 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.445 1.498 . . . . 0.0 114.152 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.37 175.43 8.62 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.245 3.297 . . . . 0.0 112.661 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.8 123.0 11.99 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.692 1.197 . . . . 0.0 111.935 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.77 -6.4 70.25 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.772 1.177 . . . . 0.0 114.682 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -102.97 -1.93 28.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.151 1.38 . . . . 0.0 114.024 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -109.63 138.97 45.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.377 1.471 . . . . 0.0 111.913 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 84.1 mt -128.07 144.93 51.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.738 1.615 . . . . 0.0 112.737 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -110.32 128.71 55.68 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.068 2.147 . . . . 0.0 108.739 169.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.19 137.42 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.231 2.212 . . . . 0.0 107.266 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -145.89 155.08 42.63 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 112.05 -175.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 78.38 26.02 0.56 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 128.151 2.58 . . . . 0.0 112.926 -172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.31 166.09 15.04 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.413 1.485 . . . . 0.0 112.263 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -61.1 150.0 86.48 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.588 2.858 . . . . 0.0 111.778 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.51 3.32 7.83 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.66 1.184 . . . . 0.0 113.171 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.65 9.15 4.61 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.534 1.934 . . . . 0.0 113.255 -178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.1 133.53 47.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.3 1.04 . . . . 0.0 111.51 -176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.11 166.53 22.29 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.747 1.165 . . . . 0.0 113.538 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -63.02 -33.36 75.25 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.046 0.938 . . . . 0.0 112.414 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -75.7 -25.98 57.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.373 1.469 . . . . 0.0 112.809 175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -73.33 -42.12 62.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 119.273 0.942 . . . . 0.0 110.501 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 21.0 tp -67.53 -34.47 77.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.533 0.733 . . . . 0.0 112.032 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.96 -55.89 27.56 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.132 0.573 . . . . 0.0 111.266 171.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.679 0.792 . . . . 0.0 112.781 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 37.9 ttm -66.82 -32.28 73.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.573 1.149 . . . . 0.0 112.87 174.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -106.74 -6.17 18.0 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -174.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 56.8 mtt -43.66 -46.27 18.23 Favored Pre-proline 0 N--CA 1.48 1.072 0 N-CA-C 116.851 2.167 . . . . 0.0 116.851 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.01 -6.07 16.99 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.347 2.032 . . . . 0.0 115.332 -168.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -97.05 -2.0 44.23 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 141.48 -167.26 25.89 Favored Glycine 0 N--CA 1.47 0.964 0 C-N-CA 125.238 1.399 . . . . 0.0 114.256 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -73.81 90.53 1.89 Allowed 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.964 -0.727 . . . . 0.0 111.642 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.9 124.41 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.996 0.919 . . . . 0.0 108.879 170.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 70.9 t -84.78 -39.17 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.055 1.742 . . . . 0.0 110.265 175.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.6 p -162.81 165.07 25.8 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.697 0.799 . . . . 0.0 112.874 169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -150.94 144.15 24.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.069 1.348 . . . . 0.0 110.636 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 20.5 tttp -158.72 129.35 6.09 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.671 0.788 . . . . 0.0 112.309 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 45.0 t -87.16 137.5 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 168.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -78.33 113.68 16.53 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.565 0.697 . . . . 0.0 110.096 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 28.0 mm -108.61 126.5 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.623 1.569 . . . . 0.0 108.719 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -67.25 124.11 22.2 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.084 0.553 . . . . 0.0 111.106 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -62.35 -14.37 39.09 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -92.36 -27.06 17.77 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.757 1.223 . . . . 0.0 112.975 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 82.6 p -128.77 -15.59 4.35 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.117 1.367 . . . . 0.0 113.926 -173.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.4 t30 64.43 24.68 13.21 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.872 2.069 . . . . 0.0 113.538 -175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.9 mt -102.14 152.04 21.47 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.107 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 18.3 t -70.09 137.12 50.9 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.477 -0.764 . . . . 0.0 111.438 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -84.75 9.04 15.1 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.058 0.943 . . . . 0.0 112.831 173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 61.7 m 72.82 7.16 5.47 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.832 2.453 . . . . 0.0 114.133 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -121.05 151.7 39.5 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 0.0 111.203 169.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -155.0 -175.88 26.57 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.195 1.855 . . . . 0.0 112.685 -177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -146.8 150.86 36.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.787 1.235 . . . . 0.0 112.404 -169.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 89.6 t -145.24 137.82 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.052 1.341 . . . . 0.0 108.163 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.4 m -130.44 137.22 49.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.222 0.609 . . . . 0.0 112.377 176.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -106.58 171.91 7.1 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.53 1.932 . . . . 0.0 111.527 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -81.76 -6.67 59.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -155.65 159.14 31.86 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.158 1.383 . . . . 0.0 111.412 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.26 -18.98 8.23 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.629 2.219 . . . . 0.0 113.981 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.71 -38.34 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.758 1.163 . . . . 0.0 110.437 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.3 m -68.26 -37.08 80.38 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.824 0.738 . . . . 0.0 112.102 175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -65.35 -47.6 75.9 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.563 0.745 . . . . 0.0 112.004 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -59.29 -42.83 92.22 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.41 79.21 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.604 0.762 . . . . 0.0 112.395 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.54 -36.53 71.03 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.371 175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.48 -48.55 86.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 119.872 1.214 . . . . 0.0 109.76 171.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -66.0 -22.14 66.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.497 1.119 . . . . 0.0 113.142 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.7 m -98.01 -24.84 15.18 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 96.7 mmm -118.82 -16.62 9.29 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -169.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -70.53 113.35 7.56 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.024 1.284 . . . . 0.0 109.996 173.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.17 6.82 61.33 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.685 1.612 . . . . 0.0 114.466 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -59.77 121.05 10.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.661 1.731 . . . . 0.0 110.74 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -81.3 126.03 31.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.413 0.685 . . . . 0.0 109.962 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.89 133.83 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.979 1.312 . . . . 0.0 109.89 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 60.35 -119.9 20.52 Favored Glycine 0 CA--C 1.532 1.148 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 31.1 ttp -111.07 19.73 18.14 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.644 1.578 . . . . 0.0 112.283 175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -142.9 -174.32 4.14 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.635 1.574 . . . . 0.0 113.089 -169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -134.34 142.2 47.15 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.548 1.539 . . . . 0.0 111.814 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 80.0 mt -77.39 139.6 39.75 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.587 1.155 . . . . 0.0 112.78 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -97.31 131.24 44.19 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.4 t -140.12 136.16 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 119.106 0.866 . . . . 0.0 110.352 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -164.18 172.94 12.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.52 1.528 . . . . 0.0 110.915 -171.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.94 138.69 58.52 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 167.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -77.82 165.97 23.5 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.6 mtp-105 -68.86 143.93 54.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.874 0.87 . . . . 0.0 111.444 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 20.7 p -80.32 143.61 33.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.927 0.891 . . . . 0.0 111.416 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -131.04 4.76 4.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.49 171.08 12.85 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.176 1.39 . . . . 0.0 110.821 169.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.65 140.36 23.64 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.838 1.255 . . . . 0.0 112.318 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 30.5 t -165.51 139.3 4.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.068 2.147 . . . . 0.0 108.828 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -128.96 1.17 5.31 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -168.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.2 p -168.1 164.26 13.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.0 1.32 . . . . 0.0 112.438 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -171.64 168.7 41.82 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.943 1.258 . . . . 0.0 113.5 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.7 147.0 34.73 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.929 3.086 . . . . 0.0 111.562 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 93.4 p -165.06 162.85 20.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.461 1.504 . . . . 0.0 111.925 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 18.7 m -135.79 10.29 3.37 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.318 1.047 . . . . 0.0 113.712 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.257 0 C-N-CA 125.33 1.443 . . . . 0.0 112.999 -177.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.541 0 C4'-C3'-C2' 100.627 -2.073 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.287 1 O4'-C1'-N19 113.645 5.445 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.195 0 O4'-C1'-N19 110.768 2.568 . 0.053 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.567 0 P-O3'-C3' 124.286 3.822 . 0.422 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.027 1 O4'-C1'-N19 114.35 6.15 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.897 0 O4'-C1'-N19 111.205 3.005 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 75.1 p -164.47 166.43 20.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.395 1.478 . . . . 0.0 111.809 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.2 t -162.32 176.97 10.01 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.442 1.497 . . . . 0.0 111.127 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 105.93 -150.62 16.95 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.788 1.661 . . . . 0.0 112.58 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 22.0 m 70.2 9.67 7.09 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 126.15 1.78 . . . . 0.0 114.543 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 71.7 m -146.51 159.37 43.5 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.309 1.844 . . . . 0.0 111.326 -175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 98.31 -151.58 19.63 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.88 1.228 . . . . 0.0 112.892 -178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 49.6 tp -156.09 150.23 25.42 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.594 1.558 . . . . 0.0 110.86 -173.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.0 t -158.27 160.92 37.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.235 1.814 . . . . 0.0 110.809 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -93.13 -5.59 49.88 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.04 1.336 . . . . 0.0 112.655 175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.16 141.92 4.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.533 1.533 . . . . 0.0 111.069 -179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.7 t -65.78 149.86 49.47 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.645 -0.659 . . . . 0.0 111.602 168.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 45.6 mt -116.71 136.06 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.086 1.754 . . . . 0.0 109.084 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 85.44 16.94 63.24 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 123.746 0.689 . . . . 0.0 113.65 -170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -74.7 -16.15 60.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 114.719 -169.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.52 135.45 48.01 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.856 1.662 . . . . 0.0 110.72 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.27 30.86 39.96 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 123.645 0.641 . . . . 0.0 111.874 -169.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 27.6 t -145.96 156.51 43.56 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.545 1.538 . . . . 0.0 111.317 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -129.02 42.93 3.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.677 1.591 . . . . 0.0 111.344 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -73.66 78.52 1.52 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 122.014 0.911 . . . . 0.0 111.309 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -67.43 133.75 50.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.172 1.389 . . . . 0.0 110.237 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -87.13 -168.41 44.78 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.969 1.747 . . . . 0.0 114.116 -173.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.27 174.31 11.68 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.882 3.055 . . . . 0.0 112.445 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.88 123.15 14.07 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.463 1.105 . . . . 0.0 111.703 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.1 -1.01 89.42 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.712 1.149 . . . . 0.0 114.781 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -99.73 -2.12 36.05 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.135 1.468 . . . . 0.0 113.621 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -99.93 139.07 36.13 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.658 1.183 . . . . 0.0 111.065 174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 73.0 mt -119.55 146.03 45.85 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.685 1.594 . . . . 0.0 111.526 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -110.77 122.57 48.15 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.337 1.855 . . . . 0.0 108.055 168.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.51 137.51 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 127.31 2.244 . . . . 0.0 107.034 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -146.67 151.55 37.42 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.137 0.975 . . . . 0.0 111.611 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.274 94.8 m-70 78.45 31.47 0.36 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 128.346 2.659 . . . . 0.0 113.398 -172.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 33.6 mt -69.31 162.6 64.98 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 126.363 1.865 . . . . 0.0 112.126 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.85 152.85 67.3 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.91 3.074 . . . . 0.0 112.556 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -74.75 1.77 11.63 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.289 1.036 . . . . 0.0 113.731 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -126.92 8.65 6.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.948 1.699 . . . . 0.0 113.428 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -72.64 132.23 43.46 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.117 0.967 . . . . 0.0 111.098 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -98.34 167.49 22.51 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.558 1.075 . . . . 0.0 113.698 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -60.19 -35.21 74.86 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.36 1.064 . . . . 0.0 112.51 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -82.72 -19.55 37.78 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.051 0.94 . . . . 0.0 112.56 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.23 -43.96 60.37 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.311 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.33 -36.86 85.51 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.482 0.713 . . . . 0.0 111.715 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 53.5 tp -59.27 -56.49 21.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.02 0.928 . . . . 0.0 111.67 173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.2 -25.61 67.01 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.8 ttp -76.79 -24.02 52.85 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.921 0.888 . . . . 0.0 113.001 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.18 -11.59 15.57 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 26.4 mtt -43.9 -41.7 9.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 169.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -59.9 -17.08 41.97 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.58 2.854 . . . . 0.0 116.766 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -102.67 -0.39 31.85 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.7 -178.66 22.42 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.827 1.68 . . . . 0.0 112.83 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -71.6 108.44 4.97 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 122.041 -0.682 . . . . 0.0 110.896 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 97.9 t -80.3 114.44 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 87.1 t -73.8 -37.24 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 126.337 1.855 . . . . 0.0 110.336 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 89.4 p -162.17 155.78 20.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.772 1.229 . . . . 0.0 111.663 170.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -147.0 142.1 27.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.554 1.142 . . . . 0.0 109.961 174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -156.3 122.44 5.01 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 122.711 0.404 . . . . 0.0 111.294 -168.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.2 t -90.63 128.44 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.257 1.423 . . . . 0.0 107.477 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -73.48 120.35 18.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.728 0.775 . . . . 0.0 109.831 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 62.0 mt -129.4 132.95 66.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 126.218 1.807 . . . . 0.0 109.147 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -63.63 127.43 31.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.529 1.131 . . . . 0.0 111.527 -176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -70.41 -10.3 58.72 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -105.04 -38.99 6.38 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.749 1.22 . . . . 0.0 112.333 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 62.2 p -103.04 -16.04 15.91 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 43.0 t30 63.05 21.33 12.83 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.487 1.915 . . . . 0.0 113.749 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.79 143.49 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.9 1.28 . . . . 0.0 110.794 173.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 4.6 t -66.55 135.16 53.76 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.507 0.67 . . . . 0.0 110.75 171.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 19.0 mtpt -83.9 13.74 4.65 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.747 1.219 . . . . 0.0 112.852 175.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 76.3 m 75.63 1.73 3.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 128.124 2.57 . . . . 0.0 114.683 175.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -121.59 152.33 39.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.722 1.146 . . . . 0.0 111.962 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -157.64 -177.21 30.53 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.879 1.705 . . . . 0.0 112.775 -177.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -142.03 151.59 42.57 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.519 1.128 . . . . 0.0 112.471 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 87.4 t -141.48 129.22 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.591 1.157 . . . . 0.0 109.008 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 31.1 t -112.82 125.76 54.7 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.016 1.726 . . . . 0.0 110.566 -178.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -107.32 166.46 10.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.12 1.368 . . . . 0.0 112.372 174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.29 -13.29 60.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.407 1.083 . . . . 0.0 113.481 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -158.78 161.15 28.81 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 125.333 1.453 . . . . 0.0 111.563 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.76 -16.01 9.23 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.867 2.378 . . . . 0.0 114.308 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 45.2 t -75.23 -39.26 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.021 1.282 . . . . 0.0 110.251 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.7 m -65.05 -39.32 93.13 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.237 0.615 . . . . 0.0 111.945 173.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -62.93 -48.38 79.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.815 0.846 . . . . 0.0 112.099 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -60.57 -42.75 97.27 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.292 -0.88 . . . . 0.0 112.973 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.93 78.01 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.83 0.852 . . . . 0.0 112.401 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -71.79 -36.86 70.44 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 118.695 -0.669 . . . . 0.0 112.657 175.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -58.94 -48.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 119.921 1.237 . . . . 0.0 109.79 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -66.18 -20.12 66.04 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.587 1.155 . . . . 0.0 113.154 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 59.5 m -100.15 -24.43 14.58 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 98.1 mmm -118.26 -16.87 9.64 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -70.7 114.39 8.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 120.169 1.35 . . . . 0.0 110.221 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 94.14 3.26 63.67 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.772 1.654 . . . . 0.0 114.632 -171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -61.74 122.51 15.53 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 119.412 1.606 . . . . 0.0 110.91 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -79.05 132.19 36.53 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.983 0.513 . . . . 0.0 110.76 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -132.93 53.28 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.316 1.446 . . . . 0.0 110.363 -171.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 95.4 -127.63 9.21 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.633 1.587 . . . . 0.0 111.116 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -77.55 7.71 5.22 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.056 1.342 . . . . 0.0 114.262 -174.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -153.29 168.01 27.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.939 1.696 . . . . 0.0 112.819 -172.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -120.34 142.42 49.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.396 1.478 . . . . 0.0 111.733 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 78.2 mt -73.24 136.38 44.62 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.538 1.135 . . . . 0.0 112.575 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 53.5 tttm -97.35 121.61 39.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.501 1.52 . . . . 0.0 107.229 167.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.99 135.5 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.978 0.911 . . . . 0.0 109.511 -173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -164.22 173.39 12.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.441 1.497 . . . . 0.0 110.018 -168.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.74 144.54 56.95 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.794 0.807 . . . . 0.0 110.204 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 22.5 tttm -65.11 149.82 49.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.646 0.778 . . . . 0.0 111.007 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -145.2 -163.02 1.62 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.536 1.534 . . . . 0.0 109.858 169.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.6 m -131.99 161.99 31.81 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.958 0.903 . . . . 0.0 111.292 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -87.66 131.47 34.43 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.267 -0.896 . . . . 0.0 111.073 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -160.13 136.57 8.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.236 1.414 . . . . 0.0 110.647 -171.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -80.82 -11.98 59.51 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 54.2 m -124.77 0.91 8.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.427 1.491 . . . . 0.0 113.743 -173.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -139.1 133.44 31.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.271 1.428 . . . . 0.0 111.65 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.0 p -167.09 162.36 15.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.521 1.528 . . . . 0.0 111.48 -176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.89 -175.52 55.01 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 124.226 0.917 . . . . 0.0 113.713 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.25 149.28 35.47 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.85 3.033 . . . . 0.0 111.289 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.8 m -77.43 -4.59 46.15 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 t -164.97 169.15 16.76 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.267 1.827 . . . . 0.0 111.201 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.133 0 C-N-CA 125.405 1.479 . . . . 0.0 112.836 -178.67 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.788 0 C5'-C4'-O4' 106.369 -2.022 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.112 1 O4'-C1'-N19 114.071 5.871 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.425 0 O5'-C5'-C4' 114.976 3.412 . 0.391 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 0 P-O3'-C3' 123.587 3.239 . 0.406 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.109 1 O4'-C1'-N19 113.9 5.7 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.858 0 O4'-C1'-N19 111.472 3.272 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.531 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.3 m -65.41 150.4 48.39 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.375 1.07 . . . . 0.0 112.756 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 8.3 t -161.24 169.99 21.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.71 1.204 . . . . 0.0 111.7 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 71.41 -136.32 24.76 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.522 1.058 . . . . 0.0 111.351 -175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 84.0 p -82.96 -12.06 57.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 50.7 m 63.19 1.08 0.85 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.045 2.138 . . . . 0.0 114.591 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -90.71 -9.68 64.08 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.247 1.403 . . . . 0.0 114.726 -176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 92.9 mt -142.38 141.12 32.24 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.404 1.882 . . . . 0.0 110.04 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.6 p -147.81 155.51 41.74 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.426 1.89 . . . . 0.0 110.508 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -147.44 137.96 23.32 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.613 1.565 . . . . 0.0 108.601 178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -64.45 -23.76 67.39 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.546 -0.721 . . . . 0.0 112.083 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.6 p -67.1 -0.04 3.0 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 173.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 26.7 mt -128.85 -41.13 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 128.471 2.708 . . . . 0.0 110.909 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -88.37 -14.7 61.53 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 126.677 2.084 . . . . 0.0 116.196 -173.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -126.03 -8.09 6.57 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 118.738 1.269 . . . . 0.0 113.976 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.28 125.44 35.5 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.351 1.46 . . . . 0.0 112.794 -174.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 84.17 2.35 89.35 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.13 1.348 . . . . 0.0 113.285 -177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 42.0 t -91.3 143.84 26.22 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.2 1.4 . . . . 0.0 111.713 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.5 pm0 -105.79 33.5 3.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.559 1.144 . . . . 0.0 112.443 171.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -70.68 80.11 0.6 Allowed 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.042 -1.036 . . . . 0.0 110.7 169.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -60.56 139.93 57.58 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.251 1.42 . . . . 0.0 110.971 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.36 -174.69 50.21 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.469 1.509 . . . . 0.0 113.805 -177.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 174.4 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.157 3.238 . . . . 0.0 112.525 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -56.92 124.97 20.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.695 1.198 . . . . 0.0 111.92 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 82.16 -4.69 75.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.84 1.209 . . . . 0.0 114.718 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -96.92 -2.32 44.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 118.838 1.319 . . . . 0.0 113.866 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -101.02 123.62 45.48 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.713 1.205 . . . . 0.0 111.428 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 39.5 mt -107.89 149.15 28.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.278 1.431 . . . . 0.0 112.127 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -116.28 129.62 56.37 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.601 1.96 . . . . 0.0 108.537 168.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.28 135.86 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 127.094 2.157 . . . . 0.0 107.928 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -138.43 148.79 44.8 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.384 1.474 . . . . 0.0 111.367 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . 0.257 93.4 m-70 89.42 20.45 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 130.076 3.35 . . . . 0.0 114.12 -174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 58.0 mt -64.36 157.22 72.79 Favored Pre-proline 0 CA--C 1.549 0.905 0 O-C-N 121.228 -0.92 . . . . 0.0 111.318 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.82 152.01 30.41 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.669 2.913 . . . . 0.0 113.108 169.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -69.34 1.34 3.92 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.294 1.438 . . . . 0.0 113.365 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -136.31 9.55 3.2 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.4 1.88 . . . . 0.0 113.336 -175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.39 134.13 50.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.869 0.868 . . . . 0.0 111.892 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -89.66 164.72 31.76 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.301 0.953 . . . . 0.0 113.217 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -67.24 -34.75 78.11 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.784 0.834 . . . . 0.0 112.41 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -72.39 -31.56 65.65 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.755 1.222 . . . . 0.0 111.513 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -68.41 -38.5 81.32 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.523 0.729 . . . . 0.0 111.323 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.9 tp -67.62 -41.81 83.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.21 0.604 . . . . 0.0 111.65 172.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.64 -56.91 15.68 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.471 0.709 . . . . 0.0 112.153 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.21 -18.49 65.38 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.58 0.627 . . . . 0.0 112.475 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.6 ttp -81.43 -28.59 34.17 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.984 1.314 . . . . 0.0 113.198 174.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -101.04 -20.94 15.16 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.641 1.576 . . . . 0.0 114.503 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 19.0 mmm -49.36 -37.64 23.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.34 -17.95 13.34 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.064 3.176 . . . . 0.0 116.405 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -99.99 -2.12 35.35 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -174.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 143.5 -173.11 24.6 Favored Glycine 0 C--N 1.344 0.977 0 C-N-CA 124.97 1.271 . . . . 0.0 114.863 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -71.93 110.23 6.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.063 0.945 . . . . 0.0 111.885 -175.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.4 t -92.15 127.9 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.27 1.428 . . . . 0.0 109.664 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 86.9 t -91.01 -33.36 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 126.326 1.85 . . . . 0.0 111.332 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 84.6 p -156.93 151.2 25.16 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.458 1.103 . . . . 0.0 111.659 173.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.81 134.31 20.87 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.791 1.236 . . . . 0.0 109.885 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -154.29 123.32 6.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.972 0.509 . . . . 0.0 111.845 -171.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 59.3 t -89.51 135.93 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 169.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -78.04 114.92 17.37 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.289 0.566 . . . . 0.0 110.058 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.4 mm -108.24 127.1 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.199 1.4 . . . . 0.0 109.146 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -70.0 124.23 23.53 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.304 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -61.16 -15.1 30.1 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -90.3 -27.92 19.11 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.608 1.163 . . . . 0.0 112.925 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 72.6 p -133.01 -13.63 2.77 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 63.69 19.74 11.88 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.222 1.809 . . . . 0.0 113.428 -174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 97.8 mt -90.79 151.12 21.31 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.272 1.429 . . . . 0.0 111.063 173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.3 t -71.58 136.96 47.66 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.602 -0.686 . . . . 0.0 110.481 169.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -82.25 17.17 1.74 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.989 0.916 . . . . 0.0 113.213 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.7 m 70.37 12.67 7.53 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.102 2.161 . . . . 0.0 113.82 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -137.12 150.9 48.28 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.455 1.102 . . . . 0.0 112.353 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -159.5 -177.55 32.7 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.725 1.155 . . . . 0.0 113.996 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -139.06 147.04 41.52 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.71 1.604 . . . . 0.0 111.379 -169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 95.1 t -140.28 125.74 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.544 1.138 . . . . 0.0 108.506 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 66.9 m -113.4 114.27 26.37 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.797 1.239 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -86.9 165.91 15.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.984 0.914 . . . . 0.0 112.598 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -73.88 -12.6 60.72 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.49 1.116 . . . . 0.0 112.984 172.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -158.09 161.13 29.33 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.619 1.568 . . . . 0.0 111.611 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.14 -17.78 9.05 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.91 2.407 . . . . 0.0 114.265 -174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.7 t -74.17 -38.89 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.88 1.218 . . . . 0.0 110.32 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 49.5 m -65.39 -38.95 91.52 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.758 -0.588 . . . . 0.0 112.089 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.06 75.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.888 0.875 . . . . 0.0 112.105 173.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -58.31 -43.82 88.3 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.885 0.874 . . . . 0.0 112.913 174.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.5 -35.86 78.86 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.714 0.806 . . . . 0.0 112.557 174.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.37 -35.58 68.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.619 -0.705 . . . . 0.0 112.786 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.03 -47.97 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 CA-C-N 120.018 1.281 . . . . 0.0 109.658 171.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -66.62 -20.54 66.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.629 1.172 . . . . 0.0 113.212 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 56.6 m -100.08 -25.92 14.13 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 97.5 mmm -114.76 -18.03 11.46 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 -170.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -69.97 110.34 5.0 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.893 1.224 . . . . 0.0 109.873 172.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 99.01 3.62 56.84 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 125.872 1.701 . . . . 0.0 114.675 -171.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -65.19 123.57 19.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.747 1.774 . . . . 0.0 110.549 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -86.3 131.25 34.26 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.365 0.529 . . . . 0.0 111.276 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.3 tt -147.07 129.93 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.076 1.35 . . . . 0.0 110.394 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.32 -71.8 0.79 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.877 1.227 . . . . 0.0 112.69 -175.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 28.4 ptm -161.77 5.77 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.028 2.131 . . . . 0.0 114.462 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -149.28 173.2 13.75 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.164 1.386 . . . . 0.0 112.356 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -111.04 134.37 52.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.918 0.887 . . . . 0.0 112.491 -169.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.55 130.46 42.49 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.878 1.271 . . . . 0.0 112.314 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.1 122.89 34.14 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 168.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.3 t -138.82 135.87 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.939 0.896 . . . . 0.0 110.241 -173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -163.74 175.14 10.81 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.153 1.381 . . . . 0.0 110.92 -172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.59 145.47 56.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.507 0.67 . . . . 0.0 109.836 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.98 152.29 40.46 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.407 1.083 . . . . 0.0 113.287 -177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -57.51 133.94 55.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.012 1.325 . . . . 0.0 111.123 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 72.0 m -148.9 141.36 24.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.645 1.578 . . . . 0.0 110.368 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -72.49 134.36 45.27 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.517 -0.74 . . . . 0.0 111.693 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -165.2 -38.38 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.019 1.328 . . . . 0.0 113.103 -178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.2 148.44 16.79 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.468 1.507 . . . . 0.0 111.132 -175.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.4 t -164.28 169.2 17.84 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.482 1.513 . . . . 0.0 111.364 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -155.69 -45.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.104 1.362 . . . . 0.0 112.94 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 57.3 p -170.37 166.6 8.55 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.545 1.538 . . . . 0.0 111.611 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -162.32 172.01 38.33 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 124.748 1.165 . . . . 0.0 113.701 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.32 156.05 46.18 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.05 3.167 . . . . 0.0 111.88 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 25.0 m -158.91 144.8 16.59 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.269 1.828 . . . . 0.0 110.735 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 50.6 p -92.54 -6.32 49.89 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 C-N-CA 125.484 1.516 . . . . 0.0 112.857 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.338 0 O4'-C1'-N19 110.86 2.66 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.302 1 O4'-C1'-N19 113.713 5.513 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.407 0 O5'-C5'-C4' 113.043 2.031 . 0.249 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 C5'-C4'-O4' 113.319 2.942 . 0.388 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.139 1 O4'-C1'-N19 113.487 5.287 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.46 0 O4'-C1'-N19 111.527 3.327 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.8 p -166.14 179.54 5.68 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.677 1.591 . . . . 0.0 111.359 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.6 m -71.24 -5.21 30.36 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.847 -1.158 . . . . 0.0 113.991 173.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 83.72 174.86 50.64 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.285 1.421 . . . . 0.0 113.589 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 21.9 m -86.74 -2.32 58.45 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 37.1 m -69.65 138.05 52.69 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.005 1.322 . . . . 0.0 113.05 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -78.94 67.06 3.3 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.125 1.345 . . . . 0.0 112.971 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.5 7.22 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.396 1.479 . . . . 0.0 114.347 -175.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.5 p -76.67 -12.98 60.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.495 1.518 . . . . 0.0 113.579 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -159.61 149.94 18.98 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.606 1.962 . . . . 0.0 108.726 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -77.92 144.05 37.19 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.724 -0.61 . . . . 0.0 110.03 169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 47.7 m -67.22 139.78 57.4 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.336 -0.853 . . . . 0.0 111.499 168.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 65.1 mt -96.43 104.41 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.108 0.963 . . . . 0.0 109.408 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -154.5 32.29 0.7 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.966 1.746 . . . . 0.0 113.111 177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -116.67 -8.4 11.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.661 1.584 . . . . 0.0 115.054 -168.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -73.04 120.29 18.47 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.799 1.239 . . . . 0.0 113.874 -169.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 76.62 -0.28 65.54 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.496 1.522 . . . . 0.0 113.751 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.1 m -75.77 151.16 37.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.171 . . . . 0.0 111.988 -173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.09 22.07 16.29 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.62 1.168 . . . . 0.0 112.107 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -76.37 81.41 3.11 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.072 -1.017 . . . . 0.0 111.468 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.1 141.23 50.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.805 1.642 . . . . 0.0 111.553 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -85.38 -178.32 50.62 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.261 1.41 . . . . 0.0 113.03 175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.75 176.01 8.12 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.981 3.121 . . . . 0.0 112.342 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -56.45 123.33 14.36 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.275 1.03 . . . . 0.0 111.783 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 84.53 -5.22 82.15 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.89 1.233 . . . . 0.0 114.774 -178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.043 1.422 . . . . 0.0 114.049 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 129.1 49.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.716 1.206 . . . . 0.0 111.338 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 63.2 mt -116.81 145.4 43.55 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.973 1.709 . . . . 0.0 111.735 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -111.89 126.42 55.09 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.706 2.002 . . . . 0.0 108.791 169.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 2.1 mp -115.89 138.16 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 127.022 2.129 . . . . 0.0 108.188 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -142.16 152.69 43.42 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.876 1.671 . . . . 0.0 111.105 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 79.76 24.32 0.43 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.721 2.808 . . . . 0.0 114.117 -174.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.05 158.4 63.34 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 120.97 -1.082 . . . . 0.0 111.773 172.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -56.1 148.76 57.22 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.241 2.628 . . . . 0.0 111.582 168.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.45 6.08 4.06 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.858 0.863 . . . . 0.0 113.211 -177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -131.86 8.53 4.48 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.811 2.044 . . . . 0.0 113.013 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.06 132.83 47.24 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.328 1.051 . . . . 0.0 111.647 -175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -90.77 165.21 30.64 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.359 0.981 . . . . 0.0 113.129 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -65.8 -33.03 74.92 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.768 0.827 . . . . 0.0 112.53 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.57 -26.65 55.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.853 0.861 . . . . 0.0 112.03 175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -69.73 -40.22 76.33 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.189 0.904 . . . . 0.0 110.699 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 20.8 tp -65.75 -35.77 81.67 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.658 0.783 . . . . 0.0 111.729 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 50.9 tp -65.67 -52.31 52.58 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.669 -0.645 . . . . 0.0 111.731 173.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -63.01 -26.19 68.74 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.751 0.705 . . . . 0.0 112.564 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 42.1 ttm -70.72 -38.71 73.62 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.701 1.2 . . . . 0.0 112.729 173.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -102.93 -20.67 14.16 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -171.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 45.2 mtm -51.04 -37.58 36.12 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.38 -15.75 6.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 124.226 3.284 . . . . 0.0 116.77 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -106.86 -0.48 23.28 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 144.94 -175.85 24.33 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.949 1.261 . . . . 0.0 114.78 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -73.02 109.53 6.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.4 t -90.39 123.54 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.949 1.699 . . . . 0.0 109.429 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 59.2 t -87.59 -31.97 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.657 1.983 . . . . 0.0 111.275 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 82.9 p -158.29 148.9 20.41 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.635 1.174 . . . . 0.0 111.726 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -141.28 126.25 18.25 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.812 1.645 . . . . 0.0 108.67 176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -144.45 106.59 4.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.552 0.741 . . . . 0.0 111.823 -168.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 58.1 t -79.3 133.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -86.54 124.72 33.16 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.516 1.126 . . . . 0.0 110.418 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 27.6 mm -119.32 142.08 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.994 1.718 . . . . 0.0 109.963 -170.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -68.18 122.83 19.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.967 0.907 . . . . 0.0 111.945 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -68.38 -9.13 46.06 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -99.38 -31.27 11.76 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.884 1.273 . . . . 0.0 112.622 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.3 p -132.97 -7.54 3.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 55.0 t30 66.61 18.69 10.8 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.188 1.795 . . . . 0.0 113.873 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.41 147.65 22.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.079 1.352 . . . . 0.0 111.042 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 33.3 t -65.62 140.47 58.51 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.163 -0.96 . . . . 0.0 112.107 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -83.31 5.49 23.05 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 171.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 71.8 m 66.76 20.28 10.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.091 1.756 . . . . 0.0 113.193 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -143.07 160.9 39.52 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.081 1.353 . . . . 0.0 111.971 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -173.05 -171.72 37.99 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.024 0.821 . . . . 0.0 114.68 -177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -126.54 149.66 49.27 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.867 1.667 . . . . 0.0 112.118 -174.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 79.8 t -138.81 127.28 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.668 1.187 . . . . 0.0 108.506 169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 68.1 m -117.62 119.61 35.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.097 0.959 . . . . 0.0 111.047 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -90.35 169.42 11.1 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.39 1.076 . . . . 0.0 112.16 172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -81.98 -3.65 54.89 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 171.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -158.83 159.12 29.6 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.213 1.405 . . . . 0.0 111.76 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.29 -18.73 8.34 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.864 2.376 . . . . 0.0 114.18 -174.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 44.6 t -73.75 -37.63 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 119.825 1.193 . . . . 0.0 110.318 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 67.4 m -66.95 -38.37 86.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.786 0.721 . . . . 0.0 112.086 174.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.52 76.68 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.738 0.815 . . . . 0.0 112.116 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -59.48 -43.83 93.2 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.836 0.855 . . . . 0.0 112.668 175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.05 77.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.705 0.802 . . . . 0.0 112.543 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -73.69 -34.6 64.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 118.648 -0.692 . . . . 0.0 112.68 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.8 mt -58.9 -48.48 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 119.894 1.224 . . . . 0.0 109.658 170.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.78 -20.59 65.98 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.52 1.128 . . . . 0.0 113.183 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.0 m -99.98 -26.73 13.89 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.8 mmm -116.38 -18.93 10.34 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -71.18 110.46 5.86 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.803 1.183 . . . . 0.0 109.895 173.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 96.93 5.82 58.29 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.915 1.721 . . . . 0.0 114.658 -171.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -62.55 128.15 34.64 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.788 1.794 . . . . 0.0 110.312 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -88.54 121.63 31.13 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.73 0.695 . . . . 0.0 110.115 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 15.6 tt -117.13 109.41 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.105 0.962 . . . . 0.0 108.477 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 68.41 -100.44 0.66 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -168.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 77.0 mtm -123.46 1.87 8.99 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.553 1.541 . . . . 0.0 113.101 172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -91.69 128.89 37.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.467 1.107 . . . . 0.0 111.147 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -90.75 116.32 28.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.771 0.828 . . . . 0.0 109.583 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.26 135.48 50.55 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.137 0.975 . . . . 0.0 111.795 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.4 tttp -104.89 120.19 40.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.476 1.91 . . . . 0.0 107.762 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.89 124.66 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.95 0.9 . . . . 0.0 109.789 -171.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -149.74 167.55 26.16 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.293 1.437 . . . . 0.0 110.073 -171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.3 142.7 56.68 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.893 -0.505 . . . . 0.0 109.767 169.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -59.4 144.1 47.78 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.739 0.816 . . . . 0.0 112.98 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.6 -124.82 2.21 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.111 1.364 . . . . 0.0 110.209 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 35.1 t -160.39 163.09 33.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.173 1.789 . . . . 0.0 110.513 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -85.33 -11.06 55.52 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.151 0.98 . . . . 0.0 113.249 169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.59 127.96 34.34 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.725 1.21 . . . . 0.0 111.978 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -151.63 1.79 0.38 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.919 1.288 . . . . 0.0 113.615 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 84.7 p -171.76 162.64 6.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.649 1.58 . . . . 0.0 111.83 -172.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -71.58 -28.32 63.75 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.302 -0.874 . . . . 0.0 113.032 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 8.6 t -168.28 162.18 12.54 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.762 2.025 . . . . 0.0 110.566 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -81.39 170.97 52.84 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 124.42 1.009 . . . . 0.0 113.708 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -72.21 118.53 5.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.724 2.95 . . . . 0.0 110.583 -178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 50.5 m 66.01 -9.49 0.28 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.21 2.204 . . . . 0.0 115.394 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 14.9 t -168.48 153.64 6.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.921 2.088 . . . . 0.0 110.649 -177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 C-N-CA 125.322 1.439 . . . . 0.0 113.031 -177.029 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.47 0 C5'-C4'-C3' 112.306 -2.129 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.491 1 O4'-C1'-N19 114.063 5.863 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.278 0 O5'-C5'-C4' 113.494 2.353 . 0.413 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.542 2.485 0 O5'-C5'-C4' 113.66 2.472 . 0.409 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.428 -2.084 1 O4'-C1'-N19 113.758 5.558 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.496 0 C4'-C3'-C2' 100.739 -1.961 . 0.35 2a . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.57 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 40.7 t -163.42 149.92 12.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.142 1.377 . . . . 0.0 111.278 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 16.5 m -81.6 -5.1 57.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.447 1.099 . . . . 0.0 113.344 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 93.52 -176.44 36.76 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.345 1.45 . . . . 0.0 113.36 -176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 46.4 p -92.12 0.88 57.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.07 1.348 . . . . 0.0 114.532 -173.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.8 p -160.65 171.05 19.6 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.403 1.481 . . . . 0.0 112.402 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 96.93 -163.13 22.22 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.005 1.288 . . . . 0.0 113.624 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.4 179.34 6.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.629 1.972 . . . . 0.0 111.113 -175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 33.7 p -67.91 168.82 10.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.166 1.787 . . . . 0.0 112.148 175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -152.02 152.06 31.94 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.712 1.605 . . . . 0.0 109.274 -177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -155.52 156.43 35.17 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.383 1.073 . . . . 0.0 111.777 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 19.2 m -88.07 19.41 3.66 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 113.686 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 24.6 mt -129.68 123.7 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.417 1.887 . . . . 0.0 109.325 -171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -75.03 -33.24 55.32 Favored Glycine 0 N--CA 1.475 1.26 0 C-N-CA 124.02 0.819 . . . . 0.0 113.384 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . 65.46 -30.27 0.13 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.175 2.99 . . . . 0.0 117.997 168.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -67.99 126.58 29.92 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -168.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 80.77 -2.08 81.02 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.94 1.733 . . . . 0.0 113.753 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 29.1 t -74.15 131.99 41.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.123 0.961 . . . . 0.0 111.799 -173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.68 0.54 26.2 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.851 2.061 . . . . 0.0 111.774 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -66.7 142.42 57.42 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.791 -1.193 . . . . 0.0 112.14 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -125.58 141.87 51.81 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.831 1.252 . . . . 0.0 110.092 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -95.11 -168.51 36.12 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 126.788 2.137 . . . . 0.0 113.809 -175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.64 170.38 19.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.706 2.937 . . . . 0.0 112.394 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.88 125.35 22.66 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.97 0.908 . . . . 0.0 111.588 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.19 -3.84 86.55 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.675 1.131 . . . . 0.0 114.599 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -97.83 -3.58 38.48 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.088 1.444 . . . . 0.0 114.242 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -103.18 126.51 50.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.786 1.234 . . . . 0.0 110.839 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 54.6 mt -114.8 141.57 47.7 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.375 1.47 . . . . 0.0 111.816 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -105.8 128.29 53.64 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.019 2.128 . . . . 0.0 108.238 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -119.77 137.1 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 127.033 2.133 . . . . 0.0 107.477 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -150.18 150.97 32.35 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.005 0.922 . . . . 0.0 111.781 -170.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 81.02 25.94 0.24 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.503 2.721 . . . . 0.0 112.774 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.29 158.8 54.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 125.237 1.415 . . . . 0.0 112.345 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.95 152.71 41.96 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.382 2.722 . . . . 0.0 111.741 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -72.14 -20.52 61.6 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.687 0.795 . . . . 0.0 112.803 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.67 7.91 28.76 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.337 1.855 . . . . 0.0 113.908 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.04 131.36 45.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.999 0.919 . . . . 0.0 112.176 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -96.76 170.02 26.19 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.866 1.222 . . . . 0.0 113.492 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -64.95 -34.9 79.52 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.042 0.937 . . . . 0.0 112.587 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -75.55 -27.57 58.7 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.379 1.472 . . . . 0.0 112.478 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -69.52 -41.35 76.14 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.071 0.85 . . . . 0.0 110.569 174.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.54 -35.62 80.68 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.742 0.817 . . . . 0.0 111.916 174.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 60.6 tp -64.38 -54.75 27.94 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.777 -0.577 . . . . 0.0 112.018 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 59.3 mm-40 -65.09 -24.7 67.51 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 118.904 0.774 . . . . 0.0 112.441 -177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 38.5 ttm -68.07 -39.08 83.04 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.978 1.311 . . . . 0.0 112.979 170.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -100.86 -10.29 20.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . . . . . . . . . 6.3 mmt -40.57 -49.46 7.05 Favored Pre-proline 0 N--CA 1.479 0.994 0 N-CA-C 116.639 2.089 . . . . 0.0 116.639 171.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.47 -4.73 15.92 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.272 1.981 . . . . 0.0 115.123 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -99.07 -4.14 33.06 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.301 1.04 . . . . 0.0 113.797 -176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 145.79 -175.91 25.05 Favored Glycine 0 N--CA 1.473 1.142 0 C-N-CA 125.128 1.347 . . . . 0.0 114.687 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.89 112.95 8.42 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.798 0.839 . . . . 0.0 111.614 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.01 120.58 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.33 1.452 . . . . 0.0 109.66 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.6 t -82.61 -29.84 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 126.717 2.007 . . . . 0.0 111.613 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 91.4 p -165.5 149.06 8.11 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.229 1.412 . . . . 0.0 110.259 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -146.47 126.78 13.94 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.8 1.24 . . . . 0.0 109.463 178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -152.46 119.0 5.64 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.865 0.466 . . . . 0.0 112.128 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.0 t -82.04 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 168.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -75.77 121.58 22.77 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.46 0.647 . . . . 0.0 109.874 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.55 132.71 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.031 1.333 . . . . 0.0 109.675 -169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -61.5 132.21 52.65 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.193 1.397 . . . . 0.0 113.042 -172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -69.31 -11.19 60.6 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -113.24 -43.59 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.88 1.272 . . . . 0.0 112.091 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 69.5 p -98.98 -14.65 19.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 60.76 24.14 14.04 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.84 1.656 . . . . 0.0 113.361 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.8 mt -89.24 142.05 27.99 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.943 1.297 . . . . 0.0 110.887 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 28.2 t -66.32 138.97 57.99 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.549 0.69 . . . . 0.0 111.286 169.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -86.58 7.65 25.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.787 0.835 . . . . 0.0 113.074 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 87.1 m 62.75 15.46 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.108 1.763 . . . . 0.0 113.832 -175.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -128.95 151.36 49.76 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.45 1.5 . . . . 0.0 110.47 169.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -158.15 -172.32 25.16 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 126.09 1.805 . . . . 0.0 112.344 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -145.58 151.65 38.46 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 124.063 0.945 . . . . 0.0 112.861 -169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 86.7 t -141.24 129.97 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.861 1.265 . . . . 0.0 108.343 173.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.0 t -113.9 135.87 53.51 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.915 0.886 . . . . 0.0 111.457 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.61 165.53 11.35 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.01 1.324 . . . . 0.0 112.518 175.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.64 -10.33 59.43 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.857 0.863 . . . . 0.0 113.092 174.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.22 161.18 29.87 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 125.455 1.502 . . . . 0.0 111.475 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -81.63 -16.89 8.92 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.844 2.363 . . . . 0.0 114.259 -175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.24 -38.91 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.969 1.258 . . . . 0.0 110.315 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 58.6 m -64.25 -40.08 95.26 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.293 0.637 . . . . 0.0 111.998 173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -64.11 -47.51 79.72 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.687 0.795 . . . . 0.0 112.239 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -59.91 -43.47 94.86 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.76 0.824 . . . . 0.0 112.81 175.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -61.62 -35.17 77.12 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.741 0.816 . . . . 0.0 112.453 174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.38 69.34 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 118.632 -0.699 . . . . 0.0 112.471 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 97.0 mt -58.45 -47.97 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 120.084 1.311 . . . . 0.0 109.933 172.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -66.0 -20.06 66.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.557 1.143 . . . . 0.0 113.19 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 58.3 m -100.21 -23.74 14.74 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 93.7 mmm -119.37 -17.31 8.83 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.475 1.658 . . . . 0.0 115.475 -168.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -70.82 111.98 6.67 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.859 1.209 . . . . 0.0 110.147 174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 95.34 8.11 58.89 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.103 1.811 . . . . 0.0 114.542 -171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -61.37 121.83 13.62 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.71 1.755 . . . . 0.0 110.429 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -86.43 130.57 34.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 -178.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.38 127.21 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 125.088 1.355 . . . . 0.0 109.815 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.28 -103.01 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 -169.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -132.97 18.28 4.14 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.113 1.765 . . . . 0.0 112.279 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -142.58 167.39 22.2 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.838 1.655 . . . . 0.0 112.464 -174.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -120.59 133.25 55.4 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.124 0.97 . . . . 0.0 112.157 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 69.0 mt -71.05 133.08 46.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.679 1.192 . . . . 0.0 111.866 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -98.02 129.12 44.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 168.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.8 130.53 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.326 1.05 . . . . 0.0 109.97 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.34 174.0 13.38 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.579 1.152 . . . . 0.0 111.702 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . . . . . . . . . 98.4 mt -60.68 144.5 51.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.918 0.887 . . . . 0.0 111.168 174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -63.36 149.23 46.3 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.254 0.622 . . . . 0.0 112.486 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -60.46 148.33 37.96 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.611 -0.681 . . . . 0.0 110.876 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 32.1 t -162.89 -46.38 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -156.56 155.0 31.16 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -164.85 149.04 9.02 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.418 1.887 . . . . 0.0 110.695 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -159.72 116.41 2.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 110.988 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 20.2 m -70.64 -11.37 60.9 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.173 . . . . 0.0 113.882 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? 42.27 -130.79 0.56 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.098 2.159 . . . . 0.0 114.067 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.4 m -78.5 0.14 27.21 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.904 1.281 . . . . 0.0 114.411 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 78.48 -162.11 49.0 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 124.328 0.966 . . . . 0.0 112.9 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.3 158.96 47.85 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.729 2.952 . . . . 0.0 111.59 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 54.3 p -79.94 -3.15 46.98 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 9.6 t -163.5 161.63 24.21 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.158 1.783 . . . . 0.0 111.175 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 125.26 1.41 . . . . 0.0 112.852 -178.011 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 491' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 C4'-C3'-C2' 100.546 -2.154 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 492' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.121 1 O4'-C1'-N19 114.16 5.96 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 493' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.372 0 C4'-C3'-C2' 100.465 -2.235 . 0.594 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 494' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.283 0 O4'-C1'-N19 111.958 3.758 . 0.452 '#a' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 495' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.009 1 O4'-C1'-N19 113.117 4.917 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 496' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.552 0 O4'-C1'-N19 111.246 3.046 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_